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Abstract 
Escherichia coli is a Gram-negative, metabolically versatile facultative anaerobe, which 
utilises either fermentation, anaerobic respiration or aerobic respiration for energy 
generation and growth.  Trimethylamine-N-oxide (TMAO) is used by E. coli as an alternative 
terminal electron acceptor, being reduced to trimethylamine (TMA).  Although the regulation 
and operation of the E. coli TMAO respiratory chain (TorCAD) are well characterised, there is 
no understanding of the dynamic adaptive processes that occur in E. coli during transition 
from fermentative to TMAO-respiratory growth.  Here, glucose-limited chemostat cultures 
were used to study these adaptive processes.  Analyses of the transcriptional and metabolic 
changes occurring when E. coli K-12 responds to TMAO revealed a number of unexpected 
components of the adaptive process.  Firstly, it was found that growth on a sub-optimal 
concentration of TMAO resulted in mixed metabolism, with two distinct sub-populations of 
cells that either activate or do not activate the transcription of the torCAD operon in 
response to TMAO.  DNA methylation was found to contribute to this regulation in response 
to low concentrations of TMAO.  Secondly, it was found that E. coli possesses TMAO 
demethylase activity, as both the products of this activity, dimethylamine and formaldehyde 
and the induction of the frmRAB operon was detected when cells were grown in the presence 
of TMAO.  Work was carried out to characterise the regulator protein, FrmR, of the frmRAB 
operon.  Here, it is shown that the FrmR transcriptional repressor specifically reacts with 
formaldehyde, resulting in the formation of two inter-molecular methylene bridges between 
the N-terminal Pro2 and Cys35 residues of adjacent FrmR subunits, leading to alleviation of 
repression.  It was also shown that growth yield was higher in the presence of TMAO under 
aerobic conditions eventhough TMAO reduction to TMA was not detected. Futhermore, the 
nitrate response regulator NarL does not directly regulate the torCAD operon.  
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1. Introduction 
1.1. The metabolic modes of Escherichia coli 
Escherichia coli is a Gram-negative, metabolically versatile facultative anaerobe, which is 
able to utilise different metabolic pathways to generate energy and promote growth.  These 
pathways differ fundamentally in terms of the mechanism of ATP synthesis and redox 
considerations.   The metabolic versatility of E. coli means that the bacterium is well adapted 
to ensure survival and reproduction in the gastrointestinal tract of a suitable host (Ingledew 
and Poole, 1984).  Certain pathogenic strains, such as uropathogenic E. coli (UPECs), are able 
to survive in other tissues and locations (Slonczewski and Foster, 2009).  Escherichia coli can 
thrive on low concentrations of a relatively limited number of low molecular mass 
compounds, sometimes only available transiently.  Through adaptation, there are three 
metabolic modes available to E. coli, aerobic respiration, anaerobic respiration and 
fermentation (summarised in Figure 1.1).   
The redox energy provided by substrate oxidation is conserved by oxido-reduction systems 
that require one or more terminal electron acceptors of higher redox potential than the 
donor.  When molecular oxygen is available, pre-eminent amongst these electron acceptor 
reactions is the four-electron reduction of oxygen to water.  Maximal energy is generated 
under aerobic conditions when, via the citric acid cycle, pyruvate is oxidised to carbon 
dioxide.  The reducing equivalents generated enter an electron transport chain, terminating 
in the reduction of oxygen to water.  This mode of metabolism gives the highest yield of 
energy possible (up to 38 ATPs per mole of glucose) (Slonczewski and Foster, 2009) (Figure 
1.1a) .   
Oxygen can readily diffuse into the cytoplasm, under normal aerobic conditions (~20 mbar).  
However, any lower (under 2-5 mbar) and oxygen availability becomes limiting and pathway, 
which utilise alternative electron acceptors to oxygen, are employed.  There are a number of 
alternative electron acceptors used by E. coli including fumarate, nitrate and trimethylamine-
N-oxide (TMAO)(Patschkowski et al., 2000; Unden et al., 1995; Unden and Bongaerts, 1997).  
Under anaerobic respiratory conditions, the energy yield is much less (4 ATP + 8[H] per mole 
of glucose), due the citric acid cycle becoming non-cyclic and thus leading to the incomplete 
oxidation of the substrate (Guest, 1996) (Figure 1.1b).  In order to utilise different alternative 
electron acceptors, adaptation must occur, which involves the synthesis of a number of co-
enzymes and co-factors that are essential for anaerobic  
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Figure 1.1a, b and c. The metabolic modes of Escherichia coli 
The main pathways of energy and carbon metabolism are illustrated for: (a) aerobic 
respiration, (b) anaerobic respiration and (c) fermentation.   
Enzymes shown are aspartase (ASP); aspartate-oxaloacetate aminotransferase (AOT); formate hydrogen-lyase (FHL); fumarate 
reductase (FRD); isocitrate dehydrogenase (ICDH); malate dehydrogenase (MDH); menaquinone (MK); succinyl-CoA synthase 
(SCS); succinate dehydrogenase (SDH); 2-oxoglutarate dehydrogenase complex (ODHC); pyruvate dehydrogenase complex 
(PDHC); pyruvate formate-lyase (PFL) and ubiquinone (UQ).  Adapted from Guest (1996).   
Up to 38 ATPs 
4 ATP + 8[H] 
3 ATP  
a 
b 
c 
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respiration and repression of any genes involved in oxygen metabolism (Kiley and Beinert, 
1998; Lynch and Lin, 1996). 
Fermentation is the metabolic mode which is adopted by E. coli when neither oxygen nor 
any exogenous alternative electron acceptors are available.  This metabolic mode utilises 
carbon and energy sources to produce more reduced products (Figure 1.1c).  Substrate level 
phosphorylation is used to conserve energy, generating much less energy than other 
metabolic modes (3 ATP per mole of glucose) (Guest, 1996).  Escherichia coli produces a 
number of different end products during fermentation and thus is classed as a mixed acid 
fermenter.  Redox is balanced during fermentation by producing varying amounts of end 
products; these include lactate, acetate, ethanol, CO2, H2 and succinate.  The relative amount 
of each is dependent upon both on the environmental conditions and the carbohydrate 
being fermented (Guest, 1996; Iuchi and Lin, 1993).    
1.2. The hierarchy of metabolism in E. coli and its regulation  
Escherichia coli operates a metabolic hierarchy in which aerobic respiration is preferred to 
anaerobic respiration, which in turn is preferred to fermentation (Gunsalus, 1992; Lin and 
Iuchi, 1991; Spiro and Guest, 1991; Unden et al., 1994).  This hierarchy is maintained by the 
coordinated action of transcription factors (TFs) and reflects the relative amounts of energy 
that can be conserved by each metabolic mode (Unden et al., 1994).  The development of 
these pathways and sensitive regulatory mechanisms have conferred on E. coli the ability to 
maximise ATP production under many redox conditions.  The ability of E. coli to adopt 
different metabolic modes is based on a number of redox-responsive regulatory mechanisms 
that coordinate this successful adaptation (Unden and Bongaerts, 1997).  Although E. coli is 
viable across changing redox environments there is a cost to this adaptability as the 
bacterium must provide genetic and enzymatic “equipment” for each metabolic system.  The 
metabolic pathways used by E. coli are dependent on oxygen availability, the nature of the 
growth substrate and also the availability of any alternative electron acceptors.  Escherichia 
coli can respire aerobically with oxygen and anaerobically by using a variety of terminal 
electron acceptors for electron transport-coupled oxidative phosphorylation (Table 1.1) 
(Unden and Bongaerts, 1997).  These compounds include, in order of decreasing potential 
energy: nitrate, dimethyl sulfoxide (DMSO), trimethylamine-N-oxide (TMAO) and fumarate 
(Unden and Bongaerts, 1997).  It has been suggested that E. coli regulates the utilisation of 
these compounds on the basis of the amount of energy potentially available in order to 
generate maximum cellular energy.  For example, in the presence of the preferred electron  
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Redox Couple Reduction potential (E0') (V) Genes 
O2 / H2O + 0.82 cyoABCDE, cydAB, appBC 
NO3- / NO2- + 0.42 narGHJI, narZYWV 
NO2- / NH4+ + 0.36 nrfABCDEFG 
DMSO / DMS + 0.16 dmsABC 
TMAO / TMA + 0.13 torCAD, torZY, dmsABC 
Fumarate / Succinate + 0.03 frdABCD 
 
Table 1.1.  Electron acceptors utilised by E. coli 
The different electron acceptors utilised by Escherichia coli and what these acceptors are 
reduced to during catabolism are listed.  The redox couples are listed in order of reduction 
potential, with the most energetically favourable redox couples towards to the top of the 
table.  The TMAO/TMA redox couple is the second to least energetically favourable redox 
couples utilised by E. coli.  Adapted from Unden and Bongaerts (1997). 
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acceptor oxygen, production of nitrate reductase and fumarate reductase enzymes is 
repressed. Furthermore, TMAO respiration has been shown to be repressed approximately 
two-fold in the presence of nitrate, the preferred anaerobic electron acceptor (Takagi et al., 
1981), with this repression not occurring in a narL mutant (Iuchi and Lin, 1987).   
Thus, this hierarchy reflects the relative amounts of energy that can be conserved by these 
metabolic modes, with oxygen availability as the major signal that governs which metabolic 
mode is adopted.  Ultimately, in E. coli, this metabolic hierarchy is rooted in and maintained 
by altered patterns of gene expression controlled by the main regulators involved in the 
aerobic/anaerobic response (Unden and Bongaerts, 1997).   
1.2.1. FNR  
In E. coli, the transcriptional regulator FNR (fumarate nitrate reduction regulator) controls 
the expression of  ≥200 genes, activating those involved in anaerobic respiration and the 
reduction of alternative electron acceptors (Constantinidou et al., 2006; Covert et al., 2004; 
Gonzalez et al., 2003; Myers et al., 2013; Salmon et al., 2003; Woltjer et al., 2007).  FNR 
belongs to the CRP/FNR superfamily of transcription factors whose members are widely 
distributed in bacteria (reviewed in (Green et al., 2001).  Other regulators in addition to FNR 
are often involved in the fine tuning of gene expression in response to availability of oxygen.  
FNR is the primary transcriptional regulator, which mediates the transition from aerobic to 
anaerobic growth by repressing genes involved in aerobic metabolism and activating genes 
involved in anaerobic metabolism and (Guest, 1996).  More recent CHIP-seq analysis 
suggested that FNR occupancy at many target sites within the E. coli genome is strongly 
influenced by nucleoid-associated proteins (NAPs) that restrict access to many FNR binding 
sites (Myers et al., 2013).  It was also found that genome-wide FNR occupancy did not 
correlate with the match to consensus a binding sites, which may be explained by genome 
accessibility.  However, FNR was found bound some promoters without regulating 
expression, highlighting a more complex system for FNR regulation than previously known 
(Myers et al., 2013).   
It is known that under anaerobiosis, FNR acquires a [4Fe-4S]2+ cluster (Khoroshilova et al., 
1997; Lazazzera et al., 1996) that causes a conformational change and dimerization of the 
protein, this conformation has increased affinity for target DNA, which in turn promotes site-
specific DNA-binding, most likely through a reorganisation of the dimer interface (Crack et 
al., 2004; Green et al., 1996; Jordan et al., 1997; Khoroshilova et al., 1997; Moore and Kiley, 
2001; Scott and Green, 2002).  Recently, the crystal structure of FNR from Aliivibrio fischeri 
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was solved, this is the same length as E. coli FNR and shares 84% amino acid sequence 
identity (Volbeda et al., 2015).  The crystal structure suggests that there is a tuneable 
monomer-dimer equilibrium that is mainly determined by two interactions: the imperfect 
interface of the two α-C helices and the top salt bridges.  In light of the crystal structure, the 
authors proposed that FNR monomerisation, involves a dimer “unzipping” process, which 
starts with the dissociation of a salt bridge near the N-terminal domain (Volbeda et al., 2015).  
This process propagates toward the C-terminal end.  Activated FNR (under anaerobic 
conditions) is able to bind a specific a 14 bp imperfect palindromic sequence of DNA 
(TTGATNNNNATCAA; bold residues highlight palindromic regions; N, any base) (Eiglmeier et 
al., 1989; Gerasimova et al., 2001; Scott and Green, 2002).  Dimeric FNR binds symmetrically 
to this region, with each subunit recognising one half of the binding site, allowing it to either 
repress or activate transcription through interactions and/or recruitment of RNA polymerase 
(Spiro, 1994).   
Upon exposure to oxygen,  the FNR [4Fe-4S]2+ cluster is rapidly disassembled, possibly via a 
[3Fe-4S]+ state to a [2Fe-2S]2+ cluster, causing FNR monomerisation (Crack et al., 2007; 
Popescu et al., 1998).  It has been suggested that oxygen-mediated [4Fe-4S] to [2Fe-2S] 
cluster degradation indirectly initiates monomerisation through a conformational change, 
which leads to the disruption of the salt-bridge in the N-terminal domain (Volbeda et al., 
2015). Monomeric FNR cannot bind DNA and thus cannot interact with RNA polyermase 
(Scott and Green, 2002).  This conversion in response to oxygen is fast in vitro and in vivo, 
occurring within minutes of exposure allowing for a fast regulatory response.  Initial cluster 
disassembly in vitro is biphasic, thus ensuring that FNR reacts optimally at low oxygen 
concentrations (Jordan et al., 1997).  After prolonged oxygen exposure, the [2Fe-2S] cluster 
is destroyed, and apo-FNR, which lacks an Fe-S cluster, is the primary form of FNR under 
aerobiosis (Popescu et al., 1998).  Under aerobiosis, the apo-FNR monomer is exposed and 
can be degraded by the ClpXP protease (Mettert and Kiley, 2005).   
Thus, FNR acts as the master switch, as its activation under anaerobic conditions leads to 
activation of genes involved in anaerobic metabolism and repression of genes involved in 
aerobic metabolism.   
1.2.2. The ArcBA system 
The ArcBA system (aerobic respiration control) is responsible for the regulation of numerous 
genes and operons across aerobic and microaerobic environments (5-10 mbar oxygen 
tension).  It is a two-component system consisting of a membrane bound sensor (ArcB) and 
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cytoplasmic regulator (ArcA)(Bauer et al., 1999; Iuchi et al., 1989; Iuchi and Lin, 1988; Sawers, 
1999).  The ArcB sensor is part of a complex class of sensor kinases that contain a primary 
transmitter domain, central receiver domain and secondary terminal histidine 
phosphotransfer domain that possesses autophosphorylation activity (Bauer et al., 1999; 
Sawers, 1999).  The actual signal detected by ArcB has been shown not to be oxygen but 
rather a number of other factors related to the metabolic and redox state of the cell 
(Georgellis et al., 2001).  It has been established that oxidised quinones, ubiquinone and 
menadione, were able to inhibit the autophosphorylation of ArcB unlike the reduced forms 
which were unable to inhibit the process (Georgellis et al., 2001).  Under anaerobic or 
microaerobic conditions, quinones accumulate in their reduced form thus stimulating ArcB 
autophosphorylation and the subsequent activation of ArcA (ArcA~P).  It has also been 
shown that the autophosphorylation of ArcB is dependent on upon the formation of a 
number of disulfide bonds between ArcB monomers so it is possible that quinones may play 
a further role in the direct oxidation of the cysteines involved in this bond formation (Malpica 
et al., 2004).  The activity of ArcBA is also sensitive to cellular NADH/NAD+ ratios.  In vitro 
studies have also shown ArcB responds to metabolites such as, lactate, acetate and pyruvate 
that accumulate under anaerobic or microaerobic conditions and are indicative of lower 
oxygen tensions.  High concentrations of these anaerobic or microaerobic intermediates are 
able to inhibit the intrinsic phosphatase activity of ArcB resulting in a prolonged signal 
duration (Georgellis et al., 1999; Rodriguez et al., 2004).  Thus, ArcB responds to electron flux 
in the aerobic respiratory chain rather than sensing oxygen directly (Iuchi and Lin, 1995).  The 
ArcA protein is a typical response regulator with an amino terminal receiver domain and 
carboxy terminal electron acceptor domain which binds a proposed consensus 
[A/T]GTTAATTA[A/T] determined from alignment of a number of ArcA target promoters and 
DNase I protection assays (Drapal and Sawers, 1995). Generally, ArcA~P acts as a repressor 
preventing the synthesis of aerobically required enzymes during anaerobic conditions, 
although it is responsible for the activation of a number of genes notably the cydAB operon, 
which encodes the high affinity terminal cytochrome d oxidase.  Regulation by the ArcBA 
system in coordination with another transcription factor is not uncommon, most notably FNR 
to coordinate the aerobic/anaerobic interface response with numerous examples being 
recorded (Table 1.2)(Govantes et al., 2000).  More recently, genome-wide analysis using 
CHIP-seq has revealed that ArcA reprograms metabolism under anaerobic conditions such 
that carbon oxidation pathways, which recycle redox carriers via respiration are 
transcriptionally repressed by ArcA (Park et al., 2013). Also, this ChIP-seq analysis revealed  
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Enzyme Gene ArcA Effect FNR Effect 
1. Citric acid cycle enzymes  
Aconitase A 
Fumarase A 
Fumerase B 
Succinate dehydrogenase  
α-Ketoglutarate dehydrogenase  
Succinyl coenzyme A synthetase 
 
acnA 
fumA 
fumB 
sdhCDAB 
sucAB 
sucCD 
 
- 
- 
+ 
- 
- 
- 
 
- 
- 
+ 
- 
- 
- 
2. Respiratory chain dehydrogenases 
Formate dehydrogenase 
NADH dehydrogenase I 
 
fdhGHI 
nuo 
 
- 
- 
 
+ 
- 
3. Terminal reductases 
Cytochrome o oxidase  
Cytochrome d oxidase 
 
cyoABCDE 
cydAB 
 
- 
+ 
 
- 
- 
4. Other enzymes  
Formate transport and pyruvate-formate lyase  
Pyruvate dehydrogenase complex and regulator  
 
focA-pfl 
pdhR-aceEF-lpd 
 
+ 
- 
 
+ 
- 
 
Table 1.2.  Regulation by the ArcBA system in coordination with FNR 
This table shows the operons that are regulated by ArcBA and FNR and the effect that each 
regulator has on the transcription.  (-) represents inhibition and (+) represents activation of 
transcription by the transcription factor.   
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that most ArcA binding sites contain additional direct repeat elements beyond the two 
required for binding an ArcA dimer (Park et al., 2013). 
Thus, the ArcBA regulon is vital to the metabolic versatility of E. coli, consisting of more than 
thirty loci with products coding for cytochrome oxidases, enzymes of the citric acid cycle, 
glyoxylate shunt and fatty acid degradation pathways (Bauer et al., 1999; Liu and De Wulf, 
2004).      
1.2.3. The Nar system  
The Nar system regulates the expression of numerous genes involved in both anaerobic 
respiration and fermentation pathways.  It comprises the homologous dual response 
regulator proteins NarL and NarP and their corresponding sensors NarX and NarQ.  These 
sensors respond to the presence of nitrate and nitrite within the environment (Darwin et al., 
1996; Rabin and Stewart, 1993; Stewart, 1993) and activate NarL and NarP via a 
phosphotransfer relay allowing them to bind DNA and control transcription (Lee et al., 1999).  
Once active, these proteins are able to act directly as conventional regulators, both 
recognising and binding to a consensus sequence known as a NarL heptamer (TACYYMT; Y, 
C or T residue; M, A or C residue) (Darwin et al., 1997) although, like ArcA, the Nar system 
often works in concert with the anaerobic response regulator FNR.  The FNR protein often 
binds near position -41, activating transcription whilst site(s) for NarL and/or NarP are 
situated further upstream (Bell et al., 1990; Darwin et al., 1993).  These upstream sites 
contribute to activation, for example the nrf gene encoding a formate-dependent nitrite 
reductase (Hussain et al., 1994) where the Nar binding site is located at -74.5 (Tyson et al., 
1994), and the nir gene which encodes a NADH-dependent nitrite reductase with an 
upstream Nar binding site situated at -69.5 (Tyson et al., 1993).  Through a series of deletions 
in the nir promoter, it was determined that removal of the Nar binding site (and preceding 
regions) allowed for full activation by FNR alone, rather than requiring the contributory 
effects of Nar binding for full expression (Wu et al., 1998).  This raised the possibility that co-
regulation may not be a simple case of independent contacts with the RNAP between the 
FNR and Nar proteins but that Nar may contribute by interfering with other upstream factors 
that in the absence of Nar inhibit FNR-dependent activation.  This was confirmed by 
Browning and co-workers when Fis and IHF were identified as these factors whose negatory 
effects are nullified by Nar binding (Browning et al., 2000).   
Thus, the Nar system is integrated with other regulatory systems playing a crucial role in 
maintaining the metabolic hierarchy of E. coli ensuring that under anaerobic conditions 
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preferred alternative electron acceptors such as nitrate and nitrite are used to maximise 
energy production.     
1.3. Reprogramming of the metabolic mode of E. coli under stable (steady-state) and 
dynamic conditions (transitions)  
Escherichia coli has long been a model organism for studying aerobic respiration, anaerobic 
respiration and fermentation (Ingledew and Poole, 1984).  Many bacteria undergo 
transitions between environments with differing oxygen availabilities as part of their natural 
lifestyles.  However, the dynamics of adaptation when bacteria experience changes in oxygen 
and alternative electron acceptor availability are much less well characterised (Bettenbrock 
et al., 2014).  
1.3.1. Gene expression and transcription factor (TF) activities under steady-state 
conditions in response to oxygen availability  
Widespread changes in gene expression have been associated with the reprogramming of E. 
coli metabolism in response to oxygen availability (summarised in Bettenbrock et al., 2014).  
Comparison of gene expression data from both aerobic and anaerobic cultures of E. coli 
grown on various different media have been previously reported (Constantinidou et al., 
2006; Kang et al., 2005; Salmon et al., 2005).  It has been suggested, based on these studies, 
that many as 1450 genes have altered expression under anaerobic conditions when 
compared to those expressed under aerobic conditions. However, only 63 genes were 
significantly regulated when steady-state cultures grown with excess oxygen were compared 
with anaerobic steady-state cultures (Rolfe et al., 2011).  These data are representative of 
the minimal set of differentially expressed genes that distinguish aerobic and anaerobic 
growth, without the fluctuations in batch culture affecting the gene expression (Hoskisson 
and Hobbs, 2005).   
Under aerobic conditions, the most important adaptive responses appeared to be enhanced 
expression of TCA cycle and glyoxylate shunt genes (Rolfe et al., 2011).  The cyclical form of 
the TCA cycle was restored as oxygen availability increased by the expression of the operon 
encoding succinate dehydrogenase (SDH)-succinyl CoA synthetase.  It was shown that 
initially the bacteria might not fully oxidize the substrate glucose by the induction of the 
glyoxylate shunt under aerobic conditions, but continue to excrete a proportion of the 
carbon supplied as acetate (Rolfe et al., 2011).  Acetate was undetectable in the culture 
medium because it was presumably ‘immediately’ taken up via the acetate transporter ActP 
(induced >10-fold under aerobic conditions) for metabolism via the glyoxylate cycle (Rolfe et 
al., 2011).  The switch to aerobic respiratory growth was completed by the down-regulation 
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of genes associated with anaerobic fermentation and the upregulation of the relatively low-
oxygen affinity terminal oxidase cytochrome bo’ (Rolfe et al., 2011).  The transcriptional 
changes observed were consistent with the inactivation of FNR and relief of ArcA-mediated 
repression.   
A total of 89 genes exhibited expression changes when the complete set of transcript profiles 
obtained in the microaerobic–aerobic range was compared with that of the anaerobic 
steady-state (Rolfe et al., 2011). Transcripts with altered abundance were associated with 
central metabolic functions (39%), unknown function (11%), transcription regulation (7%), 
outer membrane proteins and adhesions (5%), and the oxidative stress response (4%) (Rolfe 
et al., 2011).  The transcriptomic changes observed at each steady state suggested a stepwise 
switch to aerobic respiratory metabolism.  For example, the cyoABCDE operon (encoding 
cytochrome bo’) was maximally expressed under fully aerobic conditions, whereas the cydAB 
operon (encoding cytochrome bd-I) was maximally expressed at 56% aerobiosis, and appCB 
(encoding cytochrome bd-II) was maximally expressed at 0% aerobiosis (fully anaerobic 
conditions).  Cytochrome bo’ has a relatively low affinity for oxygen (Km 16–350 nM) (D'Mello 
et al., 1995) whilst cytochrome bd-I has an extremely high-oxygen affinity (Km 3–8 nM) 
(D'mello et al., 1996).  Thus, the expression profiles match the oxygen reactivities of these 
oxidases. Furthermore, changes in abundance of the cydAB and cyoA-E transcripts correlated 
well with the changes in the amounts of cytochrome bd-I and cytochrome bo’ in the cell as 
shown by spectroscopic measurements (Rolfe et al., 2011).  Thus, these shifts in oxidase 
expression were consistent with a switch from fermentation to microaerobic respiration 
(with cytochrome bd-I acting as the terminal oxidase), and then to aerobic respiration (with 
the terminal oxidase cytochrome bo’), as oxygen availability increased.   
Changes to the metabolic signals that are sensitive to oxygen availability, or in the activities 
of regulators that respond to oxygen itself, are responsible for the observed transcript and 
protein profiles.  Simultaneous inference (using TFInfer; Asif et al., 2010) of the activities of 
134 TFs in E. coli revealed that 23 responded in at least one of the steady states examined.  
All seven of the E. coli global regulators (ArcA, CRP, Fis, FNR, H-NS, IHF and Lrp; Martínez-
Antonio et al., 2003) were amongst these 23 TFs.  The predicted FNR activities from the 
TFInfer model were confirmed experimentally and showed that the activity of FNR decreased 
rapidly at aerobiosis values greater than 56% (Rolfe et al., 2012).  In contrast, the activity of 
the indirect oxygen-sensor ArcBA was predicted to decrease linearly with increasing 
aerobiosis (Georgellis et al., 2001), but not with the redox state of the ubiquinone pool.  
Measurement of the amount of phosphorylated ArcA revealed a good correlation with the 
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predicted ArcA activities and with aerobiosis suggesting that, under those conditions, 
fermentation product-mediated inhibition of ArcB phosphatase activity was the dominant 
mechanism for regulating ArcA activity (Rolfe et al., 2012).   
Thus, the switch between anaerobic to microaerobic to aerobic and vice versa is 
predominately mediated by the TFs ArcBA and FNR.  Regulation by these TF allows 
maintenance of the regulatory hierarchy of respiration in E. coli.   
1.3.2. Gene expression and transcription factor (TF) activities during transitions between 
oxygen-replete and oxygen-deficient environments 
Transitions between oxygen-replete and oxygen-deficient environments (Partridge et al., 
2007; Partridge et al., 2006; Rolfe et al., 2012; Trotter et al., 2011) are able to mimic real-life 
environmental conditions, allowing investigation into the adaptation to new oxygen 
concentrations.  Transcriptomic analysis of the transitions showed that 590 genes (12.1% of 
the genome) in an aerobic to anaerobic switch and 396 genes (8.1% of the genome) exhibited 
expression in the anaerobic to aerobic switch and during the acute phase of adaptation (first 
20 min) (Partridge et al., 2007; Rolfe et al., 2012).  Thus, many more transcripts change during 
transitions than were observed in simple comparison of aerobic and anaerobic steady-state 
cultures (Section 1.3.1). This presumably reflects the dynamic nature of the adaptive 
processes and the many stresses encountered by E. coli, whilst oxygen availability is 
changing. Once metabolism has been reprogrammed, these acute stresses no longer exert 
their influence on the transcriptome and are not apparent from analysis of steady-state 
cultures.   
Of the 396 and 590 genes that exhibited altered expression during the acute phases of the 
anaerobic to aerobic and aerobic to anaerobic transitions, respectively, 195 and 284 could 
be classified into 23 functional groups (Rolfe et al., 2012).  The major changes in expression 
were observed for transcripts encoding proteins with roles in central metabolic pathways.  
Presumably, endogenous oxidative stress is experienced in the presence of oxygen as 
indicated by the altered expression of genes associated with the oxidative stress response.  
Introduction of oxygen alters the redox state of copper as the responses of systems involved 
in copper ion homeostasis suggest (Partridge et al., 2007; Rolfe et al., 2012).  Although a 
large proportion of the transcriptional reprogramming that occurred during the aerobic to 
anaerobic transition was essentially the reverse of that of the anaerobic to aerobic transition, 
transcript changes in the aminosugars, ascorbate, C5-branched dibasic acids and galactose 
metabolism functional classes, as well as the translation category, were differentially 
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affected (Rolfe et al., 2012).  Altered patterns of abundance in the transitions were exhibited 
by the transcripts of 204 genes of unknown function. Of these genes of unknown function, 
119 responded in the aerobic to anaerobic transition, 51 in the anaerobic to aerobic 
transition, and 34 in both (Rolfe et al., 2012).  This observation emphasises the new insights 
that can be obtained by perturbation of systems by helping to assign function to some of 
these genes. 
More information about the complex regulatory events that occur during adaptation can be 
gained by inference of TF activities.  Inference of TF activities (Asif et al., 2010) when aerobic 
or anaerobic steady states were perturbed revealed the presence of a core set of 16 TFs 
(including FNR and ArcA) that exhibited expression changes (Rolfe et al., 2012).  This core 
network contains TFs that respond to oxygen availability and regulate central metabolism, 
oxidative stress responses, metal-ion homeostasis and amino acid biosynthesis. Predicted 
activity from transcriptomic data suggested that FNR remained active, in the the DNA binding 
form of the protein, under microaerobic conditions (Rolfe et al., 2012).  This could be because 
the bacterial cytoplasm remains essentially anaerobic under these conditions, perhaps due 
to the consumption of oxygen by high-affinity cytochrome bd-I (Cyd).  A lacZ reporter assay 
confirmed the predicted FNR expression under anaerobic and microaerobic conditions (Rolfe 
et al., 2012). Thus, spatial constraints have significant implications, even on the scale of the 
bacterial cell, for example here, allowing ‘hybrid’ metabolism to proceed under microaerobic 
conditions, where anaerobic processes can be supported in the cytoplasm and aerobic 
respiration proceeds close to the cell membrane. Furthermore, this could account for the 
need for two TFs consisting of a membrane-associated sensor interacting with the 
respiratory chain (ArcBA) and a sensor (FNR) responding to cytoplasmic oxygen, both of 
which work in concert to coordinate global gene expression in response to oxygen 
availability. 
Other TFs exhibited expression changes only during a specific transition (11 TFs for aerobic 
to anaerobic and 4 for anaerobic to aerobic)(Rolfe et al., 2012). Furthermore, of the 44 TFs 
predicted to respond under one or more of the conditions investigated, 23 were specifically 
associated with the transitions, whereas only five were specifically linked to the different 
steady states.  This is perhaps indicative of the additional stresses encountered during the 
environmental changes occurring during transitions compared to the consistent 
environmental conditions of the steady-state cultures. 
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Thus, there is a large body of information about the reprogramming of E. coli that occurs 
during stable (steady-state) and dynamic conditions (transitions) in response to oxygen 
availability.  However, the reprogramming of E. coli that occurs in response to alternative 
electron acceptor availability has not been characterised.   
1.4. Trimethylamine-N-oxide (TMAO) 
1.4.1. Bacterial TMAO respiration  
Trimethylamine-N-oxide (TMAO) belongs to the class of amine oxides and has the formula 
(CH3)3NO.  It is a common metabolite in many living organisms and for various bacteria serves 
as an alternative electron acceptor in anaerobic metabolism.  The various bacteria that can 
reduce TMAO inhabit three main environments: animal intestines (Enterobacteriaceae), the 
marine environment (e.g., Alteromonas and Vibrio) and the brackish pond (non-sulfur 
photosynthetic bacteria) (Barrett and Kwan, 1985). In the Enterobacteriaceae, which 
includes Escherichia coli, a normal part of the human gut flora, reduction of TMAO has been 
shown to support oxidative phosphorylation (Barrett and Kwan, 1985).  TMAO also 
represents a significant nutrient for marine bacteria (Lidbury et al., 2014).  
The biochemistry and genetics of TMAO utilisation as an alternative electron acceptor in 
respiration by E. coli have been characterised over the last two decades.  During TMAO 
respiration, TMAO is reduced to the malodorous trimethylamine (TMA) (Figure 1.2).  The 
redox potential for the TMA/TMAO couple is +130 mV (Gon et al. 2001a), making TMAO a 
relatively poor electron acceptor when compared to other electron acceptors utilised by E. 
coli (Table 1.1).  A large body of research investigating marine-fish spoilage organisms, which 
form TMA by the reduction of TMAO that is naturally present in fish, began last century as 
reviewed elsewhere (Barrett and Kwan, 1985).  Since this time, characterisation of TMAO 
reductases and other components of the TMAO respiratory chain has been conducted.   
1.4.1.1. The E. coli TMAO Respiratory Chain, TorCAD 
In the early 1980s, the observation of TMAO reduction-linked proton translocation 
confirmed a role in energy conservation processes (Takagi et al., 1981).  Research on the E. 
coli TMAO respiratory chain has shown that it utilises either a menaquinol or 
demethylmenaquinol electron donor (Wissenbach et al., 1990), consists of a membrane-
associated c-type cytochrome (TorC) and a molybdenum-containing terminal reductase 
(TorA) (Mejean et al., 1994)(Figure 1.3).  TorA is typical of the DMSO reductase family of 
molybdoenzymes and is located in the periplasm of E. coli (Czjzek et al., 1998).  TorC, which 
belongs to the NirT/NapC family of c-type cytochromes, is a 46 kDa penta-haem c-type  
A 
B 
C 
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Figure 1.2. The chemical structures of TMAO and TMA  
This figure shows the chemical structures of TMAO and TMA, the product of TMAO 
respiration.   
  
TMAO respiration 
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Figure 1.3. The E. coli TorCA respiratory chain 
The TMAO respiratory chain in E. coli is composed of c-type cytochrome (TorC), which is 
anchored to the cytoplasmic membranes and takes electrons from the menaquinone pool 
and donates them to the molybdenum-containing TMAO reductase (TorA).  The TMAO 
reductase is located in the periplasm and reduces TMAO and 2H+ to TMA and H2O.   
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cytochrome (Mejean et al., 1994).  Approximately 20 hydrophobic amino acid residues of the 
N-terminal region of TorC (TorCN) comprise a single membrane-spanning helix, which 
anchors the protein to the cytoplasmic membrane (Gon et al., 2001a).   A large portion of 
the TorC protein exists in a globular form facing the periplasm (Gon  et al., 2001a).  The TorCN, 
which is homologous to NirT and NapC (membrane-anchored multihaem c-type 
cytochromes), possesses four haem-binding sites (C-X-X-C-H motifs) and the C-terminal 
region (TorCC), which is specific for TMAO respiration, contains the fifth haem-binding sites 
(Mejean et al., 1994).  In vitro reconstitution of electron transfer experiments with the 
purified N- (TorCN) and C-terminal domains of TorC (TorCC) and TorA, showed that only full 
TorC and TorCC were capable of electron transfer to TorA (Gon et al., 2001a).  Protein 
interaction studies have shown that it is TorCN domain that binds to TorA (Gon et al., 2001a). 
Thus, the tetra haem TorCN oxidises the menaquinone and transfers electrons to TorCC, and 
eventually to TorA.  TorCN binding to TorA could ensure a confirmation suitable for electron 
transfer (Gon et al., 2001a).   
1.4.1.1.1. Molecular properties of TMAO reductases 
1.4.1.1.1.1. The Molybdenum cofactor  
TorA catalyses the reduction of TMAO to TMA and the active site contains a molybendenum 
cofactor (Méjean et al., 1994; Zhang et al., 2008).  Molybdenum-containing enzymes all 
contain a Molybdenum (Mo) ion coordinated by one or two modified pterin derivatives, 
known as molybdopterin or pyranoterin. The molybdenum cofactor in TorA is considered to 
be a bis(guanylyl molybdopterin)(Genest et al., 2008). TMAO reductases belong to the DMSO 
reductase family of molybdenum enzymes, found exclusively in prokaryotes (Hille et al., 
1998; McCrindle et al., 2005).   
1.4.1.1.1.2. Structure of TMAO reductases 
The full structure of the E. coli TorA has not yet been reported.  However, structural 
characterisation of the molybdenum site of recombinant E. coli TorA using X-ray absorption 
spectroscopy has been carried out (Zhang et al., 2008).  This analysis suggested that the 
active site of TMAO reductase can exist in three different forms, as isolated; reduced and 
redox-cycled, with a considerable resemblance to DMSO reductase (Zhang et al., 2008).  
Although the crystal structure of E. coli TorA has not been resolved, many TMAO reductases 
from other organisms have.  The periplasmic Shewanella massilia TMAO reductase, which is 
homologous to the E. coli TorA has been isolated and characterised (Figure 1.4).  The overall 
fold of the S. massilia TMAO reductase was found to be essentially the same as the DMSO  
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Figure 1.4. The crystal structure of the TMAO reductase from S. massilia 
Shown is the crystal structure of the TMAO reductase from S. massilia in the oxidised state 
at a resolution of 2.65 Å.  The view shown is from the side.  Indicated on the structure are 
the locations of the active site, containing the molybdenum cofactor, the active site funnel 
and the surface loop and the entrance of the active site tunnel.  This structure was obtained 
from the Protein Data Bank (PDB) (PDB code: 1tmo).   
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reductase structures, and is organised into four domains (Czjzek et al., 1998).  However, 
there were structural differences found in the active site of the protein, which could 
correlate to the differences in the substrate specificities of these enzymes.  In the DMSO 
reductase structure it was shown that there is a tyrosine residue closely located to the 
molybdenum ion, which is missing in the TMAO reductase structure, leaving a wider 
accessible space perhaps to accommodate the bulkier TMAO molecule (Czjzek et al., 1998).  
There are also differences in the arrangement and number of positively charged residues 
lining the inner surface of the funnel-like entrance to the active site, which could also account 
for the differences in substrate specificity.  A surface loop at the entrance of the active site 
funnel was observed in the oxidised form of TMAO reductase, and is believed to form a lid 
on the active site in the substrate bound form (Czjzek et al., 1998).   
1.4.1.1.1.3. Substrate Specificity of TMAO reductases  
TMAO and DMSO reductases can be classified according to their substrate specificity, with 
TMAO reductases having high substrate specificity towards TMAO and DMSO reductases 
having broad specificity for both S- and N-oxides (Iobbi-Nivol et al., 1996).  TorA is able to 
catalyse the reduction of several different N-oxides, including TMAO, but does not reduceany 
of the S-oxides (Iobbi-Nivol et al., 1996).  Early experiments carried out on purified E. coli 
TorA highlighted high enzymatic activity towards TMAO, adenosine N-oxide, as well as lower 
activities towards N-oxides of nicotinamide, nicotinic acid and various picolines (Shimokawa 
and Ishimoto, 1979; Yamamoto et al., 1986).  More detailed kinetic analyses have more 
recently been conducted (Iobbi-Nivol et al., 1996).  By using kinetic analysis, this group 
showed that out of a wide variety of N- and S-oxides, only two N-oxides, TMAO and 4-
methylmorpholine-N-oxide could be considered good substrates for TorA on the basis of 
their kcat/Km ratios (Iobbi-Nivol et al., 1996).  This suggests that TMAO would be the only 
substrate for TorA in nature, as 4-methylmorpholine-N-oxide is a synthetic compound.  This 
demonstrates the high substrate specificity for TMAO exerted by E. coli TorA TMAO 
reductase.    
1.4.1.1.2. Genetic organisation and regulation of operons encoding TorCAD 
There is a common pattern of gene arrangement in the TMAO reductase systems.  Analysis 
of the operon showed that the structural genes for the reductase and the cognate 
membrane-bound reductase are encoded in the same operon.  Located in close proximity to 
the structural genes is a cluster of regulatory genes (sensor kinase/response regulator), 
which is transcribed in the opposite direction.   
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1.4.1.1.2.1. The torCAD operon of E. coli 
Escherichia coli has two TMAO reductase operons, torCAD (Figure 1.5a) and torZY (discussed 
later).  In the 1980s, mutagenesis and screening experiments identified the E. coli torCAD 
operon (Takagi, 1983).  Further experiments mapped the torA gene to 28 min on the E. coli 
chromosome (Pascal et al., 1984) and a tor regulatory gene, torR, was mapped to 22 min 
(Pascal et al., 1991).  The E. coli torCAD operon is known to consist of three contiguous open 
reading frames (ORFs) (Mejean et al., 1994).   
1.4.1.1.2.2. The regulatory two-component system, TorRS 
Components of the TorCAD respiratory chain are strictly under the control of TMAO.  Thus, 
TMAO reductase is only expressed when TMAO is sensed in the environment.   
The tor locus also encodes the associated regulatory system, which involves three genes, 
torS, torT and torR (Jourlin et al., 1996a; Jourlin et al., 1996b; Simon et al., 1994). The torR-
torCAD intergenic region contains four copies of a 10 nucleotide sequence motif (5’- 
CTGTTCATAT-3’) called the “tor box” (Simon et al., 1994).  TorR binds to these tor boxes, one 
of which is contained within the torR transcribed region, thus inducing the transcription of 
both torC and torR (Simon et al., 1994).  Expression of the torCAD operon is predominately 
under the control of the TorS/TorR two-component system.  This system is composed of the 
TorS complex sensor histidine kinase, which induces expression of the tor operon through a 
phosphoryl transfer pathway involving the response regulator TorR (McCrindle et al., 2005) 
(Figure 1.5b).  The TorS transmitter domain contains three histidine phosphorylation sites 
and an aspartate phosphorylation sites in the receiver domain of TorS (Jourlin et al., 1997). 
All three phosphorylation sites proved to be essential for the induction of tor operon in vivo 
(Jourlin et al., 1997).  It was also shown that expression of the second transmitter (C-
terminal) TorS transmitter domain as a cytoplasmic protein is sufficient to cause constitutive 
expression of the tor operon (Jourlin et al., 1997). This shows that it is the second transmitter 
domain that is involved in phosphoryl transfer to TorR.  TorS is involved in both the 
phosphorylation and dephosphorylation of TorR (Jourlin et al., 1997).  The torT gene encodes 
another regulatory protein essential for torCAD expression (Jourlin et al., 1996b).  The 
product of this gene, TorT, binds TMAO promoting a conformational change in the protein 
(Baraquet et al., 2006).  This conformational change in TorT is then transduced to TorS, 
leading to TorS activation (Baraquet et al., 2006), which can go on to induce the expression 
of the torCAD operon through TorR.  Using crystal structures, it was shown that TorS and 
apoTorT form an asymmetric 2:2 complex, which binds TMAO with negative cooperativity to  
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Figure 1.5a and b.  Regulation of the E. coli torCAD operon 
a. The torCAD and torRST genes are encoded for by two divergently transcribed 
operons on E. coli MG1655 chromosome, one coding the structural genes of the 
respiratory chain (torCAD) and the other operon codes for the associated regulatory 
two-component system (torRST).  Pink boxes show binding sites for 4 TorR TFs (tor 
boxes), which activate transcription of torCAD and torRST.  The tor boxes 1,2 and 4 
contain the consensus sequence (5’-CTGTTCATAT-3’), whereas box 3 contains a 
degenerate consensus sequence (5’-CCGTTCATCC-3’; bold letters indicate 
different nucleotides to consensus) (Simon et al., 1995).  NarL (shown in green) is 
hypothesised to inhibit the expression of the torCAD operon.   
b. The two-component system (TorRS) is located in the cytoplasmic membrane of E. 
coli and is the main system for sensing TMAO.  TorT is a periplasmic binding protein 
(PBP) that is involved in signal transduction and is essential for TMAO sensing.     
  
a 
b 
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form an active symmetric kinase (Moore and Hendrickson, 2012).   The expression of the tor 
operon is negatively regulated by apocytochrome TorC via an interaction of the C-terminal 
domain of apocytochrome c with the periplasmic detector region of sensor TorS (Gon et al., 
2001b). Another level of tor regulation comes from a novel negative regulator, torI, which is 
of phage origin and encoded for by small ORF (66 amino acids) and is believed to decrease 
tor expression by preventing RNA polymerase recruitment to the torC promoter (Ansaldi et 
al., 2004).  The TorS/TorR system also activates alkalinity-resistance genes and represses 
acid-resistance genes in E. coli, which is proposed to be due to the anticipation of  
alkalinisation due to the production of alkaline TMA during TMAO respiration (Bordi et al., 
2003).   
1.4.1.1.3. Expression and Assembly of TMAO reductases 
1.4.1.1.3.1. Protein transport to the periplasm 
In prokaryotes, a number of pathways are used for protein translocation, including the 
general secretory (Sec) system (Pugsley, 1993) and the twin-arginine translocation (Tat) 
pathway (Sec-independent) (Berks, 1996).  The membrane-associated TorC, like other 
cytochromes c, is translocated across the plasma membrane by the Sec system, whilst the 
required haem groups are transported by specific export complexes to the periplasm.  The 
Sec pathway transports the unfolded protein across the membrane by a threading 
mechanism, which utilises both ATP and proton motive force (Pugsley, 1993).  The E. coli 
TMAO reductases are translocated by the Tat export system (Figure 1.6).  The E. coli TorA is 
often used as a tool to study the Tat system (Barrett et al., 2003; Thomas et al., 2001).  The 
presence of conserved twin (adjacent) arginine residues in the signal sequences of certain 
periplasmic proteins, is the reason why the Tat system is so named (Berks, 1996).  Unlike the 
Sec transport system, proteins that are transported across the membrane by the Tat 
apparatus depend solely on the proton motive force and do not require ATP (Yahr and 
Wickner, 2001).  Tat substrates are typically transported in the folded state, after cytoplasmic 
folding of the protein, with cofactors already inserted.  Tat signal peptides are found in all of 
the well-characterised bacterial TMAO reductases (Gon et al., 2000).   
1.4.1.1.3.2. The role of the TorD chaperone 
TMAO reductases are assembled in the cytoplasm and translocated across the membrane to 
the periplasm, fully assembled with the molybdenum cofactor already inserted as previously 
detailed.  TMAO reductases require protein-specific chaperones for cofactor insertion and 
export.  The first of these specific chaperones to be discovered was torD, a chaperone for E. 
coli TorA (Genest et al., 2009).  TorD is a cytoplasmic protein, which before the insertion of 
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Figure 1.6. Translocation of the E. coli TMAO reductase to the periplasm by the Tat export 
system 
Apo-TorA has the molybdenum cofactor inserted and becomes fully folded in the cytoplasm, 
prior to being bound by the chaperone TorD and translocated across the cytoplasmic 
membrane into the periplasm via the Tat apparatus.  SS represents the Tat signal sequence; 
purple hexagon, the molybdenum cofactor; and green rectangles, the Tat apparatus.   
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the molybdenum cofactor interacts with the unfolded TorA (Pommier et al., 1998).  
Characterisation of TorD highlighted a specific interaction between TorA and TorD (Pommier 
et al., 1998).  More recently, in vitro work showed that low levels of TorA were assembled 
when the molybdenum cofactor was added to the TorA apoprotein, however, when TorD 
was also added a 4-fold increase of apo-TorA activation was seen (Ilbert et al., 2003).  
Incubation of apoTorA with TorD before the addition of molybdenum, led to an increase in 
apoTorA activation (Ilbert et al., 2003).  This data suggests that TorD is involved in the first 
step of TorA maturation, causing a conformational change, which allows TorA to receive the 
cofactor.  More recent work suggests that as TorA must be correctly folded for the TorD 
chaperone to bind and thus the chaperone acts as “proofreading” step in the process 
(Hatzixanthis et al., 2005). 
1.4.1.2. The alternative TMAO reductases of E. coli 
Escherichia coli also utilises two alternative TMAO reductases in addition to the TorCAD 
system.   A second TMAO reductase is encoded for by the torZY operon.  TorZY has been 
shown to have a low level of constitutive expression and is not induced by TMAO or DMSO 
(Gon et al., 2000).  Somewhat different to TorA is the second E. coli TMAO reductase enzyme, 
TorZ.  Like TorA, only 4-methylmorpholine-N-oxide and TMAO are considered good 
substrates for TorZ (McCrindle et al., 2005).  However, TorZ can also catalyse the reduction 
of some S-oxides.   DMSO is also known to act as a competitive inhibitor of TorZ-catalysed of 
TMAO reduction, unlike TorA.  DMSO is able to bind or block the active site of TorZ, without 
being reduced itself (Gon et al., 2000).  The torZ gene was previously known as bisZ (Biotin 
sulfoxide (BSO) reductase), however, it was renamed TorZ  due to its ability to reduce TMAO 
more efficiently than BSO and also due to its periplasmic location; even though TorZ is more 
homologous to BisC than TorA (63 and 42% identity, respectively).  TorZ belongs to the torYZ 
operon.  A pentahemic c-type cytochrome homologous to the TorC cytochrome of the 
TorCAD respiratory system is encoded for by the first gene, torY (formerly yecK).  
Surprisingly, in the chromosomal region around torYZ, no torD homologue is found.  
The DMSO reductase (DmsABC) of E. coli has a broad substrate specificity, which includes 
TMAO (Bilous and Weiner, 1988; Weiner et al., 1988).  Although the DMSO reductase 
reduces TMAO in vitro, it is not induced by TMAO (Cotter and Gunsalus, 1989).  The turnover 
number of this enzyme with DMSO and TMAO were 3,000 and 9,100, respectively (Weiner 
et al., 1988).  The Km values for both these substrates were reported as 0.18 mM for DMSO 
and 0.60 mM for TMAO (Weiner et al., 1988)  In light of the turnover number and Km values, 
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it was suggested that both TMAO and DMSO would serve as the true physiological substrates 
for DMSO reductase in the natural environment (Weiner et al., 1988).    
The DmsABC reductase consists of three subunits (DmsA, B and C).  The DmsA subunit 
contains a molybdo-bis(pyranopterin guanine dinucleotide) (Mo-bisPGD) cofactor and a 
[4Fe-4S] cluster (Tang et al., 2011).  Although DmsA does not appear to be exported to the 
periplasm, it contains a twin-arginine leader peptide, which targets the protein to the 
membrane (Winstone et al., 2013). The leader peptide is also essential for expression of 
DmsA and stability of the DmsAB dimer and interacts with the redox enzyme maturation 
protein DmsD (Winstone et al., 2013).  The DmsB subunit of DMSO reductase subunit 
contains four  [4Fe-4S] clusters (Bilous and Weiner, 1988).  DmsC is the integral membrane 
subunit of the DMSO reductase complex, which is predicted to have 8 transmembrane 
helices with the N- and C-termini located in the periplasm (Sambasivarao et al., 1990). This 
subunit anchors and stabilizes the catalytic subunits DmsA and DmsB (Sambasivarao et al., 
1990).  
1.4.1.3. TMAO and the regulatory hierarchy 
The prevailing regulatory rule leads to the induction of the most energetically-efficient 
respiratory system by E. coli, whereby pathways with high ATP or growth yields are favoured 
as discussed in Section 1.2.  There is no evidence to suggest that the E. coli TorCAD 
respiratory system is regulated by FNR or by ArcBA and thus differs from the other anaerobic 
respiratory systems (Pascal et al., 1984; Simon et al., 1994).  Unlike other alternative electron 
acceptors that are reduced by E. coli, previous work has demonstrated that both the 
expression of tor and TMAO respiration occurred in the presence of the preferred electron 
acceptor oxygen (Ansaldi et al., 2007).  It was proposed that an advantage of TMAO reduction 
during aerobiosis is the production of alkaline TMA, which could enhance growth by 
maintaining the pH of the culture.  
However, TMAO respiration has been shown to be repressed ~two-fold in the presence of 
nitrate, the preferred anaerobic electron acceptor (Takagi et al., 1981), with this repression 
not occurring in a narL mutant (Iuchi and Lin, 1987).  A more recent microarray analysis 
suggested that torCAD transcript levels are decreased in the presence of nitrate 
(Constantinidou et al., 2006).  Nitrate-repression of tor would be consistent with the current 
dogma that the most energetically efficient mode is adopted because the redox potential of 
the NO3-/NO2- pair is +420 mV compared to +130 mV generated by the TMAO/TMA pair 
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(Simon et al., 1994).  However, the mechanism of nitrate-mediated regulation of tor is 
unknown.   
Thus, it appears that reduction of TMAO may sit outside of the prevailing regulatory 
hierarchy due to the reduction of TMAO taking place in the presence of oxygen.  However, 
the regulatory rule appears to apply to TMAO reduction in the presence of nitrate.   
1.4.2. TMAO and its role in human disease 
1.4.2.1. The gut microbiome and disease 
The term gut microbiome describes the composite microbial genome found in mammalian 
gastrointestinal tract.  Around 95% of the bacterial genes in the human body, which equates 
to ~3.6 million genes are located in the large intestine (Qin et al., 2010).  Over 1,000 different 
species colonise the human gut (Consortium, 2012).  There is a high inter-individual 
variability in the gut microbiota composition, which is believed to have a role in both 
maintaining health and the development of disease (D'Argenio and Salvatore, 2015).   A 
number of functions have been assigned to the microbiome, including immune system 
development, fat storage, synthesis of vitamins, polysaccharide digestion and angiogenesis 
regulation as summarised in D’Argenio and Salvatore (2015).  Over the last decade, next-
generation sequencing has developed rapidly, which has had a major impact this field.  For 
example, a specific microbiome can be characterised in depth using these methods.  This 
allows analysis and comparison between the gut microbiomes of both healthy subjects and 
individuals with specific diseases.  It is known that the microbiome can be influenced by a 
number of factors, including diet (David et al., 2014).  Thus, the modulation of the gut 
microbiota via diet to gain a healthy status is a major research area. 
1.4.2.2. Metabolism of TMAO 
Although some marine organsims endogenously synthesise TMAO, in mammals it mostly 
comes from exogenous sources (Goldstein and Funkhouser, 1972; Koeth et al., 2013; Yancey 
et al., 2001; Zeisel et al., 1989).  The role of TMAO in human disease and its metabolism has 
recently been reviewed by Ufnal et al. (2015).  The gut microbiome plays a crucial role in the 
metabolism of TMAO and its dietary precursors in the human body, as summarised in Figure 
1.7.  It has been shown that the concentration of TMAO in blood increases after ingestion of 
dietary L-carnitine and choline (Miller et al., 2014; Zeisel et al., 1983).  Choline is 
endogenously synthesised, although this synthesis does not meet human requirements, 
thus, the majority of choline is acquired from diet (Ufnal et al., 2015).  There are a number 
of dietary sources rich in choline including red meat,  poultry and eggs (Ufnal et al., 2015).   
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Figure 1.7. Metabolism of TMAO in the human body and its dietary sources   
The metabolism of TMAO and its dietary sources are shown.  Choline and L-carnitine are 
converted to TMA by the gut microbiota, which is then oxidised to TMAO by FMOs in the 
liver.  TMAO can also be directly ingested trough the intake of fish.  This TMAO can be 
reduced to TMA by enteric bacteria in the gut.  Adapted from Backhed (2013).   
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There is a threshold concentration of choline that must be ingested for it to be converted to 
TMAO (Miller et al., 2014; West et al., 2014; Zeisel et al., 1989).  Mediated transport in the 
small intestine is responsible for choline absorption, which is half saturated at choline 
concentrations in the intestines of 200 to 300 mM (Kuczler et al., 1977; Sanford and 
Smyth,1971; Sheard and Zeisel, 1986; Ufnal et al., 2015).  When the concentration of choline 
in the small intestine exceeds transport capacity, normally when choline-rich food is 
ingested, it is able to reach the large bowel, where intestinal bacteria metabolise it, 
producing TMA and dimethylamine (DMA) (Wang et al., 2011; Zeisel et al., 1985).  In humans, 
L-carnitine, which is both acquired from diet and biosynthesis, is another important source 
of TMAO (Rigault et al., 2006; Ussher et al., 2013).  It is found at high levels in poultry, red 
meat and some dairy products (Rigault et al., 2008). However, little L-carnitine is present in 
eggs and fish.  In a similar way to choline, TMA is produced from L-carnitine by bacterial 
reduction in the large bowel.  Flavin-containing monooxygenase-3 (FMO3), a hepatic enzyme 
rapidly oxidises TMA derived from bacterial metabolism to TMAO in the bloodstream (Wang 
et al., 2011; Zeisel, 1981; Zeisel et al., 1983).  Moreover, a high-protein diet has been 
associated with high urine TMAO concentration (Rasmussen et al., 2012).  Modification of 
the gut microbiota can be caused by a high-protein diet, which may affect the absorption of 
choline and L-carnitine in the small intestines.  In humans, DMA, TMA, and TMAO are 
excreted mainly in urine, as well as in sweat and exhaled air (Ufnal et al., 2015).  In healthy 
individuals, the concentration of TMAO in human blood plasma is in the range of 3 mmol/L, 
this increases to 40 mmol/L in patients with renal failure (Bain et al., 2006; Tang et al., 2013).   
There is also evidence that dietary TMAO and TMA may also be direct sources of TMAO in 
humans.  TMAO, TMA, and DMA is present at high concentrations in seafood (Bell et al., 
1991; Svensson et al., 1994).  Compared to the British population, increased urinary 
excretion of TMAO in the Swedish population has been reported and was linked with the 
higher fish consumption of the Swedish population (Lenz et al., 2004).   This is also seen when 
the Japanese population are compared with that of North America (Dumas et al., 2006).  
After treatment with broad-spectrum antibiotics, a reduction in the TMAO concentration in 
the blood of humans is seen (Tang et al., 2013; Wang et al., 2011).  This confirms that the 
key source of TMAO in the blood is gut bacteria and reduction of dietary TMAO by enteric 
bacteria, such as E. coli, is a likely contributing factor, as the TMA produced enters the 
bloodstream and is oxidised to TMAO in the liver in the gut producing TMA (see above) 
(Barrett and Kwan, 1985).   
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1.4.2.3. TMAO in cardiovascular disease 
Recent evidence shows that in humans, an elevated concentration of plasma TMAO is marker 
of an increased cardiovascular risk in humans (Koeth et al., 2013; Tang et al., 2013; Trøseid 
et al., 2015; Wang et al., 2014).  Foods that are abundant in phosphatidylcholine and L-
carnitine, such as red meat, egg yolks, and other products are considered to be atherogenic, 
suggesting a link between diet and CVD (Koeth et al., 2013).  A positive correlation between 
an increased cardiovascular risk and high blood plasma TMAO levels and has been 
determined (Koeth et al., 2013; Wang et al., 2014).  TMAO has been shown to affect lipid 
and hormonal homeostasis.  One study found that the development of atherosclerosis arise 
through TMAO as it may regulate sterol and cholesterol metabolism (Koeth et al., 2013).  This 
study showed that suppression of reverse cholesterol transport through gut microbiota-
dependent mechanisms is mediated by TMAO (Koeth et al., 2013).  Angiotensin II, a hormone 
involved in homeostasis of the circulatory system, is also affected by TMAO (Ufnal et al., 
2014).  Finally, TMAO is also know to affect protein folding (Bennion and Daggett, 2004; Ma 
et al., 2014; Mondal et al., 2013; Sarma and Paul, 2013), which may affect the activity of the 
enzymes and hormones involved in the control of the circulatory system homeostasis.   
However, TMAO may reduce the effects of oxidative stress and thus play a protective role in 
cardiovascular system.  For example, a significant increase in plasma TMA and TMAO levels 
after oral L-carnitine supplementation, decreases intracellular adhesion molecule-1, vascular 
cell adhesion molecule-1 and malondialdehyde, which are markers of vascular injury and 
oxidative stress (Fukami et al., 2015).  
1.4.2.4. Trimethylaminuria 
Trimethylaminuria, or fish odour syndrome, is an autosomal recessive disease (Hernandez et 
al., 2003). Trimethylaminuria is characterised by a FMO3 deficiency leading to both the 
accumulation of TMA in the body and its excretion in urine, breath, and sweat (Hernandez 
et al., 2003).  However, a number of healthy individuals have increased excretion of TMA in 
the absence of the classical features of trimethylaminuria (D'Angelo et al., 2013).  
1.4.2.5. Kidney disease 
End-stage renal disease results in low TMAO plasma clearance, which leads to the 
accumulation of TMA and TMAO (Bell et al., 1991).  Kidney ischemic damage causes the 
release of TMAO from the renal medulla due, which may be responsible for increased urine 
and plasma TMAO levels (Doucet et al., 2004; Hauet et al., 2000). 
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1.4.2.6. Diabetes  
High plasma TMAO levels may affect glucose metabolism and thus can be associated with 
diabetes mellitus (Gao et al., 2014; Li et al., 2012).  Compared to healthy individuals, patients 
with diabetes have a significantly higher median plasma TMAO concentration (Lever et al., 
2014).  Interestingly, TMAO was found to promote normal protein folding in diabetic rats, 
counteracting endoplasmic reticulum stress (Lupachyk et al., 2013).  
1.4.2.7. Cancer  
A recent study has positively linked plasma TMAO levels with colorectal cancer (CRC) (Bae et 
al., 2014).  It is known that a high consumption of red meat is associated with an increased 
risk for CRC (Norat et al., 2005).  TMA and DMA can become nitrosated (Lijinsky et al., 1972), 
which may act as potent carcinogens (Bartsch and Montesano, 1984).   Interestingly, whereas 
production of TMAO requires bacterial processing, the production of promutagenic 
nitrosated amines does not require the presence of bacteria to occur (Lunn et al., 2007; Tang 
et al., 2013; Ufnal et al., 2015).  
1.4.3. TMAO and fish spoilage  
In humans, most TMAO seems to come from the oxidation of TMA that is, produced by gut 
flora from TMAO (Koeth et al., 2013). However, may be synthesised endogenously by marine 
animals, although the mechanism of this is still unknown (Goldstein and Funkhouser, 1972).  
There is a higher concentration of TMAO in marine animals than in any other organism 
(Yancey, 2005).  Some contaminating bacteria, which may be present on marine organisms, 
are able to reduce TMAO to TMA.  It is the TMA that is responsible for the characteristic smell 
of decaying seafood.  This led to the usage of the TMA-to-TMAO ratio to indicate freshness 
in the fishing industry (Lundstrom and Racicot, 1983).  In fact, TMAO was first discovered in 
1909 in the muscle tissue of dogfish (Acanthias vulgaris) and bacterial reduction of TMAO 
was discovered through studying fish spoilage (Suwa, 1909).  The relationship between TMA 
production and increases in bacterial counts during the storage of marine fish was confirmed 
(Beatty and Gibbons, 1937).  Assays of the TMAO content in fish tissue showed that the 
concentration of this compound in all marine fish and molluscs was frequently more than 1% 
of the wet weight (Barrett and Kwan, 1985).  However, the concentration of TMAO in 
freshwater fish was shown to be negligible (Barrett and Kwan, 1985).  In the fishery industry, 
the demethylation of TMAO to DMA and formaldehyde catalysed by endogenous enzymes 
in the fish muscle (TMAO demethylases) is now a bigger problem than the bacterial reduction 
of TMAO to TMA (Sotelo et al., 1995).  
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1.5. Mechanisms of transcriptional repression 
Bacteria use different mechanisms to sense and respond to conditions within and outside 
the cell membrane.  These responses most frequently lead to the activation and/or 
repression of a number of genes to adapt cell physiology or metabolism to the new 
conditions.  Bacteria contain several sigma (σ) factors, each one directing RNA polyermase 
to a specific set of promoters (Gross et al., 1992), a strategy that is in itself the first level of 
regulation of transcription initiation. In principle, any factor inhibiting the access of RNA 
polyermase to the promoter can be considered a repressor. This definition includes not only 
the classical repressors but the anti-sigma factors as well.   
Regulatory proteins play key roles in responding to the different conditions that bacteria are 
exposed to.  Regulatory proteins come in two forms: activators or repressors.  Many 
repressors prevent transcription by binding DNA at positions that interfere directly with RNA 
polymerase binding (Gralla and Collado-Vides, 1996).  Thus, at many promoters subject to 
repression, operator sequences for a repressor are found to overlap or be immediately 
adjacent to the transcription start site.  Repressor proteins bind to operator sequences and 
directly prevent the transcription of target genes.  The process of repression can happen in 
one of two ways, depending on the repressor.  Some repressors bind operator DNA 
themselves and impede RNA polymerase access and thus transcription.  Expression of the 
target gene requires that a specific ligand, called an inducer, bind to the repressor, causing 
it to release from the operator DNA.   Because a small inducer molecule is required, the 
increased expression of the target gene is called induction.  The E. coli LacI when binding at 
the O1 operator of the lac promoter works in this manner (Straney and Crothers, 1987).  LacI 
and RNA polymerase can bind simultaneously to the lac promoter, forming a nonproductive 
complex that can be rendered productive upon addition of the inducer isopropyl-b-D-
thiogalactopyranoside (Straney and Crothers, 1987).  To exclude RNA polymerase from the 
promoter, a repressor does not necessarily need to bind to a site overlapping the RNA 
polymerase binding region. For example, the CytR repressor binds to position -70 at the E. 
coli deo promoter, helped by two flanking cyclic AMP receptor protein (CRP) dimers bound 
to positions -40 and -93 (as reviewed in Valentin-Hansen et al., 1996). 
Other repressor proteins do not bind well to operator DNA unless they first bind a small 
ligand called a co-repressor.  When the repressor protein binds to the co-repressor ligand, 
the complex binds to operator DNA strongly (Slonczewski and Foster, 2009).  As the co-
repressor ligand disappears, it is no longer available to bind to the repressor.  Thus, the 
repressor releases from the operator and the target gene is transcribed.  This process is 
32 
 
called derepression. The E. coli tryptophan biosynthesis operon (trp) is an example of a 
derepression system.  The expression of the trp operon is repressed 300-fold by the 
repressor TrpR (Klig et al., 1988).  TrpR-tryptophan bind the trpL promoter, possibly directly 
blocking binding by RNA polymerase and thus repressing the expression of the tryptophan 
biosynthesis machinery (Klig et al., 1988).   
Thus, a number of different molecular mechanisms are responsible for the repression of 
transcription in bacteria.   
1.6. Aims of this work 
The information provided above shows that TMAO is present in many environments that E. 
coli and other enteric bacteria inhabit.  Thus, enteric bacteria have evolved to utilise TMAO 
as an alternative electron acceptor.  This process has been well characterised.  However, 
respiration of TMAO is hypothesised to sit outside the conventional hierarchy of regulation 
of respiration in E. coli.  TMAO respiration is not regulated by FNR or ArcBA, as other modes 
of the metabolism are to ensure the most energetically efficient electron acceptor present 
is used.  Further evidence for this mode of respiration sitting out of the regulatory hierarchy 
is shown because TMAO is respired by E. coli in the presence of oxygen, the preferred 
electron acceptor.  Recently, TMAO has been the focus of a number of publications, linking 
the molecule to various disease processes in humans.  Based on current evidence, the 
hypothesis is that respiration of TMAO by E. coli is not regulated in the same way as other 
modes of the respiration, i.e. no involvement of ArcBA or FNR, and the presence of TMAO 
simply results in the induction of the E. coli TMAO reductases.  The experiments described in 
this thesis were carried out to test this hypothesis using a range of molecular techniques.   
A range of different state of the art molecular technqiues are planned to be used in order to 
study this hypothesis and see if using these newer techniques can highlight any additional 
information, adding further to the body of previous knowledge.  One of the techniques 
planned to be used is transcriptional profiling using microarrays.  Using this method should 
enable the study of the change in transcript levels in E. coli in response to TMAO.  This will 
highlight any changes that occur in dynamic environmental conditions in real-time.  
Metabolite profiling is also planned to be used, in order to determine the different 
metabolites produced by E. coli in the presence of TMAO.  NMR is used to carry out 
metabolite profiling and enables accurate detection of different metabolites in complex 
cultures.  Transcript and metabolite profiling can then be used to garner information on the 
expression levels and activities of various TFs involved in the initiation of the E. coli response 
to TMAO.  All of this will be carried out on chemostat cultures, to ensure reproducibility and 
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accuracy.  It is hoped that using such molecular techniques may highlight new findings, which 
could add to the body of knowledge around TMAO respiration by E. coli.   
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2. Materials and Methods 
2.1. Strains and plasmids 
The strains of Escherichia coli used in this study are listed in Table 2.1.  Strains were 
maintained on LB agar plates (containing antibiotics where appropriate) at 4oC and 
subcultured every 6 – 8 weeks.  Longer term storage was in LB medium (containing 
antibiotics where appropriate) containing 7% (v/v) dimethylsulfoxide (DMSO) at -70oC. 
Plasmids used in this study are described in Table 2.2.  Plasmids were stored in distilled H2O 
(dH2O) at -20oC.   
2.2. Media  
All heat stable solutions were sterilised by autoclaving at a pressure of 1.1 kg cm-2 at 121oC 
for 20 min.  Heat labile solutions were sterilised by filtration through a 0.2 µm membrane.   
2.2.1. Rich media 
Luria Bertani (LB) medium and agar      (L-1) 
          Tryptone        10 g 
Yeast Extract        5 g 
NaCl         10 g 
Agar (when added)      15 g 
pH 7.0 
Rich medium         (L -1) 
Tryptone       32 g 
Yeast extract       20 g  
MgSO4.7H2O       0.16 g 
K2HPO4        6 g 
NH4NaHPO4.4H2O      2.4 g 
pH 7.0  
2.2.2. Minimal media 
Evans minimal medium        (L-1) 
2 M NaH2PO4.2H2O        5 ml  
 2 M KCl         5 ml    
0.25 M MgCl2.6H2O        5 ml  
 4 M NH4Cl         25 ml  
 
35 
 
Table 2.1. Strains of Escherichia coli used in this study 
Strains  Relevant characteristics  Source or reference  
K-12   
MG1655  F- λ- ilvG- rfb-50, rph-1 Lab collection  
JRG6703 MG1655 ΔfrmRAB (KnR) This work 
JRG6705 MG1655 PtorC-gfp, ΔtorC (KnR) This work  
JRG6726 JRG6703/ pGS2486 (KnR, ApR) This work 
JRG6825 JRG6703/ pGS2547 (KnR, ApR) This work 
JRG6826 JRG6703/ pGS2548 (KnR, ApR) This work 
JRG6437 MG1655/ pKD4 (KnR) Lab collection 
ER2925 ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 
galK2 galT22 mcrA dcm-6 hisG4 rfbD1 
R(zgb210::Tn10)TetS endA1 rpsL136 
dam13::Tn9 xylA-5 mtl-1 thi-1 mcrB1 hsdR2 
(CmR) 
New England BioLabs, Inc. 
JRG6842 ER2925 PtorC-gfp, ΔtorC (CmR, KnR) This work 
B-strain    
BL21 λ(DE3) Escherichia coli BL21 λ(DE3) lysogen 
carrying a copy of the T7 RNA polymerase 
under the control of the IPTG-inducible 
lacUV5 promoter  
Lab collection 
JRG6782 BL21/ pGS2516 (ApR) This work 
JRG6783 BL21/ pGS2517 (ApR) This work 
JRG6784 BL21/ pGS2518 (ApR) This work 
JRG6437 BL21/ pVJS1043 (ApR) Lab collection 
ApR – ampicillin resistant, KnR- kanamycin resistant, CmR – chloramphenicol resistant strain.   
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Table 2.2. Plasmids used in this study  
Plasmid  Relevant characteristics  Source or reference  
pGS2486 ApR, plasmid encoding the MG1655 frmRAB 
operon plus 300 bp of the upstream native 
promoter region. 
This work   
pGS2547 ApR, plasmid encoding the MG1655 frmRAB 
operon plus 300 bp of the upstream native 
promoter region, with the frmR gene 
carrying a C35A mutation.   
This work   
pGS2548 ApR, plasmid encoding the MG1655 frmRAB 
operon plus 300 bp of the upstream native 
promoter region, with the frmR gene 
carrying a P2A mutation.   
This work   
pVJS1043  ApR, pMAL plasmid containing narL gene 
for overexpression of MBP-NarL fusion 
protein. 
Lab collection  
pKD4 KmR, plasmid encoding a kanamycin 
resistance cassette for the use in λred 
recombination method of gene deletion.   
Lab collection 
pSIM18 HygR, deriviative of pSC101 carrying 3 λred 
genes (gam, bet and exo) under the control 
of the λ pL promoter, which is regulated by 
the temperature sensitive Cl857 repressor. 
Lab collection 
pDOC-G KmR, plasmid allowing C-terminal tagging of 
chromosomal genes or promoter regions 
with a GFP tag or deletion of chromosomal 
regions. 
Lab collection  
pGS2516 ApR, pET22a plasmid carrying frmR for 
overexpression of untagged FrmR 
Dr Peter Chivers, 
University of Durham 
pGS2517 ApR, pET22a plasmid carrying frmR, with a 
C35A, mutation for overexpression of 
untagged FrmR C35A 
Dr Peter Chivers, 
University of Durham 
pGS2518 ApR, pET22a plasmid carrying frmR, with a 
P2A, mutation for overexpression for 
overexpression of untagged FrmR P2A 
Dr Peter Chivers, 
University of Durham 
ApR – ampicillin resistance, KnR - kanamycin resistance, HygR – hygromycin resistance genes on the 
plasmids listed.   
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0.4 M Na2SO4         5 ml  
 Titriplex (nitrilotriacetic acid)       0.38 g   
0.004 M CaCl2.2H2O        5 ml  
 Trace elements        5 ml  
 3 mg/ml sodium selenite     10 μl    
pH 6.9  
Evans medium buffered with 50 mM phosphate buffer   (L-1) 
 As above except 2 M NaH2PO4.2H2O (5 ml) was replaced with: 
1 M Na2HPO4         33 ml  
1 M NaH2PO4.2H2O        17 ml   
Trace elements        (L-1) 
ZnO         0.41 g 
FeCl3.6H2O       5.40 g 
MnCl2.4H2O       2.00 g 
CuCl2.2 H2O       0.17 g 
CoCl2.6 H2O       0.48 g  
H3BO3        0.06 g 
Na2MoO4.2 H2O       4.00 mg 
HCl (37%)       8.00 ml 
2.2.3. Media supplements  
Bacteria carrying antibiotic resistance plasmids or cassettes were grown in the presence of 
the appropriate antibiotics.  Antibiotics were added to the autoclaved media (cooled to 50oC) 
at the following concentrations: 
Ampicillin      100 µg ml-1 
Kanamycin      25 µg ml-1 
Hygromycin      100 µg ml-1 
Chloramphenicol     25 µg ml-1 
Other supplements were used at the following concentrations 
Glucose      20 mM  
2.3. Culture techniques 
2.3.1. Chemostat culture of Escherichia coli MG1655 
Escherichia coli K-12 sub-strains MG1655 and JRG6705 were used to establish steady-state 
continuous cultures in a 2 L Labfors chemostat (Infors-HT, Bottmingen, Switzerland) at 37oC, 
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a 0.2 h-1 dilution rate, a 950 ml working volume, a stirring rate of 400 rpm and a gas flow rate 
of 1 L/min.  The pH was maintained at 6.9 by titration with 1 M NaOH.  Continuous cultures 
were grown in 20 mM glucose-limited Evans minimal medium plus antibiotic when required.  
Initially, 5 ml of overnight culture was added to 1 L Evans medium in the chemostat. This was 
batch cultured aerobically overnight, before starting the medium feed (0.2 h-1) and setting 
the gas mix to anaerobic (N2 and 5 % CO2 gas, (BOC)) to establish a fermentative steady-state 
over the next 24 h.  After 24 h the fermentative steady-state samples were taken from the 
chemostat using SureSEAL universal tubes.  Then the culture was perturbed by adding 45.76 
± 1.48 mM TMAO to both the Evans feed and directly into the chemostat.  Transcriptomic 
and metabolite samples (Section 2.7) were taken at 2, 5, 10, 15, 20 and 60 min after the 
addition of TMAO (~40 mM).  The chemostat was then left to establish a TMAO respiratory 
steady-state over 24 h, before final samples were taken.   
2.3.2. Aerobic batch culture of Escherichia coli MG1655 
Escherichia coli strains were grown in liquid batch cultures in either LB, Evans medium pH 7.0 
or in Evans medium pH 7.0 buffered with 50 mM phosphate, with supplements as indicated.  
Cultures were grown in conical flasks with vigorous shaking (250 rpm) at 37oC, unless 
otherwise indicated.  Cell growth was monitored by measuring optical density at 600 nm.  
Cultures on solid medium were grown on LB plates at 37oC unless otherwise indicated.    
2.3.3. Anaerobic batch culture of Escherichia coli MG1655 
Liquid cultures were grown in in either LB, Evans medium pH 7.0 or in Evans medium pH 7.0 
buffered with 50 mM phosphate, with supplements as indicated.  Cultures were grown in 
air-tight bottles filled to the top.  Anaerobic cultures were grown at 37oC without shaking.   
2.4. Cell viability assays  
Anaerobic cultures were grown overnight at 37oC in Evans medium, buffered with 50 mM 
phosphate buffer, pH 7.0, and supplemented with 20 mM glucose in 7 ml bijoux filled to the 
top.  After overnight growth, a 10% inoculum of the cultures was added to 7 ml fresh Evans 
medium in an anaerobic workstation.  Pre-treatment viable counts were measured from this 
culture, by serial dilution in Evans medium.  The 7 ml culture was then split in half (2 x 3.5 
ml), and 40 mM TMAO was added to one of the two subcultures.  The cultures were 
incubated in parallel anaerobically for 1 h at 37oC, before post-treatment viable counts for 
both cultures were measured.  Plated cells were grown overnight at 37oC on LB agar, 
supplemented with antibiotics when appropriate, and CFUs ml-1 calculated.  Viability assays 
were carried out with three technical repeats and three biological replicates for each strain.   
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2.5. Formaldehyde-sensitivity of FrmR mutants in vivo 
A 1% (v/v) inoculum of an overnight culture of E. coli JRG6703, harbouring either pGS2497 
(frmR wild type), pGS2547 (frmR P2A) or pGS2548 (frmR C35A) was grown in LB aerobically 
until A600 0.5 was reached. Cultures were then diluted to A600 0.05 in LB, in LB medium in a 
sterile 96-well plate.  Formaldehyde was added to the cultures, with an increasing 
concentration gradient across the plate (0-1650 µM), with total volume adjusted to 200 μl.  
The growth of the cultures aerobically at 37oC with shaking (250 rpm) was monitored using 
a Sunrise absorbance reader (Tecan), with A595 recorded for 25 kinetic cycles at intervals of 
20 min. Biological replicates were carried out in triplicate.  The maximum growth rate (μmax 
h-1) for each strain was determined using the steepest part of the growth curve.   
2.6. Transformation 
2.6.1. Preparation of electrocompetent cells 
Strains were grown overnight from a single colony in 5 ml LB. An aliquot (2.5 ml) of this 
culture was then used to inoculate 250 ml LB and grown at 37oC with 250 rpm shaking until 
an A600 of 0.6 was reached.  Cells were chilled on ice for ~20 min before being harvested by 
centrifugation at 6,000 g for 10 min at 4oC.  The cells were then kept on ice throughout the 
rest of the protocol.  Cells were resuspended in 50 ml ice-cold 10% (v/v) glycerol.  
Centrifugation and washing was repeated for 3 washes.  Finally, the cells were resuspended 
in 1-2 ml of ice cold 10% (v/v) glycerol to form a thick cell suspension.  Competent cells were 
kept on ice and used with 2 h.   
2.6.2. Bacterial transformation 
Electrocompetent cells (50 µl), were mixed with up to 1 µg of purified plasmid DNA.  The cells 
were left on ice for 10 min and then transformed by electroporation using a Hybaid Cell Shock 
unit.  Luria-Bertani medium (1 ml) was immediately added to the cells, before being 
incubated for 1 h with shaking at 37oC.  The cells were then plated on selective agar plates 
and grown overnight at 37oC.  Any colonies that grew overnight on selective media were 
analysed.   
2.7. Sampling of chemostat cultures 
2.7.1. RNA 
At each time-point, culture samples (6 ml) were removed from the chemostat vessel 
(anaerobic) using SUREseal tubes (SLS select), directly into 12 ml RNAprotect Bacteria 
Reagent (QIAGEN).  The samples were vortexed immediately for 5 s, before being centrifuged 
at 4,020 g for 10 min.  Pellets were resuspended in the residual supernatant, which was then 
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centrifuged at 8,000 g for 3 min.  Excess supernatant was removed by gentle tapping of the 
inverted tubes.   
2.7.2. Cell pellets 
Chloramphenicol (20 µl of 25 mg ml-1) was added to 6 ml of culture to prevent protein 
synthesis after removal from the chemostat.  The culture was pelleted via centrifugation for 
3 min at 10,000 g.  Cell pellets were then stored at -80oC.    
2.7.3. Supernatant  
Samples of culture (6 ml) were pelleted by centrifugation at 3,400 g for 10 min.  The 
supernatant was then filtered using a 0.2 µm syringe filter (Sartorius Stedim biotech).  
Samples were at -80oC until required.    
2.7.4. Stabilisation of phospho-Asp residues 
Chemostat culture samples (6 ml) were collected directly into chloramphenicol (50 mg ml-1 
final concentration) and formic acid (1 M final concentration) as previously described (Rolfe 
et al., 2011).  Aliquots of the suspension (500 µl) were pelleted by centrifugation (8,000 g for 
3 min) in 1.5 ml Eppendorf tubes and resuspended in 50 μl of 1 M formic acid, before storing 
at -80oC. 
2.7.5. Cell dry weight 
Falcon tubes (15 ml) were weighted to a milligram degree of accuracy.  Culture (10 ml) was 
added to half of the tubes, before centrifugation at 3,400 g for 10 min.  The supernatant was 
poured off, and the pellet resuspended in molecular grade water (Sigma), before further 
centrifugation at 3,400 g for 10 min.  All tubes were dried in an oven overnight, after the 
removal of the supernatant.  The tubes were re-weighed, the following day; weight change 
of tubes containing sample after addition of observed weight loss due to heating of the tubes 
lacking cells was equivalent to cell dry weight.   
2.8. Nucleic acid methods 
2.8.1. PCR amplification 
2.8.1.1. Oligonucleotide primers 
Oligonucleotide primers (20 – 60 bases) were designed to anneal to DNA sequences flanking 
those to be amplified.  Generally, the G and C content was 50-60%, the Tm was 55-80oC with 
comparable annealing temperature for primer pairs.  Primer design was carried out using 
Primer3 software.  All oligonucleotides were synthesised by Eurofins Genomics (Ebersberg).  
The synthetic oligonucleotides used in this work are listed in Appendix 1. 
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2.8.1.2. Polymerase chain reaction (PCR) 
All PCR reactions were carried out using a Techne TC-3000 thermocycler.  Typical conditions 
were as follows: 
Forward primer     0.5 µM 
Reverse primer     0.5 µM 
Template DNA     ~250 ng 
DMSO       3% (v/v) 
Phusion High-Fidelity PCR Master Mix1 (2X) 25 µl 
dH2O      to 50 µl   
1 The Phusion High-Fidelity PCR Master Mix with HF buffer (New England BioLabs Inc.) was composed of Phusion 
DNA polymerase (1 U), 1.5 mM MgCl2, dNTPs (200 µM each) in HF buffer.   
The DNA polymerase was added last to the mixtures, immediately prior to placing the 
reactions in the thermocycler.  The following basic programme was used: 
98oC, 30 s     1 cycle 
98oC, 10 s; 55 – 70oC2, 30 s; 72oC, 30 – 90 s3  30 cycles  
72oC, 8 min     1 cycle 
4oC 
2The annealing temperature depended on the Tm of the primers.   
3The extension time was dependent on the size of the fragment being amplified, with 30 s per kb being used.   
The PCR products were purified by PCR purification kit (QIAGEN) (Section 2.8.2) or by gel 
extraction kit (QIAGEN) (Section 2.8.3) after analysis by gel electrophoresis (Section 2.8.8). 
2.8.2. PCR purification 
PCR products were purified using QIAquick PCR purification kit (QIAGEN) following 
manufacturer’s instructions, with DNA being eluted into 50 µl of molecular grade water 
(Sigma). Purified PCR products were stored at -20oC.   
2.8.3. Gel extraction 
DNA fragments were removed from agarose gels and purified using the QIAquick Gel 
Extraction kit (QIAGEN) according to manufacturer’s instructions.  
2.8.4. Purification of plasmid DNA 
Plasmid DNA purification from 5 ml (high-copy number plasmid DNA) or 10 ml (low-copy 
plasmid DNA) of aerobic overnight E. coli cultures in LB broth was carried out using the 
QIAprep Spin Miniprep Kit (QIAGEN), according to the manufacturer’s instructions.   
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2.8.5. Purification of genomic DNA 
Genomic DNA was purified using DNeasy kits (QIAGEN) from 1 ml of an overnight aerobic 
culture.  This protocol yields up to 40 µg of genomic DNA.   The kit was used to purify genomic 
DNA using the protocol outlined in the manufacturer’s instructions.   
2.8.6. Isolation of RNA 
RNA was isolated from sample pellets using a RNeasy Mini kit (50) (QIAGEN) according to the 
manufacturer’s instructions.  Briefly, RNeasy-stabilised cell pellets (Section 2.7.1) were 
resuspended in 200 μl TE buffer containing lysozyme (15 mg ml-1), mixed by vortexing for 10 
s and incubated at room temperature for 5 min.  Samples were vortexed for 10 s every 
minute during the incubation time.  Buffer RTL, 700 μl, containing β-mercaptoethanol (10 μl 
ml-1) was added, followed by vigorous vortexing and centrifugation at 20, 000 g for 2 min.  
The resulting supernatant was transferred to a clean tube and 500 μl of ethanol (96% (v/v)) 
was added.  The lysate (including any precipitation) was transferred to an RNeasy Mini spin 
column, placed in a 2 ml collection tube, and centrifuged for 15 s at 8,000 g, with the flow 
through discarded.  Buffer RW1 (350 μl) was added to the column and centrifuged for 15 s 
at 8,000 g to wash the membrane.  After the flow through was discarded, a mixture of 10 μl 
DNase I (27 Kunitz units) and 70 μl Buffer RDD was transferred directly onto the RNeasy 
column gel membrane and incubated at room temperature for 15 min.  Buffer RW1, 350 μl, 
was then added to the spin column and centrifuged for 15 s at 8,000 g following 5 min 
incubation at room temperature.  The column was then transferred to a new 2 ml collection 
tube and washed twice with buffer RPE (500 μl).  To elute RNA, 30 μl RNase-free H2O was 
pipetted directly on the membrane of the column and centrifuged for 1 min at 8,000 g.  The 
concentration and purity of isolated RNA was determined (Section 2.8.7).   
2.8.7. Quantification of nucleic acid concentration and purity 
Determination of DNA and RNA purity and concentration was by means of a Nanodrop ND-
1000 UV-VIS spectrophotometer, using 2 µl of sample.  The pre-configured methods for 
measuring dsDNA and RNA concentrations at 260 nm wavelength were used.  The purity of 
samples was assessed using the A260/A280 ratio, whereby a ratio between 1.7 and 2.0 shows 
high-purity as defined in the Two-Color Microarray-Based Prokaryote Analysis (FairPlay III 
Labeling) Protocol (Agilent, 252009).  The purity of RNA samples was also determined by 
running on an agarose gel (Section 2.8.8) and looking for the presence of two distinct species 
corresponding to ribosomal RNA (rRNA) to show a lack of RNA degradation in the samples.   
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2.8.8. Agarose gel electrophoresis  
Analysis, recovery and purification of target DNA fragments were carried out using agarose 
gel electrophoresis using a Flowgen electrophoresis apparatus and concentrations of 1-3% 
(w/v) agarose gels (depending on size of fragment) buffered with 1X TAE buffer 
supplemented with 1:10,000 GelRed (Biotium). DNA loading buffer, 5X, (Bioline) was added 
to DNA samples with 10 to 100 ng of DNA loaded per lane.  HyperLadder I (Bioline) (200 ng) 
was run as a marker alongside the samples to estimate the sizes of DNA fragments. DNA was 
visualized by exposure to a source of ultraviolet light (254 nm).  
50x TAE buffer 
Tris    242 g 
Glacial acetic acid  57.1 ml 
EDTA, pH 8.0 (0.5 M) 100 ml 
dH2O   to 1 L   
2.8.9. DNA digestion with restriction endonucleases  
Restriction endonucleases were used with compatible 10X buffers.  In the case of double 
enzyme digestion, a 10X buffer was chosen to maintain conditions for both enzyme activities.  
Digestions were usually performed in a 20 µl reaction mixture containing 0.5 – 50 µg of DNA 
and 5 units of enzyme per 1 µg of DNA.  Reactions were incubated at 37oC for 1 – 3 h.  
Reactions were loaded directly onto agarose gels for analysis and purification of the 
separated fragments.   
2.8.10. Site-Directed Mutagenesis (SDM) 
Site-Directed Mutagenesis was carried out using QuickChange II XL Site-Directed 
Mutagenesis kit (Agilent).  The manufacturer’s instructions were followed, using the 
following oligonucleotide primers to introduce the required mutations to pGS2486: C35A, 
pGS2516 C35A SDM F and pGS2516 C35A SDM R; P2A, pGS2516 P2A SDM F and pGS2516 
P2A SDM R (Appendix 1). Briefly, two complementary primers containing the desired 
mutation flanked by the unmodified nucleotide sequence, were designed and synthesised. 
Thermo cycling was used to synthesise the mutant strand, using the reaction:  
10X reaction buffer     5 μl 
pGS2486 DNA      10 ng 
Forward primer     125 ng 
Reverse primer     125 ng 
dNTP mix       1 μl 
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QuikSolution reagent     3 μl  
PfuUltra HF DNA polymerase (2.5 U/μl)  1 μl 
dH2O       to 50 μl  
Each reaction was cycled following the profile outlined below:  
95oC, 1 min  1 cycle  
95oC, 50 s   18 cycles  
60oC, 50 s   18 cycles  
68oC, 7 min   18 cycles  
68oC, 7 min  1 cycle 
The reactions were incubated on ice for 2 min after thermo cycling.  The reactions were then 
digested with Dpn1 (10 U) for 1 h at 37°C.  Digested DNA products (2 μl) were used to 
transform E. coli XL10-Gold ultracompetent cells (Agilent) via heat shock at 42°C as per 
manufacturer’s instructions. Each reaction was plated on agar plates with the appropriate 
antibiotic and incubated at 37°C for 24 h.  Plasmids were then isolated and sequenced to 
confirm base changes, before being used to transform relevant host strains.   
2.8.11. Gene deletion and creating a reporter fusion using the λred system  
All mutant and reporter fusion strains used in this study were constructed using λred 
recombineering (Datsenko and Wanner, 2000).  In this procedure, recombination requires 
the phage λred recombinase, which is synthesised under the control of an inducible 
promoter.  Firstly, PCR products were generated using primers with 40 nucleotide extensions 
(Appendix 1), which were homologous to regions adjacent to the gene to be modified and 
the template plasmids (pKD3, pKD4 or p-DOC-G) (Table 2.2) carrying the appropriate 
antibiotic resistance genes/reporter genes that are flanked by FRT (FLP recognition target) 
sites.  PCR products were purified using a PCR purification kit (Section 2.8.2) or by gel 
extraction (Section 2.8.3) to select for DNA of the correct size, if multiple PCR products were 
present.  Mutants of the required gene/reporter fusions were isolated as antibiotic resistant 
colonies after transformation of bacteria carrying the λred expression plasmid, pSIM18 
(Table 2.2), by the linear PCR product (3 – 5 µg).  Correct insertion of the antibiotic resistance 
cassette was confirmed by extracting total genomic DNA, carrying out PCR using upstream 
and downstream sequencing primers (Appendix 1) and then sequencing the PCR product.  
Once a mutant had been successfully created, the cassette was transferred to a genetically 
clean strain, using generalised P1 transduction (Section 2.9).   
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2.8.12. In-Fusion HD cloning system 
The In-Fusion HD cloning system (Clonetech) was used to create plasmid pGS2486.  A purified 
PCR fragment encoding the frmRAB operon and its own promoter region with appropriate 
15 bp overhangs (synthesised with primers Frm In-Fusion F and Frm In-Fusion R) (Appendix 
1) was incubated with linearised pBR322 vector (digested with EcoR1 as described in Section 
2.8.11) according to manufacturer’s instructions.  The reaction was as follows: 
5X In-Fusion HD Enzyme Premix   2 μl 
Linearised pBR322 vector    50 ng 
frmRAB PCR product with 15 bp overhangs 80 ng 
Nuclease-free water    To 10 μl final volume 
Part of the reaction mix (2.5 μl) was then transferred into Stellar Competent Cells, which 
were then plated onto ampicillin containing LB agar plates.  Ampicillin resistant colonies were 
then selected, re-streaked onto fresh plates, and the insertion of frmRAB was confirmed by 
isolating the plasmid and carrying out PCR (with primers Frm In-Fusion seq F and Frm In-
Fusion seq R).  The DNA sequence of the frmRAB insertion was verified by sequencing and 
the plasmid was used to transform E. coli JRG6703 (Table 2.1).  
2.8.13. Transcriptomics: Microarray analyses  
An indirect method of microarray analysis was used, with cDNA samples labelled with the 
Cy3 fluorophore and E. coli MG1655 genomic DNA labelled with Cy5 fluorophore as a 
reference.  The indirect method has advantages over dye-swap experiments, such as multiple 
datasets, for which genomic DNA has been used as a reference can be compared (Yang and 
Speed, 2002).      
2.8.13.1. Direct labelling of genomic DNA 
Labelling of genomic DNA was carried out using a protocol based on the BioPrime DNA 
Labeling Kit (Invitrogen, 18094-011).  Escherichia coli MG1655 chromosomal DNA (2.0 μg) 
(Section 2.8.5), was added to a sterile Eppendorf tube and the volume made up to 21 μl.  To 
this was added 20 μl of 2.5X Random Primer/Buffer Mix (Invitrogen) before boiling for 5 min, 
followed by incubation on ice for 5 min.  On ice 5 μl of 10X dNTP mix (1.2 mM each dATP, 
dGTP, dTTP; 0.6 mM dCTP, 10 mM Tris pH 8.0; 1 mM EDTA), 3 μl Cy5-dCTP (1 mM stock, 
Amersham) and 1 μl of Klenow (40 U) (Invitrogen) was added, before being incubated 
overnight at 37oC.  Following the incubation, the labelling reaction was cleaned up using the 
QIAquick PCR purification kit (QIAGEN) (Section 2.8.2), making sure to wash with buffer PE 
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twice and eluting the labelled DNA into 50 μl RNase-free H2O.  The concentration of DNA and 
labelling efficiency of the Cy5 dye were determined using the Nanodrop spectrophotometer.   
2.8.13.2. cDNA synthesis and labelling 
RNA (16 μg) (Section 2.7.1 and 2.8.6) for each sample was incubated with 5 μg random 
primers (Invitrogen) in a PCR block for 10 min at 72oC, then chilled on ice for 10 min.  cDNA 
synthesis was initiated by adding a reaction mixture consisting of 6 μl 5X First Strand (FS) 
buffer (Invitrogen), 3 μl 0.1 M DTT (Invitrogen), 0.6 μl 50X dNTPs (25 mM dATP, dGTP, dTTP 
and 10 mM dCTP) and 2.9 μl nuclease-free H2O.  Cy3-dCTP (1 mM stock, GE Healthcare), 2 
μl, and 1.5 μl SuperScript III (200 U ml-1) were added to each sample followed by a 5 min 
incubation at 25oC, then incubation overnight at 50oC.  Samples were hydrolysed by addition 
of 15 μl of freshly prepared 0.1 M NaOH and incubation at 72oC for 10 min, followed by 
neutralisation with 15 μl 0.1 M HCl.  Labelling reactions were purified using the QIAquick PCR 
purification kit (QIAGEN) (Section 2.8.2), washing with buffer PE twice and eluting the 
labelled DNA into 50 μl RNase-free H2O.  Labelled Cy3-cDNA was quantified using the 
Nanodrop spectrophotometer.  The following equations were used to calculate the yield of 
cDNA and its specific activity: 
Yield of cDNA: 
cDNA (ng) = A260 x 330 ng μl-1 x 50 μl (sample volume) 
Specific activity: 
(Concentration of Cy3) / (Concentration of cDNA) * 1000 = pmol Cy3 or per μg cDNA 
The samples were hybridised if the yield was >825 ng and the specific activity was >8 pmol 
Cy3 per μg cDNA.  
2.8.13.3. Hybridisation and washing of hybridised array slides 
To a 1.5 ml nuclease-free microfuge tube was added an appropriate volume of Cy3-labelled 
cDNA and Cy5-labelled gDNA to give a final concentration of 400 ng of each.  Nuclease-free 
water was added to make up the final volume to 25 μl, before boiling samples at 100oC in a 
PCR block for 2 min followed by chilling on ice for 2 min.  Blocking agent (5 μl of 10X stock) 
was then added to each reaction, followed by 25 μl 2X GEx Hybridization Buffer HI-RPM 
before being immediately loaded onto the array.  The Agilent SureHyb hybridisation chamber 
was assembled and 40 μl of sample was slowly dispensed onto a gasket well in “drag and 
dispense” manner.  An array slide (Agilent E.coli Custom Gene Expression Microarray) was 
placed “active side” down onto the SureHyb gasket slide.  The slide chamber was placed in a 
rotisserie in a hybridisation oven set to 65oC with gentle rotation at 10 rpm for 17 h.  The 
47 
 
washing of hybridised slides was carried out according to the Two-Color Microarray-Based 
Prokaryote Analysis (FairPlay III Labeling) Protocol.  Before use, the equipment was washed 
with MilliQ H2O at least 4 times.  Gene Expression (GE) wash buffers were supplemented 
with 0.005% Triton X-102 (Agilent).   
2.8.13.4. Scanning of slides 
Slides were scanned immediately after washing using an Agilent DNA microarray scanner 
(Agilent Technologies, G2505) using the Agilent Scan Control software (v8.5), according to 
the scanning instructions in the Two-Color Microarray-Based Prokaryote Analysis (FairPlay III 
Labeling) Protocol (Agilent, 252009).  This resulted in two colour .tiff image files being 
produced for further analysis.   
2.8.13.5. Analysis of data  
Data acquisition from the .tiff images was carried out using Agilent Feature Extraction 
software (v6.5), which allows quantification of the Cy3 fluorescence of each feature from the 
scanned array image.  Data were normalised and interpreted using GeneSpring 7.3.1.  The 
LOWESS normalisation was applied and identification of statistically significant gene 
expression changes was achieved by applying a t-test with a 3-fold cut off and p <0.05.  Three 
biological replicates were carried out for microarrays, using three different chemostat 
cultures.  The relative activities of TFs were inferred using the software package TFInfer as 
previously described (Asif et al., 2010). 
2.8.14. Quantitative real time-PCR (qRT-PCR) 
The Brilliant III Ultra-Fast SYBR Green QPCR Master Mix (Agilent) was used as a one-step for 
quantitative PCR amplifications.  In this system, direct detection of the PCR product was 
monitored by measuring the increase in fluorescence, as an indicator of amplicon 
production, caused by binding of SYBR green dye to double-stranded DNA.  Fluorescence 
data were acquired when the PCR amplification was in the exponential phase.  The cycle 
threshold (CT) at which the SYBR green dye emission intensity rose above the background 
noise was determined.  CT is inversely proportional to the copy number of the target 
template and therefore the greater the template concentration, the lower the CT value. 
2.8.14.1. RT-PCR oligonucleotide primer design 
Primers used for RT-PCR were designed using Primer3 software to give PCR products within 
the target genes of approximately 100 bp in size.  The primers were approximately 20 
nucleotides in length, had Tm ~60oC and primer pairs were designed to have similar annealing 
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temperatures. All oligonucleotides were synthesised by Eurofins Genomics (Ebersberg).  The 
synthetic oligonucleotides used for RT-PCR are listed in Appendix 1. 
2.8.14.2. Amplification of target and control genes 
Anaerobic cultures were grown overnight at 37oC in Evans medium buffered with 50 mM 
phosphate buffer, pH 7.0 and supplemented with 20 mM glucose.  The amounts of stabilised 
frmR mRNA in samples of total RNA (100 ng; stabilised as in Section 2.7.1 and isolated as in 
Section 2.8.6) after exposure to different concentrations of TMAO (0 – 40 mM) for 30 min 
were determined on an RT-PCR plate in a Mx3005P Thermocycler (Agilent Technologies).  In 
order to calculate expression levels of the target gene, frmR, a control housekeeping gene, 
gyrA, was also amplified to allow a relative comparison to baseline expression levels.  A single 
reagent mixture for replicate experimental reactions was prepared, so that each individual 
reaction was composed of the following: 
SYBR Green QRT-PCR Master Mix4 (2X)   10 µl 
Upstream primer     500 nM 
Downstream primer     500 nM 
DTT (100 mM)      0.2 µl 
RT/RNase block5      1 µl    
Nuclease-free dH2O     up to 20 µl  
Isolated RNA (20 ng µl-1)    5µl 
4 SYBR Green QRT-PCR Master Mix was composed of a mutated Taq DNA polymerase, 2.5 mM MnCl2, dNTPs, 
DNA-binding dye SYBR Green I and a buffer formulated for fast cycling.    
5 RT/RNase block provided in the SYBR Green QRT-PCR Master Mix 
As a negative control, no-template control reactions were produced for each primer pair, 
with the addition of 5 μl nuclease-free water instead of RNA.  The reactions were gently 
mixed without creating bubbles and then briefly centrifuged.  The following programme was 
used on the Mx3005P Thermocycler: 
50oC, 10 min   1 cycle 
95oC, 3 min   1 cycle 
95oC, 15 s; 60oC, 20 s  40 cycles 
Fluorescence data was collected for each cycle at the 60oC step and analysed by the machine.  
Each primer pair was tested in duplicate and biological repeats (e.g. RNA from cells with and 
without TMAO treatment) were carried out in triplicate.   
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2.8.14.3. Standard curve method 
For a comparison of expression levels to be valid, the rate of amplification of the target and 
control genes must be similar.  This was determined by measuring the CT values for each 
primer pair using genomic DNA as the template.  The genomic DNA was serially diluted and 
the CT values measured and plotted against the log concentration of DNA.  A best fit line was 
applied and the gradient and intercept derived from the equation of the straight line.   
Each reaction was carried out in 25 μl volumes, as in Section 2.8.14.2, but the DNA template 
used here was genomic DNA (Section 2.8.5).  Serial dilutions of the genomic DNA were 
carried out across the plate in a range of 100 ng to 0.2 ng, for each primer pair.  As a negative 
control, no-template control reactions were added for each primer pair, with the addition of 
5 μl ultra-pure water instead of the genomic DNA.  The data was collected and analysed by 
the machine.  The mean CT value of the duplicates was calculated and plotted against the 
log10 of the genomic DNA concentration. 
The relative expression levels of the genes of interest in the TMAO-treated samples 
compared housekeeping gene (gyrA) were calculated according to the protocol for the 
standard curve method in the User Bulletin #2 (ABI PRISM 7700 Sequence Detection System, 
Subject: Relative quantification of gene expression) supplied by Applied Biosystems.  To 
summarise, from each CT value, the intercept of the corresponding genomic DNA plot was 
subtracted and the resulting value divided by the gradient of that plot.  The mean of the 
primer duplicates was calculated and the antilog of the value taken.  This value was divided 
by the value for the housekeeping gene in the corresponding sample to normalise the data.  
Averages of the replicate samples were then calculated to determine the fold change for 
each target gene in the experimental samples compared to the control samples (no TMAO). 
2.9. Generalised transduction with bacteriophage P1 vir 
2.9.1. Preparation of lysates 
Lysates were prepared according to Miller (1972).  Donor cells were grown overnight at 37oC 
in TY medium supplemented with CaCl2 (5 mM). P1 vir stock was diluted from 108 – 103 PFU 
ml-1; each was mixed with a 100 µl culture and incubated at 37oC for 20 min.  Pre-warmed 
(37oC) TB (1 ml) and 1.5 ml warm (55oC) TB soft agar were mixed and added to the phage/cell 
mix and poured onto phage lysate plates.  The plates were incubated at 37oC in a “wet box” 
(with a humid atmosphere) until plaques had taken on a “lacey” appearance, after which the 
plates were chilled at 4oC for 30 min and an overlay of cold phage dilution buffer added.  
Plates were stored overnight at 4oC and the overlaying liquid harvested using a Pasteur 
50 
 
pipette.  Lysates were stored at 4oC and for long term storage a few drops of chloroform 
were added.   
TY broth        (L -1) 
Tryptone        8.0 g  
NaCl        5.0 g 
Yeast extract       5.0 g 
TB broth       (1 L-1) 
Tryptone        4.0 g  
NaCl        5 g  
Agar (when required for soft agar)    7 g 
Phage lysate plates       (0.5 L-1) 
Tryptone        4.0 g  
NaCl        2.5 g 
Yeast extract       2.5 g 
Glucose        1 g 
Agar        6.0 g  
After autoclaving, the medium was cooled to 50oC and the following was added: 
0.5 M CaCl2   5 ml 
1 M MgSO4    5 ml 
10 mM FeCl3   0.5 ml  
Phage dilution buffer 
Trisma base    0.60 g 
MgSO4.7H2O    1.23 g 
CaCl2.2H2O   0.37 g 
NaCl    1.46 g 
dH2O    up to 500 ml 
pH 7.5 
2.9.2. Generalised transduction 
Recipient cells were grown overnight at 37oC in 2.5 ml TY medium supplemented with CaCl2 
(5 mM).  P1 vir stock from a lysate preparation (100 µl) were mixed with the same volume of 
recipient cells and incubated at 37oC for 20 min.  The mixture was spread onto P1 plates 
containing appropriate antibiotics plus Na4P2O7 (0.125 mM) and incubated overnight at 37oC 
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(Miller, 1972).  After overnight incubation, potential transductants were re-plated onto 
selective medium and the phenotype verified.    
2.10. Protein methods  
2.10.1. Overproduction of proteins  
2.10.1.1. Overproduction of FrmR and related variants 
For isolation of FrmR and the C35A and P2A variants, cultures of the E. coli expression strains 
(JRG6782, 6783 and 6784, respectively) were grown at 37oC in LB containing ampicillin, to an 
A600 of ~0.6, at which point 1 mM IPTG was added and the cultures incubated for a further 3 
h.  Typically, 2 x 500 ml cultures were grown.  Bacteria were pooled, collected by 
centrifugation and stored at -20oC after incubation with IPTG.   
2.10.1.2. Overproduction of MBP-NarL 
NarL was amplified as a MBP-NarL fusion in E. coli JRG6437.  Generally, 2 x 500 ml cultures 
were grown aerobically at 37oC in rich medium containing both ampicillin (100 μg ml-1) and 
glucose (2%) to A600 ~0.6, at which point expression was induced by the addition of 300 µM 
IPTG.  Incubation was continued for a further 3 h when bacteria were pooled, collected by 
centrifugation and stored at -20oC.   
2.10.2. Production of cell-free extracts (CFE)  
2.10.2.1. Production of FrmR containing CFE  
Cells were lysed after re-suspension in Buffer A (50 mM Tris containing 0.1 M NaCl, 2 mM 
EDTA, 10 mM dithiothreitol (pH 8.0)) in a ratio of 1:8 (w/v) (pellet:buffer) by sonication 
(Soniprep150 ultrasonic disintegrator) at ~16 microns for 2 cycles of 20 s, followed by 
centrifugation.   
2.10.2.2. Production of Maltose binding protein (MBP) fused NarL containing CFE 
Clarified cell-free extracts were produced by re-suspending the bacteria from 1 L culture in 
15 ml of extraction buffer (20 mM Tris-HCl containing 1 mM EDTA, 100 mM NaCl and 10 mM 
β-mercaptoethanol), and lysing the cells by two passages through a French pressure cell, 
followed by centrifugation.  The fraction containing the soluble proteins was then extracted 
for analysis.   
2.10.3. Protein purification 
2.10.3.1. Purification of FrmR and its variants 
Purification of FrmR and its variants was carried out by Dr Svetlana E. Sedelnikova 
(Department of Molecular Biology and Biotechnology, University of Sheffield, UK).  Cell-free 
extract was applied to a Heparin-HP column (GE Healthcare) and FrmR was eluted using a 
NaCl gradient (0 to 0.5 M) in Buffer A (Section 2.10.2.1).  Fractions containing FrmR protein, 
as detected by SDS-polyacrylamide gel electrophoresis, were combined and concentrated 
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using a VivaSpin column 500 MWCO 30,000 (GE Healthcare).  The concentrated fractions 
were applied to a HiLoad Superdex 200 column (GE Healthcare) equilibrated with 50 mM Tris 
(pH 8.0) containing 0.5 M NaCl.  FrmR-containing fractions were pooled and the purity of the 
samples was assessed by SDS-polyacrylamide gel electrophoresis.  The authenticity of FrmR 
was confirmed by total amino acid analysis (Section 2.10.9) allowing calibration of FrmR 
protein concentrations measured by the A280 (Section 2.10.4.2). FrmR protein was stored for 
up to 2 weeks at room temperature until required.   
2.10.3.2. Purification of MBP-NarL  
The MBP-NarL fusion protein (~5 ml crude extract) was absorbed onto a 15 ml amylose resin 
column (BioLabs Inc.).  Prior to absorption of the protein, the column was equilibrated with 
50 ml column buffer (20 mM Tris-HCl (pH 7.4) containing 1 mM EDTA (pH 8.0), 10 mM NaCl 
and 10 mM β-mercaptoethanol).  The crude extract was passed through the column, which 
was then washed with 50 ml column buffer.  MBP-NarL was eluted from the column in ~ 2 
ml column buffer containing maltose (10 mM).  Eluate was collected in 200 µl fractions and 
analysed using SDS-PAGE.  Fractions containing MBP-NarL were pooled and concentrated 
using a VivaSpin column 500 MWCO 30,000 (GE Healthcare).  The concentration of the 
purified protein was determined using Bio-Rad protein reagent and was stored at – 20oC until 
required.  To release NarL from the fusion protein, NarL (~160 µM) was incubated with 3 
units of enterokinase (BioLabs Inc.) at room temperature for ~ 18 h.   
2.10.4. Estimation of protein concentration  
2.10.4.1. Bradford assay 
Protein concentration was estimated by the dye-binding method of Bradford (1976) with 
bovine serum albumin as the standard.  The protein sample (10 µl) was mixed with 1 ml of 
the 1:5 diluted reagent (Bio-Rad), according to manufacturer’s instructions.  Absorbance was 
then measured at 595 nm.   
2.10.4.2. Measuring protein concentration using A280 
To measure the protein concentration of purified FrmR, the scan function on a Varian Cary 
50 Bio UV-Visible Spectrophotometer was used to record the protein spectrum between 200-
400 nm, with absorbance at 280 and 320 nm being recorded.  A total volume of 1 ml was 
used with a 1:10 ratio of protein to protein buffer (50 mM Tris pH 8.0 containing 0.5 M NaCl) 
in a Quartz cuvette. A blank containing protein buffer was used. To convert absorbance to 
protein concentration the equation below was used.  
Protein concetration (M) =
(A280 nm −  A320 nm)
Extinction coefficient
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Molar extinction coefficient of FrmR (2980 M-1cm-1) 
The extinction coefficient was determined using the ProtParam tool on ExPASy (Gasteiger et 
al., 2005).  For FrmR, the first methionine residue is cleaved upon translation, thus, the amino 
acid sequence entered excluded this.  
2.10.5. In vitro protein phosphorylation  
Purified proteins (NarL and ArcA (provided by Dr Matthew Rolfe, Department of Molecular 
Biology and Biotechnology, University of Sheffield, UK)) were phosphorylated in vitro as 
described by Bekker et al. (2010).  Briefly, proteins were incubated in TEGD buffer (50 mM 
Tris (pH 7.5) containing 0.5 mM EDTA, 10% glycerol), to which 5 mM MgCl2 and 100 mM (final 
concentration) carbamoyl phosphate were added at 30oC for 1 h.  It was assumed that this 
procedure yielded 100% phosphorylation of the protein. In parallel, similar incubations with 
mixtures lacking carbamoyl phosphate were conducted to prepare unphosphorylated 
protein.   
2.10.6. SDS-PAGE  
SDS-PAGE was carried out according to Laemmli (1970), using Bio-Rad Mini Protean gel kits.  
A 15% resolving gel and 6% stacking gel were routinely used.  The gel mixtures were made 
up as below, and a Tris-glycine SDS running buffer was used.  Protein samples were diluted 
with dH2O, where appropriate, to equalise protein concentrations.  SDS sample buffer was 
added to a final concentration of 1X to samples, which were then denatured by boiling for 
10 min.  The gels were electrophoresed at 200 V per gel, until the dye front was judged to 
have travelled a sufficient distance.  All Blue standards (Bio-Rad) were run alongside the 
samples.   
SDS-PAGE gels  
      Resolving gel (15 %)   Stacking gel (6%) 
30% (w/v) acrylamide/bisacrylamide (37.5:1)  4.00 ml   0.75 ml 
Tris-HCl, pH 8.8 (1.5 M)     2.00 ml 
Tris- HCl, pH 6.8 (1 M)        0.47 ml 
SDS (10% w/v)      80 µl   37.5 µl 
dH2O       8.00 ml   2.46 ml 
APS (10% w/v)      80 µl   37.5 µl 
TEMED       8 µl    3.75 µl 
SDS sample buffer  
Tris-HCl, pH 6.8 (1 M)     1.88 ml 
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SDS       600 mg 
Glycerol       3.00 ml 
Bromophenol-blue     A tiny amount of powder 
dH2O        10.00 ml 
β-mercaptoethanol     1.50 ml 
Tris-glycine SDS running buffer       (L-1) 
Tris        3.0 g 
Glycine       14.4 g 
SDS       1.0 g 
Gels were stained using Coomassie brilliant blue.  Staining was carried out for 30 min to 16 
h, followed by thorough de-staining.   
      Staining solution Destaining solution  
Coomassie brilliant blue R250           0.575 g 
Methanol              200 ml   400 ml 
Acetic acid                50 ml    100 ml 
dH2O               250 ml   500 ml 
2.10.7. Total amino acid analysis  
Amino acid analysis was carried out by Alta Biosciences (University of Birmingham, UK) by 
complete acid hydrolysis for 24 h at 110oC of aliquots of FrmR that had previously been 
assayed for protein concentration (Section 2.10.5.2).   
2.10.8. Estimation of the number of reactive sulphydryl groups  
The number of reactive sulphydryl groups in purified protein was estimated using the 
protocol outlined by Thelander (1973).  In a Quartz cuvette, a total reaction volume of 1 ml 
was prepared consisting of purified protein (100 µl), 700 µl 50 mM Tris containing 0.5 M NaCl 
(pH 8.0) and 200 µl DTNB solution (0.2 ml 0.4% (w/v) 5,5'-dithiobis-(2-nitrobenzoic acid) 
(DTNB) in ethanol and 1.8 ml 1 M Tris-HCl (pH 8.0)).  Absorbance at 412 nm was immediately 
measured using a Cary 50 Bio UV Vis Spectrophotometer that had been blanked with a 
sample of buffer and DTNB solution.  The NTB concentration in the sample was calculated 
using the equations below to work out the number of reactive sulphydryl groups:  
NTB concetration (M) =
A412 nm
𝜀𝑙
 
ε = Molar extinction coefficient of NTB (13,600 M-1cm-1) 
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l = Path length (cm) 
Reactive sulphydryl groups =
NTB concetration (M)
FrmR concetration (M)
 
2.10.9. Intrinsic Fluorescence Spectroscopy 
In a fluorescence cuvette (1 ml), FrmR protein was diluted in protein elution buffer (50 mM 
Tris-HCl, pH 8.0 containing 0.5 M NaCl) to give a peak fluorescence intensity of at least 100 
a.u. on a Cary Eclipse Fluorescence Spectrophotometer.  Protein samples were maintained 
at 25oC for emission spectra (290-400 nm; excitation at 278 nm).  FrmR was titrated with 
increasing zinc and manganese concentrations, typically to a 10-fold molar excess of 
[Zn(II)/Mn(II)]:[tetrameric FrmR]. The peak intensity of the fluorescence emission at 304 nm 
was measured and the value was corrected to account for dilution of the protein.   
2.10.10. Liquid chromatography Mass Spectrometry (LC-MS) 
Protein samples (~12 µM) were incubated with either an 8-fold or 40-fold molar excess of 
formaldehyde relative to FrmR tetramer concentration at room temperature.  After 3 min, 
reactions were quenched with 10 mM glycine.  Samples were loaded onto an Agilent 1260 
Infinity liquid chromatograph fitted with an Agilent Extended C18 column (2.1 mm x 50 mm) 
and eluted with a gradient of 5-95% (v/v) acetonitrile in 0.1% (v/v) formic acid at 400 µl min-
1 over 8 min.  The eluent was directly coupled to an Agilent 6530 Q-ToF mass spectrometer 
fitted with an electrospray ionisation (ESI) source for determination of the mass of each peak.   
2.10.11. Inductively couple plasma mass spectrometry (ICP-MS) 
ICP-MS was carried out by Dr Jamie Young (Biomolecular Sciences Research Centre, Sheffield 
Hallam University, UK).  The total metal ion content of FrmR was estimated by ICP-MS on 
samples of purified FrmR protein (200 µM) in 50 mM Tris (pH 8.0) containing 0.5 M NaCl 
buffer.  The ion content of the buffer was also determined.  FrmR or buffer was incubated 
with concentrated nitric acid (1:1 ratio) at 60oC for 1 h.  Samples were cooled, diluted with 
dH2O (up to 10 ml) and filtered.  Samples were analysed on a Perkin Elmer Nexlon ICP-Ms 
system.  Ions were full quantified in both the buffer and protein samples using an external 
calibration method.  A dilution series of certified multi element reference standard (Sigma-
Aldrich) was created and analysed via ICP-MS.  Counts per second values for elements in the 
buffer and protein samples were then compared with the calibration curve to determine 
actual concentrations.   
2.10.12. Western Immunoblotting  
Pellets of chemostat culture (Section 2.7.2) were stored at -80oC until required.  Defrosted 
samples were standardised with respect to their OD600 value by dilution with water and 
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separated on an SDS-PAGE gel.  Wet transfers were performed using mini-transblot 
apparatus (Bio-Rad).  The cassette was assembled as described in the manufacturer’s 
instructions.  All apparatus was pre-soaked with transfer buffer (for at least 15 min) and the 
blotting process was carried out in transfer buffer.  Blotting was carried out at 100 V for 1 h, 
allowing transfer of the protein onto Hybond-C Extra membrane (Amersham).  After blotting, 
the membrane was placed into 10 ml blocking solution (5% (w/v) Marvel in PBST) and 
incubated for 1 h with gentle shaking at room temperature.  Membranes were then washed 
with 50 ml PBST for 1 x 15 min and 3 x 5 min washes.  Primary anti-body was either diluted 
1:10,000 (anti-ArcA antisera) or 1:1,000 (anti-TorA antisera; supplied by Dr Chantal Lobbi-
Nivol, National Centre for Scientific Research, France) in 20 ml PBST, added to membrane 
and incubated at room temp for 1 h.  Washes were repeated as above and followed by 1 h 
incubation at room temperature with a 1:100,000 secondary antibody (Amersham ECLTM 
Rabbit IgG, HRP-linked antibody) in 20 ml PBST.  Secondary antibody containing solution was 
removed and washed as above, but using PBS for the last wash.  ECL PlusTM Western blot 
detection reagents (GE Healthcare) were then placed over the membrane and incubated for 
5 min at room temperature in the dark.  The membrane was then and exposed to Hyperfilm-
ECL for 5 – 30 s in a dark room.  Hyperfilm was then developed and fixed in Kodak developing 
and fixing solutions and left to dry.     
Transfer buffer     (L-1) 
Tris     5.8 g  
Glycine     2.7 g 
SDS (10% w/v)    3.7 ml  
Methanol     200 ml 
PBST      (L-1) 
NaCl     8.00 g 
KCl     0.20 g 
Na2HPO4    1.44 g 
KH2PO4     0.24 g 
Tween 20    0.05% 
pH 7.4 
2.10.13. Phos-tagTM-acrylamide gel electrophoresis 
The degree of ArcA phosphorylation was measured using Phos-tagTM-acrylamide gel 
electrophoresis and subsequent Western immunoblotting. The samples (Section 2.7.4) were 
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defrosted and diluted to 2.5 OD600 units ml-1 for running on a 37.5 µM Phos-tagTM (NARD 
Institute, Ltd., Amagasaki City, Japan) 10% acrylamide resolving gel in the following 
proportions: 
Volume of cells in 1 M formic acid 56.4% 
Volume of 3S SDS loading buffer  33.3% 
Volume of 5 M NaOH   10.3% 
Samples were then immediately resolved on a Phos-tagTM gel, with a 6% stacking gel, for 1 h 
at 200 V in SDS running buffer.  Purified ArcA (provided by Dr Matthew Rolfe, Department of 
Molecular Biology and Biotechnology, University of Sheffield, UK), which had been 
phosphorylated with 100 mM carbamoyl phosphate (Section 2.10.5) and unphosphorylated 
ArcA were run as controls alongside.  The Phos-tagTM gel was soaked in transfer buffer 
containing 1 mM EDTA for 15 min, and then pre-equilibrated for 15 min in transfer buffer 
(no EDTA).  Standard wet transfer to Hybond-C membrane (Amersham) and 
immunodetection using rabbit ArcA antiserum and the ECL detection system (GE Healthcare) 
were carried out.   
Phos-TagTM resolving gel (10%)  
dH2O    1.44 ml 
30% (w/v) acrylamide (29:1) 1.36 ml 
Tris-HCl, pH 8.8 (1.5 M)  1.08 ml 
SDS (10% w/v)   40 µl 
Phos-TagTM acrylamide (5 mM) 20 µl 
MnCl2 (10 mM)   20 µl 
APS (10% w/v)   50 µl 
TEMED    20 µl 
2.11. Protein-DNA interaction techniques 
2.11.1. Bio-Layer Interferometry (BLItz) 
Biotinylated-promoter DNA for frm (Pfrm) and ydhY (PydhY) was amplified from E. coli MG1655 
genomic DNA by PCR using oligonucleotides described in Appendix 1.  Where indicated, FrmR 
tetramers were incubated with formaldehyde (up to an 800-fold molar excess) for 3 min 
(before quenching with 10 mM glycine) or Zn(II) (16-fold molar excess) at room temperature, 
prior to taking association measurements.   Analysis of the interaction between purified 
FrmR and biotinylated-promoter DNA was carried out using the BLItz system (FortéBio), with 
all measurements taken at room temperature.  Streptavidin (SA) biosensors (FortéBio) were 
hydrated by soaking the tips in 250 µl protein elution buffer (50 mM Tris, 0.5M NaCl (pH 8.0)) 
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for at least 10 min.  The measurements were made using the Advanced Kinetics function of 
the BLItz Pro 1.1.0.31 software.  The sequence for each run was as follows:  
1. Baseline step with protein elution buffer for 60 s  
2. Loading step with 100 nM biotinylated Pfrm DNA in buffer for 240 s 
3. Baseline step with buffer for 60 s  
4. Association step with various concentrations of purified FrmR in buffer for 240 s 
5. Dissociation step with buffer (or formaldehyde-containing buffer) for 120 s 
Baseline and dissociation steps were carried out by placing the biosensor in a black 500 µl 
Eppendorf tube filled with 250 µl buffer. Loading and association steps were carried out by 
placing the biosensor in the drop holder containing either 5 µl of Pfrm DNA or FrmR protein 
depending on the step. For each subsequent run, a new biosensor was used. Analysis of the 
data was carried out using the BLItz Pro 1.1.0.31 software using global fitting and correcting 
both association and dissociation curves.  
2.11.2. In vitro transcription (IVT) assays 
The promoter and part of the coding regions of frmR and ndh (~200 bp upstream of the start 
codon to ~190 bp (frmR) or ~100 bp (ndh) into the gene) were amplified from E. coli MG1655 
genomic DNA using appropriate oligonucleotides (Appendix 1).   These DNA fragments (~0.1 
pmol) were incubated for 30 min at 37oC in a 10.5 µl reaction volume containing 40 mM Tris-
HCl, pH 8.0, 10 mM MgCl2, 1 mM dithiothreitol, 75 mM KCl, 0.1 mM EDTA, 5% (v/v) glycerol, 
250 µg ml-1 bovine serum albumin, 20 units of RiboLoc RNase inhibitor (Fermentas), 1 pmol 
E. coli RNA polymerase holoenzyme (New England BioLabs, Inc.) and 0 or 1 nM EcFrmR 
tetramer.  FrmR was reduced with 10 mM dithiothreitol and when required treated with 200-
fold molar excess of formaldehyde for 5 min at room temperature, before quenching with 
10 mM glycine.  Transcription was initiated by the addition of 2 µl solution containing UTP at 
50 µM; ATP, CTP and GTP at 1 mM; and 2.5 µCi of [α-32P]UTP (800 Ci mmol-1, PerkinElmer 
Life Sciences), followed by incubation for 15 min at 37oC.  Reactions were terminated by the 
addition of 12.5 µl Stop/Loading dye solution (95% (v/v) formamide, 20 mM EDTA, pH 8.0, 
0.05% (w/v) bromophenol blue, 0.05% (w/v) xylene cyanol).  Samples (10 µl) of each reaction 
were loaded onto a 6% (w/v) acrylamide, 1X TBE, 8 M urea gel, run at 20 mA buffered with 
1X TBE and analysed using phosphorimaging (Section 2.11.2.1).  Markers (0.1- 1 kb) were 
prepared using Perfect RNA Marker template mix (Novagen).  A 20 µl reaction containing 
0.75 µg of RNA template mix, 80 mM HEPES, pH 7.5, 12 mM MgCl2, 10 mM NaCl, 10 mM 
dithiothreitol, 2 mM ATP, 2 mM GTP, 2 mM CTP, 0.1 mM UTP, 5 µCi of [α-32P]UTP (800 Ci 
mmol-1, PerkinElmer Life Sciences), 20 units of RiboLoc RNase inhibitor (Fermentas) and 50 
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units of T7 RNAP (Novagen), was incubated for 1 h at 37oC, before storing at -20oC.  Markers 
from ~20 ng template were used for gel calibration.  
6% acrylamide resolving gel containing 1X TBE, 8 M urea  
40% (w/v) Acrylamide                                      3 ml 
TBE (10X)                                                            1 ml 
Urea                                                                     9.6 g 
10% (w/v) APS         0.20 ml 
TEMED                                                                 0.04 ml 
 dH2O                                                                   up to final volume of 20 ml  
10X TBE          (L-1) 
Tris          108 g 
Boric acid          55 g   
0.5 M EDTA (pH 8.8)         40 ml 
2.11.2.1. Phosphorimaging 
In vitro transcription assays were visualized using phosphorimaging.  The gel was exposed to 
a phosphor screen in a Hypercassette (Amersham) for ~16 h at 4oC.  The phosphor screen 
was scanned using a Typhoon FLA 700 laser scanner (GE Healthcare) using the IP filter type 
(band pass of 390 nm).  Scanned images were analysed and converted to .tiff images using 
ImageQuant TL 8.1 Software (GE Healthcare).   
2.11.3. Electrophoretic Mobility Shift Assays (EMSAs) 
LightShift Chemiluminescent EMSA Kit (Thermo Scientific) was carried out to investigate 
protein binding to biotin-labelled promoter DNA, following manufacturer’s instructions.  All 
reactions were carried out in a 20 μl volume, incubated on ice for 20 min, and contained; 20 
fmol Biotin-labelled promoter DNA; 10X Binding buffer (10 mM Tris containing 50 mM KCl, 
1mM DTT, pH 7.5); Poly-deoxy-inosinic-deoxy-cytidylic acid (poly [d(I-dC)]) (1 μg), where 
indicated; purified NarL (0 to 20, 000 nM).  The biotin-labelled promoter DNA being studied 
and NarL were added in amounts described in Section 6.3). Samples were separated on a 6% 
(w/v) native-PAGE gel (below) for 1 h in 0.5X TBE (Section 2.11.2), followed by transfer onto 
Hybond-N+ nylon membrane (GE Healthcare) and crosslinking 120 mJ cm2 -1 using a 
commercial UV-light crosslinking instrument (Amersham, 80-6222-31) for 60 s.  Visualisation 
of the binding reactions was carried out using the Nucleic Acid Detection Module (Thermo 
Scientific) as described in the manufacturer’s instructions.  The X-ray film was then 
developed and fixed in Kodak developing and fixing solutions and left to dry.     
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                6% Native PAGE resolving gel  
                30% (w/v) Acrylamide                                      4 ml 
                TBE (10X)                                                            1 ml 
                dH2O                                                                    14.85 ml 
                10% (w/v) APS           0.20 ml 
                TEMED                                      0.04 ml 
2.12. Nuclear magnetic resonance (NMR) spectroscopy  
Metabolite measurements using NMR were carried out by Dr Matthew Rolfe (Department 
of Molecular Biology and Biotechnology, University of Sheffield, UK) as previously described 
(Trotter et al., 2011). Cell-free supernatant fractions (Section 2.7.3) were analysed in a 
volume of 500 μl containing 450 μl supernatant sample, 50 μl deuterium oxide (D2O) and 1 
mM trimethylsilyl-propionate (TSP) as a standard using a Bruker DRX-500 spectrometer 
operating at 500 MHz, with samples analysed in 5 mm diameter tubes at 298 K.  In order to 
reduce the H2O signal, a pre-saturation for 2 s was applied during the recycle time.  Carbon 
decoupling was applied during acquisition to suppress 13C satellites.  Topspin was used to 
process the spectra and quantify the peaks.  Metabolite concentrations were established by 
reference to TSP.  When required, peak identities were verified using spiking experiments 
with the corresponding metabolite at a known concentration.  To measure ethanol loss from 
the chemostat, ethanol was added directly to the chemostat and Evans medium feed and 
then the remaining ethanol concentration in the chemostat after 20 h was measured using 
NMR.   
2.13. Biochemical assays 
2.13.1. Methyl viologen linked – TMAO reductase assay 
Whole cell samples were taken from the chemostat in a final concentration of 50 mg ml-1 
chloramphenicol in 50 ml aliquots and were pelleted by centrifugation at 4,020 g for 10 min.  
Cell pellets were defrosted on ice, washed in 25 ml sodium phosphate (25 mM) buffer pH 
7.0, and resuspended in a final volume of 10 ml buffer.  OD600 measurements were made for 
each sample.  An Agilent CARY 50 UV-Visible, pre-warmed to 37oC, was used for 
measurements.  To a screw septa capped cuvette, 960 μl sodium phosphate buffer, 20 μl 
methyl viologen (10 mM) and 10 μl cell suspension were added.  The spectrophotometer was 
blanked with the cuvette, before the assay solution was sparged with argon for 6 min.  
Around 3 μl of dithionite solution (made by adding one small spatula of sodium dithionite 
per 5 ml dH2O) was added to the cuvette though the septa with a Hamilton syringe and 
inverted.  Once the absorbance was constant for about 60 s, a final concentration of 5 mM 
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TMAO was added to the cuvette, which was quickly inverted twice before methyl viologen 
oxidation was measured at 585 nm for 300 s.  Assays were carried out in duplicate for each 
sample.    
100 mM sodium phosphate buffer (pH 7.0) (L-1) 
Na2HPO4 (1 M)     57.7 ml 
NaH2PO4 (1 M)     42.3 ml 
To make 25 mM sodium phosphate buffer,  the 100 mM sodium phosphate buffer stock was 
diluted 1 in 4 with dH2O and pH adjusted to 7.0.     
2.13.2. Copper (II) reduction assays  
Cultures of E. coli MG1655 were grown anaerobically overnight at 37oC in Evans medium (pH 
7.0), supplemented with 20 mM glucose and 40 mM TMAO.  Cells were pelleted and washed 
three times in anaerobic Evans medium, pH 7.0.  Cells were resuspended in Evans medium 
plus 20 mM glucose to an OD600 ~25.  The assays were performed as previously described 
(Volentini et al., 2011) in an anaerobic workstation.  Briefly, 100 µl of washed cells were 
incubated with 0.05 mM CuSO4, 40 mM TMAO (when appropriate) in a total volume of 1 ml 
citrate-phosphate buffer, pH 7.0, at 37oC.  Control assays with no cells and no CuSO4 were 
carried out in parallel.  At the indicated times, the assays were stopped by centrifuging 
samples for 3 min at 8,000 g.  The resulting supernatant had 0.1 mM bathocuproine 
disulfonate (Sigma-Aldrich) added.  The absorbance at 412 nm for the supernatant was 
measured and the molar coefficient for the Cu (I) complex (12,220 M-1 cm-1) used to 
determine Cu (II) reduction by samples per A600 unit.     
Citrate-phosphate buffer 
Citric Acid (0.1 M)   13 ml  
Na2HPO4 (0.2 M)   87 ml 
Adjust volume to 200 ml with dH2O, pH to 7.0 
2.13.3. Measurement of formaldehyde production 
Formaldehyde was measured using acetylacetone reagent (Nash, 1953).  Anaerobic cultures 
of E. coli MG1655 were grown overnight with stirring at 37oC in LB supplemented with 0.2% 
(w/v) glucose.  Preparation of cell samples and setting up of assays were performed in an 
anaerobic workstation.  Cells were pelleted and washed in 25 mM sodium phosphate buffer 
pH 7.0 and finally resuspended in a final volume of 2 ml anaerobic cell breakage buffer.  An 
oxygen scavenger, which would convert any oxygen to water, 1 ml, was added to the 
resuspended cells before sonication (6 x 15 s, 15 micron amplitude).  Any unbroken cells 
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were removed by centrifugation at 4,020 g for 1 min.  Cell-free extracts were added to a 1 
ml total volume of 25 mM sodium phosphate buffer and 40 mM TMAO (in TMAO-containing 
samples only).  Assays were incubated anaerobically at 37oC and at the indicated times were 
stopped by precipitation using 5% (w/v) trichloroacetic acid and centrifugation at 20,000 g 
for 2 min.  Resulting supernatants were treated as previously described (Fu et al., 2006).  
Briefly, the stopped reaction was combined with the acetylacetone reagent in a 1:1 ratio and 
incubated at 60oC for 15 min.  The OD412 of the reaction was recorded.  Formaldehyde 
content was calculated using the extinction coefficient at 412 nm (8,000 M-1 cm-1).  Protein 
content of the cell-free extracts was determined using the Bio-Rad assay.  
Cell breakage buffer 
Tris      20 mM  
NaCl     500 mM  
Glycerol    5% (w/v) 
Adjust to required volume with dH2O, pH to 7.5.   
Oxygen scavenger  
Glucose    10% (w/v) 
Catalase    10 µg ml-1 
Glucose oxidase    5 µg ml-1 
 
Acetylacetone reagent (Nash reagent) (L-1) 
Ammonium acetate    150 g 
Acetic acid     3 ml 
Acetylacetone     2 ml 
Filter sterilise   
2.14. Fluorescence Microscopy and Flow Cytometry  
2.14.1. Cell preparation for microscopy and flow cytometry 
Escherichia coli JRG6705 cells were grown anaerobically at 37oC in Evans medium buffered 
with phosphate buffer.  After overnight growth, TMAO (2 – 40 mM) was then added to the 
culture, in an anaerobic workstation.  After the addition of TMAO, samples were incubated 
for 1 h at 37oC.  After incubation, cells were harvested by centrifugation at 4,020 g for 10 min 
and washed in sterile dH2O, with the resulting cell pellet being fixed.  Cells were also grown 
in continuous culture in a 1 L culture vessel under anaerobic conditions as previously 
described (Section 2.1.5.1) and washed as described above.  
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2.14.2. Fixing of cells with paraformaldehyde 
Cell pellets were resuspended in fixative for 30 min at room temperature. Fixed cells were 
washed at least twice in sterile PBS by centrifugation at 4,020 g for 3 min at room 
temperature.  Samples were resuspended in PBS to give a suitable concentration of cells and 
were immediately fixed to microscope slides for imaging.  Alternatively, for flow cytometry 
analysis, fixed samples were stored at 4oC in the dark for a maximum of 24 h before analysis.   
Preparation of 16% (w/v) paraformaldehyde: 
100 mM sodium phosphate buffer (pH 7)  50 ml 
Paraformaldehyde     8.0 g 
To prepare the paraformaldehyde, the solution was heated to 60°C in a water bath and mixed 
vigorously. NaOH (≥5 M) solution was added drop wise, until the solution cleared and was 
then stored at 4°C. 
Fixative 
Paraformaldehyde, 16% (w/v)    0.5 ml 
100 mM sodium phosphate buffer (pH 7)  2.00 ml 
Phosphate Buffered Saline (PBS) 
NaCl       8.00 g 
KCl       0.20 g 
Na2HPO4      1.44 g 
KH2PO4       0.24 g 
 The volume was adjusted to 1 L with dH2O and pH adjusted to 7.4. 
2.14.3. Slide preparation for light microscopy 
Poly-Prep Slides (Sigma) were wiped with 70% (v/v) ethanol and left to air dry. An appropriate 
sample dilution was prepared in dH2O, and 5 µl spread gently onto the poly-L-lysine coated 
slide and left to air-dry. A coverslip was then mounted with 5 µl dH2O, and sealed by spotting 
colourless nail varnish at each corner. 
2.14.4. Fluorescence microscopy 
Fluorescence microscopy was carried out using a DeltaVision deconvolution microscope 
(Applied precision) equipped appropriate filters for imaging various fluorophores.  To image 
GFP the FITC (Fluorescein isothiocyanate) filter set was used (details shown below).  The 
objective lens used was 100X (with immersion oil).  Images were deconvolved using 
SoftWoRx suite v.3.5.1. Deconvolved fluorescence images were processed using ImageJ 
version 1.48v. 
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2.14.5. Flow cytometry  
Flow cytometric analysis was performed using an Attune Autosampler (Life Technologies 
Ltd., Paisley, UK).  Typically, the fixed culture (Section 2.4.2) was diluted 10-fold with PBS in 
order to obtain the correct concentration of cells to analyse. The instrument settings were 
chosen using a GFP-negative E. coli JRG6705 control sample, which had no TMAO added. 
Instrument settings were kept the same for each sample. A GFP-negative sample was run for 
each flow cytometry experiment in order to correctly gate for GFP-positive cells. Routinely, 
10,000 events were recorded for each analysis.  The BL1 detector was used for detecting GFP 
(details shown below). Flow cytometry data was analysed using FlowJo V10 (Tree Star Inc., 
USA). 
 
 
  
Filter set Excitation filter/bandpass (mm) Emission filter/bandpass(nm) 
FITC 490/20 528/38 
Detector Filter (center/bandpass) (mm) Filter range  
BL1 530/30 515-545 
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3. Adaptation of anaerobic cultures of Escherichia coli K-12 in response to trimethylamine-
N-oxide                                                                                                                                   
3.1. Introduction 
Trimethylamine-N-oxide (TMAO), a common metabolite and an osmolyte in marine 
organisms, is often found in many anaerobic environments.  Consequently several enteric 
bacteria, including E. coli have evolved to use TMAO as an alternative electron acceptor 
(Barrett and Kwan, 1985). As a metabolically versatile enteric bacterium, E. coli is able to 
grow in both the presence and absence of oxygen.  It has three major metabolic modes, 
including aerobic respiration, anaerobic respiration and fermentation (Bock and Sawers, 
1996; Gennis and Stewart, 1996; Guest et al., 1996).  Anaerobic respiration with TMAO as 
the terminal electron acceptor is more energetically efficient than fermentation, but less 
than aerobic respiration (Guest et al., 1996).   
As explained in Chapter 1, there is a large body of information concerning both the regulation 
and operation of the E. coli K-12 respiratory chain.  However, there is little or no 
understanding of the dynamic adaptive processes that occur during the transition from 
anaerobic respiration to TMAO respiratory growth.   In order to address this issue, glucose-
limited chemostat cultures have been used to study the effects of perturbing anaerobic 
fermentative E. coli K-12 cultures by addition of the terminal electron acceptor TMAO.  
Transcript profiling, metabolite and biochemical measurements, combined with probabilistic 
modelling of transcription factor activities, have all been undertaken in order to obtain a 
deeper understanding of the adaptive process.   
3.2. Analysis of over-metabolite production by anaerobic cultures of E. coli K-12 in the 
absence and presence of TMAO 
In order to study the process of E. coli K-12 adaptation to the presence of TMAO, glucose-
limited (20 mM) anaerobic fermentative steady state chemostat cultures of E. coli K-12 
MG1655 were established (Section 2.3.1).  Analysis of over-metabolite production by 
anaerobic chemostat cultures (dilution rate 0.2 h-1) of E. coli MG1655 in the absence and 
presence of TMAO were carried out using NMR (Section 2.12).   
Glucose-limited anaerobic fermentative growth of E. coli under these conditions can be 
described using the equations (Equations 1 and 2) below: 
C6H12O6 + H2O  CH3COOH + CH3CH2OH + 2 HCOOH (1) 
HCOOH  CO2 + H2 (2)  
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In addition to this, other minor fermentation products (over-metabolites) such as succinate 
and lactate are produced (Table 3.1).  Measurement of over-metabolites present in the 
chemostat culture medium during the fermentative steady state showed the presence of 
acetate (13.7 ± 0.6 mM), ethanol (10.9 ± 0.2 mM), formate (13.6 ± 2.7 mM), succinate (3.9 ± 
0.2 mM), fumarate (0.03 ± 0.01 mM), lactate (0.08 ± 0.01 mM) and orotate (0.16 ± 0.01 mM), 
with the concentrations measured being consistent with anaerobic fermentative growth, 
where ~40% of the formate produced was converted to CO2 and H2 by formate hydrogen-
lyase (Table 3.1, Equations 1 and 2).   
The anaerobic fermentative steady-state was perturbed by the introduction of 45.8 + 1.1 
mM TMAO both directly to the chemostat culture and the growth medium feed.  Equation 3 
describes anaerobic respiratory growth on glucose with TMAO as the electron acceptor: 
C6H12O6 + 4 (CH3)3NO  2 CH3COOH + 4 (CH3)3NH2 + 2 CO2 + 2 H2O (3) 
However, as expected, introduction of 45.8 ± 1.1 mM TMAO to the culture, resulted in a 
mixed anaerobic TMAO respiratory and fermentative metabolism (TMAO-
respiratory/fermentative growth) (Equation 4).   
C6H12O6 + 2.4 (CH3)3NO  1.6 CH3COOH + 0.4 CH3CH2OH + 2.4 (CH3)3NH2 + 0.5 HCOOH + 1.5 
CO2 + 0.76 H2O (4) 
A remodelling of metabolism was seen during the first 60 min after TMAO was added to the 
chemostat.  The concentration of fumarate increased (0.08 ± 0.03 mM), whereas succinate 
(3.10 ± 0.20 mM) and formate (11.00 ± 3.00 mM) decreased (Table 3.1).  During this period, 
the concentration of TMAO concomitantly decreased from 45.8 ± 1.1 mM to 40.4 ± 2.30 mM.   
The new TMAO-respiratory/fermentative steady-state was established after 1440 min, 
where TMAO was undetectable and TMA, the product of TMAO respiration, reached a 
concentration of 45.8 ± 1.4 mM.  Higher production of acetate (24.5 ± 1.2 mM) and orotate 
(0.37 ± 0.02 mM), but less succinate (1.5 ± 0.6 mM) and ethanol (2.3 ± 0.4 mM) was detected 
in the external milieu of the new steady-state.   
During the transition phase, physiological changes accompanied the metabolic changes 
described above, with an increase in biomass being observed.  The biomass supported by the 
TMAO-respiratory/fermentative steady state was ~2-fold greater (0.61 g L-1) than that under 
fermentative conditions (0.29 g L-1).  The YATP value for E. coli growing under anaerobic 
conditions at a dilution rate of 0.2 h is ~5 g cell dry weight (cdw) per mol of ATP (Hempfling 
and Mainzer, 1975).  The cdw of the initial fermentative steady state is consistent with this  
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Table 3.1.  Concentrations of extra-cellular metabolites produced by E. coli MG1655 during transition from anaerobic fermentative growth to TMAO 
anaerobic respiratory growth measured using NMR 
 
a. The values reported for ethanol are corrected to account for losses to the gas phase 
Data are the mean values ± standard deviation (n = 3).  ND = not detected.   
Time after addition 
of TMAO (min) 
TMAO 
(mM) 
TMA 
(mM) 
DMA 
(mM) 
Acetate 
(mM) 
Formate (mM) Ethanol (mM)a Succinate 
(mM) 
Lactate (mM) Fumarate 
(mM) 
Orotate 
(mM) 
Biomass 
(mg cell dry 
weight mL-1) 
0 ND ND ND 13.70.6 13.62.7 10.90.2 3.90.2 0.080.01 0.030.01 0.160.01 0.290.07 
2 45.81.1 0.40.1 0.080.01 13.60.7 11.02.8 10.70.1 3.70.2 0.050.01 0.020.01 0.130.02  
5 46.0.51.2 0.50.1 0.090.01 13.70.7 10.92.8 10.70.1 3.70.2 0.060.01 0.030.01 0.110.01  
10 45.01.2 0.80.1 0.100.01 13.50.8 10.62.8 10.40.1 3.60.2 0.050.01 0.030.01 0.120.01  
15 44.51.3 1.10.1 0.120.02 13.40.9 10.63.0 10.20.1 3.60.2 0.050.01 0.040.01 0.130.02  
20 43.22.0 1.40.1 0.120.02 13.21.0 10.53.0 10.00.2 3.40.2 0.060.01 0.050.01 0.130.02  
60 40.42.3 4.20.5 0.230.01 13.61.0 11.03.0 10.71.1 3.10.2 0.070.01 0.080.03 0.120.04 0.440.08 
1440 ND 45.81.4 0.150.03 24.51.2 6.71.4 2.30.4 1.50.6 ND 0.050.01 0.370.02 0.610.04 
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YATP, assuming that glucose fermentation yields 3 ATP per glucose molecule (60 mmol ATP 
from 20 mmol glucose yielding 0.29 g cdw, which is equivalent to YATP = 4.8 g cdw per mol of 
ATP) (Table 3.1).  Addition of TMAO to the chemostat, results in an increase in biomass (an 
additional 0.32 g L-1).  The dry weight of an E. coli cell is 0.28 pg (Neidhardt et al., 1990).  Thus, 
the increase in biomass was equivalent to an additional ~1.2 x 1012 bacteria in the TMAO-
respiratory/fermentative steady state.  A contribution of 6 H+ per oxidised NADH molecule 
to the proton motive force is made from an electron transport chain, consisting of NADH 
dehydrogenase I and TMAO reductase (Keseler et al., 2013).  Per TMAO molecule, 1.8 ATP 
molecules are produced with a H+/ATP ratio of 3.3 (Futai et al., 2012), which equates to the 
production of 5 x 1022 molecules of ATP in the TMAO-respiratory/fermentative steady state.  
The synthesis of an E. coli cell requires ~40 x 109 ATP molecules; thus, the additional ATP 
gained from respiration with TMAO as the terminal electron acceptor accounts for the 
synthesis of an additional ~1.3 x1012 cells (0.364 g).  Therefore, the metabolic map shown in 
Figure 3.1 accurately captures the physiological state of the TMAO-respiratory/fermentative 
steady state.   
3.3. The transcriptional response of E. coli K-12 during adaptation to TMAO respiratory 
conditions 
Transcript profiles were obtained from the E.coli K-12 chemostat cultures under anaerobic 
fermentative conditions and then 2, 5, 10, 15, 20 and 60 min after the addition of the electron 
acceptor TMAO;  then again at 1440 min after the new TMAO-respiratory/fermentative 
steady state was established (Section 2.7.1).  If at one or more of the time-points, the 
abundance of a transcript was ≥3-fold greater or smaller after the addition of TMAO when 
compared to the initial fermentative steady state, then an operon was deemed to be 
significantly regulated (Table 3.2).  Using the ≥3-fold cut-off, 34 operons were judged to be 
significantly regulated in response to TMAO, with 29 operons being upregulated and 5 being 
downregulated.   
The transcripts that were upregulated in response to the presence of TMAO could be 
classified into six groups based on function (Table 3.2).  The transcription of the torCAD 
operon (encodes TMAO reductase) was induced within 2 min of the addition of TMAO to the 
culture (Table 3.2, group A).  This upregulation suggests that the presence of the electron 
acceptor had been detected and a transcriptional response had been initiated within 2 min.  
Concomitantly, within 2 min TMA (0.4  0.1 mM) was detected in the medium by NMR (Table 
3.1), which also indicates that TMAO reduction had been initiated.  The abundance of the 
torCAD transcript was maximal (11.6-fold greater than in the fermentative steady state) 10 
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Figure 3.1. Metabolic map of the TMAO-respiratory/fermentative steady state 
Glucose provides 120 atoms of carbon to the system, 25 of which are converted into biomass 
based on ∼50% of cdw is carbon (Heldal et al., 1985). Therefore, 95 carbon atoms are able 
to enter glycolysis, producing phosphoenolpyruvate (PEP) and in the process of doing so 
generating 32 reducing equivalents (RE).  CO2 reacts with a small amount of PEP and is 
converted to succinate (6 carbon atoms) (Table 3.1), concomitantly re-oxidizing three RE 
(Table 3.1).  Pyruvate formate-lyase then converts the 26% of the PEP to pyruvate and the 
remainder (74%) of the PEP (90 carbon atoms in total) is converted to pyruvate also, 
generating 22 RE.  Acetyl CoA (60 carbon atoms) is produced and this is converted to acetate 
(50 carbon atoms) along with small amounts of ethanol (5 carbon atoms; re-oxidizing five 
RE) and orotate (2 carbon atoms; generating 0.4 RE) (Table 3.1). In this scheme, reduction of 
TMAO to 46 molecular equivalents of TMA results in a total of 46.4 RE being created and re-
oxidized (REox) (Table 3.1).  Bold numbers in parentheses are measured quantities as shown 
in Table 3.1 and those shown in normal font are estimates. 
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Table 3.2. Transcripts that are altered in abundance by ≥3-fold in response to the addition of TMAO to anaerobic fermentative steady-state cultures 
of E. coli K-12 MG1655   
Operona  Product Fold change in abundance relative to the anaerobic fermentation steady 
stateb 
Regulatory proteinsc 
   2 min 5 min 10 min 15 min 20 min 60 min TMAO 
respiratory  
steady state  
 
 Predominantly up-regulated operons 
 (A) Respiration  
cyoA-E  Cytochrome bo' terminal 
oxidase 
2.5 3.8 6.4 3.3 3.2 2.2 1.1 ArcA (-), Cra (-), CRP (+), FNR (-), Fur 
(-), GadE (+), PdhR (-) 
torCAD  Trimethylamine-N-oxide 
reductase 
4.4 6.1 11.6 7.9 7.6 7.6 3.5 NarL (-) TorR (+) 
 (B) Carbon metabolism 
acs-yjcH-
actP 
 Acetyl-CoA synthetase, 
inner membrane protein, 
acetate transporter 
1.7 3.3 6.1 3.1 1.8 1.0 1.2 CRP (+), Fis (-), IHF (-) 
frmRAB  Transcription regulator, 
formaldehyde 
dehydrogenase, S-
formylglutathione 
hydrolase 
2.4 4.6 4.9 6.1 10.9 9.5 1.3 FrmR (-) 
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glpABC  Anaerobic glycerol-3-
phosphate dehydrogenase 
2.1 3.5 2.1 1.3 -1.2 -1.4 1.0 ArcA (-), CRP (+), Fis (+), FlhDC (+), 
FNR (+), GlpR (-)   
glpD  Aerobic glycerol-3-
phosphate dehydrogenase 
2.9 4.6 2.8 1.6 1.2 1.1 1.2 ArcA (-), CRP (+), GlpR (-) 
glpFK  Glycerol channel and 
glycerol kinase 
2.2 3.8 3.4 1.2 -1.3 -1.3 1.3 CRP (+), GlpR (-) 
pdhR-
aceEF-lpd 
 PdhR regulator, pyruvate 
dehydrogense complex 
1.6 1.7 2.3 3.1 2.7 1.6 1.0 ArcA (-), Cra (-), CRP (+), Fis (+), FNR 
(+/-), Fur (+/-), NsrR (-), PdhR (-) 
sdhCDAB-
sucA-D 
 Succinate dehydrogenase, 
2-oxo-glutarate 
dehydrogenase 
2.3 3.6 3.6 2.4 1.6 1.3 1.2 ArcA (+/-), CRP (+), FNR (-), Fur (+) 
 (C) Methionine metabolism 
metBL  O-Succinylhomoserine 
lyase, aspartate kinase 
1.2 -1.3 1.2 2.4 5.6 1.2 1.2 MetJ (-), PhoP (+), YjiE (+) 
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metF  5, 10-
Methylenetetrahydrofolat
e reductase 
-1.1 -1.5 -1.2 1.5 3.8 1.1 1.1 MetJ (-) 
metR  Methionine regulator 1.0 -1.3 -1.2 1.4 3.2 1.1 1.0 MetR (-) 
mmuPM  S-Methyl-L-methionine 
transport 
1.1 1.1 1.1 1.9 3.5 1.1 1.1  
sbp  Sulfate-binding proten -1.1 1.0 1.0 1.8 3.6 1.7 -1.2  
ybdL  Methionine 
aminotransferase 
1.1 -1.6 1.0 1.8 4.0 1.0 1.1  
 (D) Transport proteins 
cstA  Peptide transport 2.2 4.0 3.6 1.4 1.1 1.1 1.6 CRP (+) 
dctA  C4-
dicarboxylate/orotate:prot
on symport 
2.1 3.8 4.3 1.8 1.6 1.3 1.6 ArcA (-), CRP (+), DcuR (+) 
mglBAC  Galactose transport 2.1 2.5 3.7 1.1 1.0 -1.2 2.0 Crp (+), GalR (-), GalS (-) 
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ugpBAEC
Q 
 Glycerol-3-phosphate 
transport 
1.8 3.3 2.4 1.5 1.2 1.2 1.2 PhoB (+) 
 (E) Motility and chemotaxis 
flgAMN  Flagella biosynthesis 1.0 1.1 -1.1 1.1 1.1 -1.1 3.0 FlhDC (+) 
flgB-J  Flagella proteins -1.1 -1.2 -1.1 -1.2 -1.1 1.0 3.3 FlhDC (+) 
fliAZY  Flagella regulation and 
biosynthesis 
-1.1 -1.1 -1.3 -1.1 -1.1 1.1 4.0 FlhDC (+), H-NS (+), MarA (-), NsrR (-
) 
motB-
cheAW 
 Flagella and chemotaxis 
proteins 
1.1 -1.1 1.0 1.1 1.0 1.0 3.2 CpxR (-) 
tar-tap-
cheRBYZ 
 Chemotaxis proteins 1.0 1.3 1.5 1.1 -1.1 1.0 3.1 FNR (+) 
 (F) Others 
betIBA  Betaine aldehyde 
dehydrogenase and 
regulatory protein 
1.8 3.3 2.5 1.9 1.6 1.4 1.0 ArcA (-), BetI (-) 
bsmA  Conserved protein 1.7 3.0 1.4 1.0 -1.2 1.0 1.0  
glcC  Glycolate regulator 1.8 3.9 2.3 1.4 1.1 1.0 1.0 Cra (-), CRP (+), Fis (-), GlcC, (-) 
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putA  Fused transcriptional 
repressor-proline 
dehydrogenase 
1.6 2.8 5.5 2.2 2.2 1.7 1.2 BasR (-), MarA (+), PutA (-) 
ybdH  Predicted oxidoreductase 1.3 1.2 1.3 1.9 3.0 1.1 1.2  
 Predominantly down-regulated operons 
borD  Predicted lipoprotein -1.8 -3.0 -1.4 1.5 1.8 1.2 1.1 PhoP (+) 
cusCFBA  Copper efflux -1.1 -2.2 -3.3 -2.5 -3.0 -2.9 1.0 CusR (+) 
manXYZ  Mannose PTS permease -1.8 -1.4 -3.7 -5.0 -3.0 -2.3 -1.1 CRP (+), Cra (-), DgsA (-), NagC (-) 
ompF  Outer membrane protein 1.0 -2.4 -3.1 -2.4 -1.3 1.1 1.7 CpxR (-), CRP (+), EnvY (+), Fur (+), 
IHF (+/-), OmpR (+/-), RstA (-)  
thrABC  Threonine and homoserine 
biosynthesis 
-1.6 -1.6 -2.4 -3.2 -2.3 1.0 -1.5 DksA (+) 
aUnless indicated in bold type the data shown are for the first gene in the operon. 
bNumbers are fold increase or decrease (by at least 3-fold, p ≤0.05, at one or more sampling points) in transcript abundance after introduction of TMAO. 
cRegulatory proteins are indicated (-) negative regulation, (+) positive regulation, (+/-) dual regulation. 
PTS, phosphotransferase system 
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min after initial exposure of the culture to TMAO.  The increase in abundance of the 
transcript was maintained across the transition, but declined to be only 3.5-fold greater than 
that of the initial fermentative steady state in the new TMAO respiratory/fermentative 
steady state.  With the exception of the motility and chemotaxis transcripts (Table 3.2, group 
E), the torCAD operon was the only transcript to exhibit >3-fold increased abundance in the 
final TMAO-respiratory/ fermentative steady state.  Thus, during the transition there is a high 
expression phase of capacity building for TMAO reduction during initial adaptation, this was 
followed by decreased expression in the new TMAO-respiratory/fermentative steady state 
to a level commensurate with the growth rate of the culture.  Surprisingly, the transcript 
encoding a low oxygen affinity terminal oxidase (cytochrome bo’; Cyo) was strongly induced 
during the first 10 min of the transition before returning to its initial level of abundance, 
despite anaerobic conditions being maintained throughout (Table 3.2, group A).  However, 
there was an absence of the broad transcriptional response that is observed upon transfer 
of E. coli cultures to aerobic growth conditions (Partridge et al., 2006; Rolfe et al., 2012; 
Trotter et al., 2011), which indicates that unintended introduction of oxygen to the 
chemostat was not the cause of the increased abundance of the cyo transcript.   
There were seven upregulated operons that were involved in carbon metabolism (Table 3.2, 
group B).  These operons  returned to their initial abundances in the TMAO 
respiratory/fermentative steady state, but, were all transiently expressed during the 
transition to TMAO-respiratory growth, like the cyoA-E operon (Table 3.2, group B).  This 
group of operons includes transcripts encoding key components of central metabolism: 
pyruvate dehydrogenase, succinate dehydrogenase and 2-oxo-glutarate dehydrogenase 
indicating that the presence of the electron acceptor TMAO invokes a shift towards 
enhanced substrate oxidation.  Also upregulated were transcripts associated with glycerol 
and acetate acquisition and metabolism, including both the anaerobic and aerobic glycerol-
3-phosphate dehydrogenase operons and the glycerol-3-phosphate transport system (ugp 
operon, assigned to group D).  The establishment of respiratory chains with succinate and 
glycerol-3-phosphate as the electron donors in the presence of TMAO is suggested by the 
activation of the anaerobic and aerobic glycerol-3-phosphate dehydrogenases and succinate 
dehydrogenase (complex II).  The decrease in extracellular succinate concentration and 
increase in fumarate concentration after addition of TMAO was consistent with the induction 
of complex II.  However, extracellular glycerol was not detected by NMR (Table 3.1).  Osmotic 
re-balancing in the 5 min period after addition of the osmolyte TMAO to the culture was 
suggested by the activation of the betIBA operon (glycine-betaine synthesis from choline).  
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Transcripts which encode a regulator and enzymes involved in formaldehyde detoxification 
(frmRAB operon) exhibited a more sustained (>60 min after TMAO addition) expression 
profile across the transition (Table 3.2, group B).   
Group C is formed of transcripts involved in methionine metabolism, which were transiently 
upregulated 15-20 min after the addition of TMAO, before returning to pre-TMAO addition 
level (Table 3.2, group C).  MetJ is the regulator of three of the six transiently induced 
operons in group C, which suggests that the supply of S-adenosylmethionine, a molecule 
used in methyl transfer reactions, is restricted during this period of enhanced biomass 
production.  Group D contained peptide, C4-dicarboxylic acid/orotate, galactose and glycerol-
3-phosphate transport systems (Table 3.2, group D).   
In the new TMAO respiratory/fermentative steady state, enhanced abundance of the flagella 
and chemotaxis transcripts were observed and these form group E.  The increased 
abundance of these transcripts was only seen in the final TMAO-respiratory/ fermentative 
steady state (Table 3.2, group E).   
Group F consisted of transcripts that were transiently induced, including transcripts encoding 
proteins involved in osmotic homeostasis (betIBA operon), regulatory proteins and proteins 
of unknown function.   
In response to addition of TMAO, five operons were transiently downregulated ≥3-fold, these 
operons encode proteins of various biological functions.  The downregulated operons have 
roles in copper resistance, threonine biosynthesis, mannose transport and outer membrane 
function (Table 3.2, group G).  During the initial phases of adaptation, a decrease in the cus 
operon transcripts was observed.  This operon encodes an anaerobic copper detoxification 
system, which suggests that any copper stress experienced by the culture during this phase 
of the transition was diminished.   
3.4. Using TFInfer to simultaneous infer the activities of transcription factors during the 
switch of metabolic mode 
Complex interactions between signalling molecules and transcription factors (TFs) have 
resulted in changes in gene expression, substrate utilisation and over-metabolite production 
(Sections 3.2 and 3.3), during the adaptation of E. coli K-12 to the presence of TMAO.  During 
the transition, there were widespread changes that are components of the transcriptional 
response that sit below the statistical filter used (≥3-fold (t-test, p=0.05)) to deem an operon 
significantly regulated.  Therefore, in order to capture the full breadth of the transcriptional 
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response when the fermentative culture was perturbed by the addition of TMAO, open 
access TFInfer software (Asif et al., 2010) was used to simultaneously infer the activities of 
167 TFs that are recorded as able to directly regulate target genes in the EcoCyc database 
(Keseler et al., 2013) from the transcript profiles.  TFInfer is based on a state space model 
that employs a linear approximation (in log space) to the dynamics of transcription and treats 
noise in a way such that the estimated TF activities are associated with confidence limits 
(Sanguinetti et al., 2006).  The TFInfer model has been previously used in several studies 
(Partridge et al., 2007; Rolfe et al., 2012).  During this analysis here, TFs that exhibited a signal 
to noise ratio of >2 were deemed to have activities significantly altered following the 
introduction of TMAO (Figure 3.2).  From the analysis, the inferred activities of only 20 TFs 
could account for many of the changes in transcript abundance during the transition (Table 
3.2), as one or more TFs exhibiting altered activity are known to regulate transcription from 
the corresponding promoters, thus potentially regulating the expression of a number of 
operons (Table 3.2).  A visual representation of the regulatory events (as inferred by TFInfer) 
during the time course is shown in Figure 3.3.   
When the TMAO-respiratory steady state was compared to the initial fermentative steady 
state, there were only two TFs (FlhDC and TorR) that displayed >2-fold enhanced activity 
(Figure 3.2).  The inferred activity of TorR in the TMAO respiratory/fermentative steady state 
which was ~6-fold lower (0.51) than the maximal (3.16), which occurred 10 min after 
introduction of TMAO, is sufficient to maintain an appropriate concentration of TMAO 
reductase in the new steady state.  It is unclear why there is enhanced FlhDC and thus 
increased expression of motility and chemotaxis genes.   
During the first 60 min of the transition, four TFs (ArcA, CusR, CsgD and PutA) showed lower 
activity before returning to their original levels in the TMAO-respiratory/fermentative steady 
state (Figure 3.2).  In order to validate the inferred activities of ArcA, the amounts of 
phosphorylated ArcA (ArcA~P) present in the bacteria were measured (Section 2.10.13) 
(Figure 3.4).  In order to do this, ArcA and ArcA~P were separated by Phos-tag gel 
electrophoresis (Wako Pure Chemical Industries Ltd.) and using anti-ArcA serum were 
detected via Western blotting (Section 2.10.12).  The proportion of ArcA~P in the samples 
was then determined using quantitative densitometry.  This analysis showed that the ArcA~P 
decreased to 0% in the 2–20 min period after TMAO addition from the expected ~50% level 
in the fermentative steady state (Rolfe et al., 2011), before slowly increasing to ~30% after 
60 min and returning to ~50% in the TMAO-respiratory/fermentative steady state (Figure 
3.4). Active ArcA is believed to exist in an octameric form, with 50% of the ArcA monomers  
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Figure 3.2. Changes in TF activities in response to perturbation of anaerobic fermentative 
cultures of E. coli with the electron acceptor TMAO 
At the indicated times (min) after TMAO addition to anaerobic fermentative steady state 
cultures, the output from the TFInfer software (Asif et al., 2010) of TF activities with the signal 
to noise ratios ≥2 are shown. The colour of each cell provides a visual representation of the 
TF activities inferred from the complete transcript profile dataset. TF activity 0–1, blue; 1–2, 
green; 2–3, yellow; 3–4, orange; >4, red.  
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Figure 3.3. The regulatory dynamics that occurred after the addition of TMAO to anaerobic 
fermentative steady state cultures 
Graphical representation of regulatory dynamics. The ﬁgure shows the time course of all 
1,381 genes used in the TFInfer analysis; time is re-scaled to have equal spacing between 
time points. The panels above and below the time course show the three TFs exhibiting the 
greatest fold increase (red) or decrease (blue) in activity compared with previous time point 
as inferred by TFInfer, providing a depiction of the main regulatory events that occurred in 
response to the addition of TMAO.    
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Figure 3.4.  Measurement of ArcA~P validate the inferred activity of ArcA 
A typical Phos-tagTM gel developed with anti-ArcA serum.  Lane 1 contains purified His-tagged 
ArcA protein (1.2 µg) phosphorylated in vitro by incubation with carbamoyl phosphate (50 
mM); lane 2, purified His-tagged ArcA dephosphorylated; lane 3-10, whole cell samples taken 
at time = 0 (anaerobic fermentative steady state), 2, 5, 10, 15, 20, 60 and 1,440 min (TMAO 
respiratory/fermentative steady state) after addition of TMAO to the anaerobic fermentative 
steady state culture.  The locations of both ArcA and ArcA~P are indicated.   
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being phosphorylated (1:1 ratio ArcA:ArcA~P).  However, inactive ArcA is in a dimeric form 
and does not contain any phosphorylated monomers (Jeon et al., 2001).  Thus, direct 
measurement of the ArcA phosphorylation profile correlated well with the predicted ArcA 
activities inferred from transcript profiles, as a decrease in ArcA activity is suggested by these 
measurements.  At least three signals have been suggested to affect the activtity of the 
cognate histidine kinase for ArcA, ArcB: oxidised ubiquinone acts negatively; reduced 
menaquinone acts positively; and fermentation products, e.g. acetate, promote ArcB kinase 
activity and ArcA phosphorylation (Alvarez et al., 2013; Bekker et al., 2010; Georgellis et al., 
1999, 2001; Rodriguez et al., 2004; Rolfe et al., 2012; Rolfe et al., 2011).  The dynamics of 
ArcA activity here suggests that ArcA was initially dephosphorylated after the introduction 
of TMAO to the fermenting culture, presumably because the addition of TMAO caused net 
oxidation of the menaquinone pool.  Then, perhaps mediated by the enhanced production 
of acetate (Table 3.1), ArcA activity was restored in the final TMAO-respiratory/fermentative 
steady state.  The changes in ArcA activity account for 7 of the 29 transcripts that were 
upregulated ≥3-fold in response to the presence of TMAO, as these transcripts are repressed 
by ArcA, including the unexpected transient upregulation of the cytochrome bo’ operon, as 
well as genes encoding the pyruvate, 2-oxoglutarate and succinate dehydrogenases (Table 
3.2).   
Maximal activity during the adaptive phase (2-60 min) of the transition was seen for the 
majority (15 out of 20) of the responsive TFs (signal to noise ratio ≥2), including TorR, before 
their activities returned to values close to those in the initial fermentative steady state, in 
the final steady state.  The greatest activities for ArgR, CRP and PurR were 5 min after the 
introduction of TMAO; IlvY, Lrp, MalT, MetJ and TorR after 10 min; CysB, RcsAB and PhoP 
after 20 min; and GlpR after 60 min (Figure 3.2).   
3.5. Regulation of the TorA protein is at the level of transcription as suggested by 
measurement of TorA protein and TMAO reductase activity  
After the introduction of TMAO measurements of the TorA protein content (Section 2.10.12) 
(Figure 3.5a) and TMAO reductase activities (Section 2.13.1) (Figure 3.5b) were made.  
Western blotting was used to estimate the TorA content of the bacteria using TorA anti-sera 
(Dr Iobbi-Nivol, CNRS, Marseille) (Figure 3.5a).  This showed that the abundance of TorA 
increased during the first 60 min of the transition and was maintained in the final steady 
state.  The TMAO reductase activity of bacteria grown under fermentative conditions was 
low, but increased ~2-fold 60 min after the addition of TMAO (Figure 3.5b).  The changes in  
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Figure 3.5a and b.  The amount of TorA protein and TMAO reductase activity during 
adaptation to TMAO-respiratory growth correlate with the changes in tor operon 
transcription  
a. Typical Western blot, developed with anti-TorA serum, of whole cell samples taken 
from anaerobic fermentative chemostat cultures 0, 2, 5, 10, 15, 20, 60 and 1,440 min 
after the addition of TMAO.   
b. Quantitative densitometric analysis of Western blot (shown in Figure 5a) was used 
to measure the increase in the amount of TorA protein present in the bacteria after 
TMAO addition (open bars). The amounts of TorA shown are relative to the level in 
the 1,440 min sample (100%).  TMAO reductase activities (filled bar) were measured 
for duplicate samples obtained at the same time points used for quantification of 
TorA protein (Figure 5a).  The TMAO reductase activity data are also shown relative 
to the activity in the 1,440 min sample (100%). 
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TMAO reductase enzyme activity in the new TMAO-respiratory/fermentative steady state 
compared to the initial fermentative sample (~4-fold higher), correlated with the 3.5-fold 
increase in tor operon transcript abundance (Table 3.2).  This suggests an absence of any 
post-transcriptional regulation of TMAO reductase activity.  Western blotting of TorA protein 
during the transition suggested a greater overall increased in abundance than the TMAO 
reductase activity increase.  However, there was a good positive correlation between 
enzyme activity and TorA protein content in the samples obtained in the 10 – 1,440 min 
period after TMAO addition (Figure 3.5a and b).   
3.6. Formaldehyde dehydrogenase FrmAB induction is likely to be the result of the 
presence of TMAO demethylase activity  
Unexpectedly, there was a transient increase in abundance of the frmRAB transcript upon 
exposure of the cultures to TMAO (Table 3.2).  This was surprising because the frmRAB 
operon is known to be induced by formaldehyde (Herring and Blattner, 2004).  The 
expression of the operon is negatively regulated by the transcriptional regulator FrmR, which 
is encoded by the first gene of the operon.  The FrmA and FrmB proteins catalyse the 
glutathione-dependent two-step conversion of toxic formaldehyde to non-toxic formate 
(Gutheil et al., 1992) (Equation 5).   
           FrmA            FrmB 
Formaldehyde + Glutathione      S-formylglutathione        Formate + Glutathione + H+ (5) 
As this upregulation was unexpected, confirmation of frmRAB induction in the presence of 
TMAO was first sought by quantitative reverse transcription polymerase chain reaction (qRT-
PCR).  Analyses of RNA isolated from batch cultures of E. coli MG1655 after 60 min exposure 
to a range of different TMAO concentrations (0–40 mM) were carried out (Section 2.8.14.1).  
The abundance of the frmRAB transcript was significantly increased when the bacterial 
cultures were exposed to ≥5 mM TMAO (Figure 3.6).  Therefore, these experiments 
confirmed the transcriptional response detected by the transcript profiling.  They also show 
the sensitivity of the induction, as upregulation of frmRAB occurred at concentrations of 
TMAO ≥5 mM (Figure 3.6) and that this adaptation occurred both in continuous and batch 
cultures (Table 3.2).   
In separate experiments, the Nash reagent (Nash, 1953) was used to detect formaldehyde 
accumulation by E. coli K-12 cell-free extracts incubated with TMAO (40 mM).  No 
formaldehyde was accumulated in reactions lacking cell-free extract or TMAO (Section  
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Figure 3.6. The frmRAB operon is induced after exposure of E. coli MG1655 to 
concentrations of TMAO ≥5 mM   
Anerobic batch cultures were exposed to different concentrations (0-40 mM) of TMAO.  After 
30 min incubation with TMAO, total RNA was isolated from the cultures for qRT-PCR analysis 
of frmR mRNA.  The data shown are the mean and standard deviation for the fold increase 
relative to the 0 mM TMAO culture from three technical replicates and are representative of 
three indepent biologial experiments.   
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2.13.3).  However, formaldehyde was detected in the complete assays producing 20 nmole 
mg
-1
 of cell-free extract after 40 min incubation (Figure 3.7).  Furthermore, the presence of 
0.23 mM dimethylamine (DMA) was found in the extracellular metabolite profile of the 
chemostat cultures after the addition of TMAO (Table 3.1).  These observations suggest that 
E. coli K-12 possesses TMAO demethylase activity (EC4.1.2.32), which results in the 
accumulation of DMA and formaldehyde, with the production of the latter inducing frmRAB 
expression.  The frmRAB operon has previously been shown to be induced when cultures of 
E.coli are exposed to 0.25 mM formaldehyde (Herring and Blattner, 2004), which is a 
concentration very similar to the amount of DMA detected here (Table 3.1).  The induction 
of the frmRAB operon during transition to TMAO respiratory growth; the detection of 
formaldehyde production by cell-free extracts incubated with TMAO and the detection of 
DMA in the culture supernatant suggested that a frmRAB mutant would be unable to detoxify 
formaldehyde and therefore would have compromised viability in the presence of TMAO.  To 
test this, an isogenic E. coli MG1655 frmRAB mutant (JRG6703) was created using λred 
recombineering (Section 2.8.11) with the kanamycin resistance cassette from the pKD4 
plasmid, along with a plasmid (pGS2486) to complement the mutant by expressing frmRAB 
under the control of its own promoter.  The complementation plasmid was created using the 
In-Fusion Cloning Kit (Clonetech) (Section 2.8.12).  The numbers of colony forming units (cfu) 
present in anaerobic cultures of the parent, mutant and complemented mutant before and 
after incubation with TMAO were measured (Section 2.4).  The cfu values of the parent and 
complemented mutant cultures increased after 60 min exposure to TMAO (40 mM), 
reflecting the utilisation of the more efficient metabolic mode.  However, the cfu value of 
the frmRAB mutant did not increase (Figure 3.8).  This result shows that induction of a 
regulatory response in order to detoxify the production of potentially toxic concentrations 
of formaldehyde is necessary to prevent inhibition of growth during transition to anaerobic 
respiration with TMAO as the terminal electron acceptor.   
3.7. Copper(II) is in competition with TMAO/TMAO reductase for electrons from the 
anaerobic electron transport chain 
The decrease in cus transcripts in the transcriptional profiling and the inferred decrease in 
activity of the TF CusR implied that, after introduction of TMAO, the exposure of the E. coli 
cultures to Cu(I) was diminished.  This is because the cognate sensor for CusR is CusS, for 
which Cu(I) is the signal.  Under aerobic conditions, E. coli can use electrons transferred to 
ubiquinone by NADH dehydrogenase II (Em NAD+/NADH, -320mV; ubiquinone/ubiquinol,  
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Figure 3.7.  Detectable concentrations of formaldehyde are produced upon incubation of 
E. coli MG1655 cell-free extracts with TMAO  
Cell-free extracts of E. coli K-12 were incubated with TMAO (40 mM) at 37°C.  At the indicated 
times formaldehyde production was measured using the Nash reagent.  Open bars, cell-free 
extract only; closed bars, cell-free extract plus TMAO.  The data shown are the mean and 
standard deviation values obtained from three independent experiments. 
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Figure 3.8. The E. coli MG1655 frmRAB mutant is attenuated when exposed to TMAO 
Anaerobic cultures of E. coli MG1655 (wild type), wild type transformed with the vector 
pBR322, the frmRAB mutant, and the mutant complemented with the frmRAB expression 
plasmid (pGS2486) were grown on glucose minimal medium buffered with 50 mM phosphate 
buffer, pH 7.0 at 37°C.  In an anaerobic cabinet, each culture was divided into two separate 
cultures and samples for viable count measurements were taken (t = 0 min; white bars).  
TMAO (40 mM) was added to one (black bars), but not the other (grey bars), of each pair of 
cultures and anaerobic incubation was continued for a further 60 min, at which point 
samples for viable count measurements were taken.  The data shown are the mean and 
standard deviation values, normalised to those obtained at t=0 min, from three independent 
biological replicates.         
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+110 mV) to reduce the trace element Cu(II) to Cu(I)  (Em + 340 mV) (Thauer et al., 1977; 
Volentini et al., 2011).  Menaquinone (Em menaquinone/menaquinol, -74 mV) is the electron 
donor for the TMAO reductase under anaerobic conditions, (Wissenbach et al., 1992) and 
has the potential to reduce Cu(II), like ubiquinone.  Therefore, under anaerobic conditions in 
both the presence and absence of TMAO, the capacity of E. coli K-12 MG1655 whole cells to 
reduce Cu(II) to Cu(I) was tested (Section 2.13.2).  Reduction of Cu(II) was detected in both 
the presence and absence of TMAO, but was diminished ~1.6-fold in the presence of TMAO 
(Figure 3.9).  This was interpreted as follows: under anaerobic fermentative conditions there 
is a relatively low flux of electrons from the menaquinone pool to fumarate reductase to 
reduce fumarate to succinate, as suggested by the analysis of over-metabolite production 
(Table 3.1).  This allows electrons to leak directly or indirectly to periplasmic Cu(II) from 
reduced quinones, resulting in the production of Cu(I) and activation of the CusSR 
transcriptional response (Table 3.2, Figure 3.10a).  An additional outlet for electrons in the 
menaquinone pool is provided when TMAO is supplied, resulting in the decreased reduction 
of Cu(II) to Cu(I) (Figure 3.9) and decreased reduction of fumarate to succinate (Table 3.1) 
during the initial adaptive phase (Figure 3.10b).  Also, the presence of TMAO invokes a shift 
towards a more oxidised menaquinone pool, which would contribute to the inactivation of 
ArcA and hence de-repression of cyoA-E, phdR-aceEF-lpd and sdhCDAB-sucA-D operons 
(Figure 3.4, Table 3.2).   
3.8. Discussion  
The experiments described in this chapter provide new insights about the adaptive 
processes, which occur when E. coli K-12 switches metabolic mode from fermentative 
growth to anaerobic growth with TMAO as the terminal electron acceptor (Figure 3.10a and 
b).   
Several of the measured changes in transcript and metabolite profiles were predictable, such 
as the reduction of TMAO to TMA via the induction of the torCAD operon, the main TMAO 
reductase of E. coli K-12.  However, some unexpected components of the adaptive process 
were highlighted.  For example, the detection of DMA and formaldehyde suggested that E. 
coli possesses TMAO demethylase activity (EC4.1.2.32).  This activity produced detectable 
and physiologically significant amounts and of formaldehyde when TMAO was supplied in 
excess.  The amount of formaldehyde generated by this activity was of sufficient quantity to 
induce the expression of the formaldehyde detoxifying enzymes (FrmAB) when TMAO was 
abundant.  TMAO demethylase activity, although never reported before in E. coli, has been 
found in a number of different marine wild life species, including the Jumbo Squid (Dosidicus  
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Figure 3.9. The effect of TMAO on Cu(II) reduction by E. coli MG1655 
Bacterial cell suspensions (final OD600 ~2.5) in Evans medium were incubated at 37°C for up 
to 60 min in the presence and absence of CuSO4 (0.05 mM) and/or TMAO (40 mM).  At the 
indicated time points, aliquots were removed and the amount of Cu(I) present was 
measured.  Open circles, no bacteria; open triangles, no Cu(II); closed diamonds, bacteria 
plus Cu(II) plus TMAO; closed squares, bacteria plus Cu(II).  The data are the mean values  
standard deviation obtained from three independent experiments.     
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Figure 3.10a and b. Excess TMAO activates TorTSR, inhibits Cu(II) reduction by the electron 
transport chain and permits activation of ArcA 
a. During anaerobic fermentation, at the expense of menaquinol (MQH2), fumarate is 
reduced to succinate and the trace element Cu(II) is reduced to Cu(I).  The Cu(I) 
generated by this process is sensed by the CusSR two-component system and the 
copper efflux system CusFCBA is activated.  There is a high MQH2:MQ ratio and flux 
through the electron transport chain is relatively low, resulting in the 
phosphorylation of ArcA (ArcA~P) and repression of the cyoA-E, pdhR-aceEF-lpd and 
sdhCDAB-sucA-D operons.   
b. Addition of TMAO to the fermenting cultures is sensed by the TorTSR sensor-
regulator system, activating the expression TMAO reductase (torCAD operon).  The 
MQH2:MQ ratio becomes low as TMAO reductase is able to utilise for the electrons 
of the menaquinone pool.  This results in a decreased phosphorylation of ArcA 
resulting in de-repression of the cyoA-E, pdhR-aceEF-lpd and sdhCDAB-sucA-D 
operons.  A respiratory chain with succinate as the electron donor and TMAO as the 
electron acceptor, could also be permitted and is consistent with the observed 
transcriptional profile and the concentrations of succinate and fumarate in the 
culture medium. The capacity of the bacteria to reduce Cu(II) to Cu(I) is lower as the 
flux of electrons to TMAO increased, thus the TF CusR is switched off.  The width of 
the regulatory arrows is an indication of the relative rate of each step and font size 
is used to indicate the NADH:NAD+ and MQH2:MQ ratios.   
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gigas) and Walleye Pollock (Gadus chalcogrammus).  In Walleye Pollock, the protein Aspolin 
is responsible for iron-mediated TMAO demethylation and is an extremely aspartic acid-rich 
protein (179 Asp residues) composed of 186 amino acids (Takeuchi et al., 2003).  The TMAO 
demethylase enzyme from Jumbo Squid has also been isolated and characterised (Fu et al., 
2006).  The molecular mass of the TMAO demethylase was 17.5 kDa, had an optimum 
temperature of 55oC and converted TMAO to DMA and formaldehyde stoichiometrically with 
a Km of 26.2 mM (Fu et al., 2006).  Work on TMAO demethylase activity in fish is of 
commercial significance, as upon death of the fish, production of formaldehyde by the 
demethylase activity could result in food spoilage.  But, TMAO demethylase activity is not 
restricted to marine lifeforms, as recently the activity has been discovered in prokaryotes 
including Pseudomonas putida (Liffourrena et al., 2010) and Methylocella silvestris (Zhu et 
al., 2014).  Studies on the recombinant TMAO demethylase of M. silvestris suggest that it is 
hexameric, has a high affinity for TMAO and has narrow substrate specificity (Zhu et al., 
2014).  The enzyme also does not share any sequence homology or similar characteristics to 
eukaryotic TMAO demethylases (Zhu et al., 2014).  Sequence analysis of the E. coli K-12 
genome was carried out and showed that there was no similar gene, with sequence 
homology present.   In light of these recent findings, work was attempted to identify the 
source of the TMAO demethylase activity in E. coli K-12.  However, technical difficulties with 
using the Nash reagent to detect low concentrations of formaldehyde produced from the 
TMAO demethylase activity prevented this work from being followed through.  The failure 
to purify the TMAO demethylase activity could be simply due to low enzymatic activity and 
thus difficulty in obtaining the pure enzyme responsible.  However, there is also the 
possibility that the TMAO demethylase activity detected here is a side reaction of another 
cellular demethylase enzyme present in E. coli K-12, and that TMAO is demethylated by this 
enzyme when TMAO is present in excess.  It should still be feasible to identify and purify the 
source of the activity regardless of where the source is specifically a TMAO demethylase or 
another demethylase enzyme present in E. coli, which recognises and is able to demethylate 
TMAO and work needs to continue here. 
Despite maintaining anaerobic culture conditions through the experiments, there was a 
surprising induction of the cyoA-E transcript, which encodes a low oxygen-affinity terminal 
oxidase.  This was explained by the transient inactivation of ArcA, which was predicted by 
probabilistic modelling of transcription factor activities and validated by the direct 
measurement of ArcA~P.  A number of other ArcA~P-repressed operons, as well as cyoA-E, 
were induced and this could be accounted for by the temporary inactivation of ArcA.  The 
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two-component system, ArcBA, acts as an indirect sensor of oxygen, as ArcB monitors the 
redox state of the electron transport chain and the production of fermentation products, 
such as acetate.  Therefore, the activity of ArcBA is sensitive to cellular NADH/NAD+ ratios 
(Holm et al, 2010).  Using glucose-limited chemostat cultures, it was shown that E. coli are 
affected by the availability of electrons acceptors fumarate, nitrate and oxygen, which act as 
effective NADH sinks.  During anaerobic fermentative growth, the greatest NADH/NAD+ 
ratios were observed.  Lower NADH/NAD+ ratios were measured when an external electron 
acceptor (~0.3 with 7.5 mM nitrate; ~0.4 with 70 mM fumarate; and ~0.08 under fully aerobic 
conditions) was present (de Graef et al., 1999; Alexeeva, 2000).  Adding excess TMAO to an 
anaerobic fermentative culture would be expected to result in a decreased NADH/NAD+ 
ratio, as an additional outlet for electrons in the menaquinone pool is being provided.  The 
result of the additional outlet for electrons results in the inactivation of ArcBA, which is then 
activated again by increased production of acetate as TMAO-respiratory metabolism is 
established.  This work highlights further the complexity of ArcBA regulation and the number 
of different factors, which effect the two-component system’s activity.   
The downregulation of copper resistance genes in the presence of excess TMAO can be 
accounted for by competition for electrons from the menaquinone pool.  Work previously 
published showed that electrons from the E. coli respiratory chain can reduce Cu(II) to Cu(I) 
(Volentini et al., 2011).  Here, it was shown that the presence of the electron acceptor TMAO 
was able to inhibit reduction of Cu(II) by E. coli, which suggests that TMAO reductase/TMAO 
are effective competitors for electrons that might otherwise have contributed to the 
reduction of Cu(II) to Cu(I).  The inactivation of CusR and downregulation of copper resistance 
genes are a result of the lower Cu(I) production.   
Performing similar experiments with mutants lacking some of the key regulators (e.g. ArcA, 
FlhDC, FrmR and MetJ) identified here could further characterise the roles played by their 
respective regulons in adaptation to TMAO exposure. It would also be interesting to use 
other alternative electron acceptors (e.g. nitrate, nitrite, DMSO) in these experiments to 
characterise the different dynamic adaptive processes that E. coli K-12 utilises in order to 
respond to other electron acceptors.  However, the systematic analysis of E. coli K-12 cultures 
carried out in this chapter has provided new insights into the dynamics of transcriptional and 
physiological changes required to successfully adapt to anaerobic environments containing 
TMAO.   
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4. Analysis of the transcriptional initiation of the torCAD operon in individual E. coli cells 
after exposure to TMAO 
4.1. Introduction  
The major pathway for TMAO respiration in E. coli requires the expression of the torCAD 
operon, which encodes the TorC, TorA and TorD proteins (Gon et al., 2001a; Méjean et al., 
1994).  TMAO respiration through the TorCAD pathway is strictly regulated by the presence 
of TMAO in the environment.  This strict regulation is exerted by the TorT-TorS-TorR signal 
transduction system and means that components of the E. coli TMAO respiratory chain are 
only expressed in the presence of TMAO (Jourlin et al., 1997; Jourlin et al., 1996b).   
As shown in Chapter 3, E. coli MG1655 grown under anaerobic conditions with a sub-optimal 
concentration of TMAO as the terminal electron acceptor and glucose as the sole carbon 
source, resulted in mixed TMAO respiratory and fermentative metabolism (TMAO-
respiratory/fermentative growth) after 24 h.  Both the products of TMAO respiration and 
fermentation were present in culture supernatants that had been exposed to TMAO.  This 
behaviour might arise from a single population of cells that simultaneously ferment and 
respire, or sub-populations that exclusively ferment or respire (Figure 4.1).   
In order to test these hypotheses, single cell experiments were carried out to determine 
whether heterogeneity in torCAD transcription was responsible for the mixed metabolism 
reported in Chapter 3, i.e. did mixed metabolism arise from all cells utilising both respiration 
and fermentation or from a mixed population of TMAO-respiring cells and cells carrying out 
fermentation.   To carry out single cell studies, a PtorC-gfp reporter strain of E. coli K-12 was 
created (E. coli JRG6705), to determine whether all cells were utilising TMAO when it is 
present (i.e. all cells express GFP) or whether only a sub-population reduce TMAO (i.e. only 
a proportion of the cells express GFP) (Figure 4.1).   
4.2. Creation of PtorC-gfp, ΔtorC reporter strain (E. coli JRG6705) using λred recombineering 
In order to investigate the metabolic mode of individual E. coli K-12 cells in the presence of 
excess TMAO, a PtorC-gfp, ΔtorC fusion strain (E. coli JRG6705) was created using λred 
recombineering (Datsenko and Wanner, 2000) (Section 2.8.11) (Table 2.1).  As a result of 
transducing the reporter fusion into the strain, the chromosomal torC gene was replaced 
with genes coding for green fluorescent protein (GFP) and kanamycin resistance from the 
plasmid p-DOC-G (Lee et al., 2009) (Table 2.2).  Creation of the PtorC-gfp fusion, thus led to the 
knockout of the torC gene (Figure 4.2a).  Once the genotype of the reporter strain had been  
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Figure 4.1. Schematic diagram showing the possible behaviours of individual cells in a 
mixed metabolic culture 
Option 1, occurs when all cells within the population are carry out both fermentation and 
TMAO-respiration simultaneously; option 2, occurs when there are two sub-populations of 
cells each carrying out a different mode of metabolism with only one sub-population utilising 
TMAO.  Ovals represent individual cells within the whole population; F, represents cells 
carrying out fermentation; R, represents cells utilising TMAO.  Cells are coloured green when 
TMAO is being utilised as this will express gfp via the reporter fusion (Ptor-gfp).   
  
One population of cells: 
• All carrying out both 
fermentation and TMAO-
respiration 
Two subpopulations of cells: 
• One population carrying out 
fermentation  
• One population utilising 
TMAO  
F/R 
F/R 
F/R 
F/R 
F/R 
F/R 
F/R 
F 
Option 1: Option 2: 
R 
F 
F 
F 
R 
R 
Cell carrying out both fermentation and TMAO respiration 
 
Cell carrying out fermentation only 
 
Cell carrying out TMAO respiration only  
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Figure 4.2a and b. Creation of the PtorC-gfp fusion using homologous recombination  
a. A schematic diagram representing the creation of the PtorC-gfp fusion in the E. coli 
MG1655 genome (JRG6705) created using homologous recombination with the p-
DOC-G plasmid (Section 2.8.11) (Table 2.2).  The gfp and kanamycin resistance genes 
are encoded for on the p-DOC-G plasmid.  Numbers represent either size of the 
indicated genes or position of the genes on the E. coli MG1655 chromosome.  
Oligonucleotide primer (F1 and R1) annealing sites are shown with dotted black lines 
highlighting the regions containing homology to the torC gene with these sites also 
being shown on the E. coli MG1655 chromosome (H1 and H2).  FLP are Flp 
recombination sites.  Dotted purple lines represent where homologous 
recombination events take place. 
b. An agarose (1%) gel showing PCRs using TorC-fusion seq F and R oligonucleotide 
primers (Appendix 1) and either E.coli JRG6705 or E.coli MG1655 genomic DNA as 
the template.  Lane 1, Hyperladder I (Bio Line); Lane 2, PCR using E.coli MG1655 
genomic DNA; Lane 3, PCR using E.coli JRG6705 genomic DNA.  Sizes of PCR products 
are indicated by the arrows and sizes of DNA markers are indicated. 
b 
~2,000 bp - (tor-gfp-kanamycinR insert)   2,500 bp 
 1,500 bp 
2,000 bp 
~1,200 bp - (wild type torC) 
3,000 bp 
1,000 bp 
   1         2        3 
p-DOC-G plasmid  
E. coli MG1655 chromosome  
a 
96 
 
verified by PCR (Figure 4.2b) and DNA sequencing, the phenotype was confirmed using NMR 
(Section 2.12).  The reduction of TMAO by anaerobic cultures of both wild type and E.coli 
JRG6705 after ~ 18 h growth at 37oC was analysed.  Wild type cells, which had a fully 
functioning TorCA respiratory chain were able to reduce the majority of the TMAO added to 
the culture, as shown by 13-fold decrease in the concentration of TMAO in the culture 
supernatant and production of TMA (TMAO: 0 h, 42.3 mM; 18 h, 3.3 mM; TMA: 0 h, 0 mM; 
18 h, 32.0 mM) (Figure 4.3).  However, E. coli JRG6705 cultures were unable to reduce TMAO 
to the same level as the wild type, with only 1.6-fold decrease in TMAO over the same time 
period (TMAO: 0 h, 42.9 mM; 18 h, 27.2 mM; TMA: 0 h, 0 mM; 18 h, 10.4 mM) (Figure 4.3).  
Therefore, replacing torC with gfp in the chromosome of E. coli JRG6705 resulted in an overall 
8.2-fold decrease in TMAO reduction when compared to wild type.  Creation of the fusion 
does not completely render the strain unable to reduce TMAO, as seen by the presence of 
TMA in the supernatants of E. coli JRG6705 cultures.  Reduction of TMAO in this strain will 
still be carried out by the two other TMAO reduction systems present in E. coli (TorZY and 
DmsABC) (Bilous and Weiner, 1988; Gon et al., 2000).  As these systems are expressed at low 
levels, they account for the smaller amount of TMAO reduction seen here (Figure 4.3).  It is 
important to note that the decrease in TMAO reduction associated with E. coli JRG6705 cells 
will mean that less TMAO is converted to TMA, thus the signal for induction of Ptor-gfp will 
persist.   
4.3. Analysis of torCAD expression in response to TMAO over time 
Continuous cultures of E.coli JRG6705 cells were grown in 1 L chemostat vessels under 
anaerobic conditions as previously described (Section 2.3.1).  Cells were grown in order to 
use fluorescence microscopy and flow cytometry to observe the expression of torCAD in 
individual cells in response to TMAO.   
4.3.1. The expression of torCAD in response to TMAO does not occur in every cell (all cells 
are not GFP-positive) and the mean level of expression changes (intensity of GFP signal) 
over time 
Flow cytometry experiments were carried out on fixed cultures, removed from the 
chemostat at the indicated time points (Sections 2.3.1, 2.14.1 and 2.14.2).  Cells were washed 
and fixed under aerobic conditions to allow for GFP maturation.  Samples were analysed with 
an Attune Autosampler using the BL1 detector for GFP detection (Section 2.14.5).  Flow 
cytometry experiments were gated using a sample of GFP-negative cells (no TMAO, 
anaerobic conditions) such that a cell would only qualify as being GFP-positive if the BL1  
97 
 
 
 
Figure 4.3. Cultures of E. coli JRG6705 exhibit impaired TMAO reduction  
NMR was used to quantify the reduction of TMAO (~40 mM) after ~18 h of growth at 37oC 
under anaerobic conditions by cultures of both E. coli JRG6705 and wild type.  The 
concentrations of the metabolites (mM) in the cell-free supernatants of both cultures are 
shown.  Grey bars represent the metabolite profile of the E. coli MG1655 culture; white bars 
represent the E. coli JRG6705 culture.  The metabolite concentrations are given for one 
experiment.   
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intensity for that cell was higher than that of the GFP-negative sample.  By applying a gate in 
this way, it was seen that the number of individual cells expressing GFP increased the longer 
the culture was exposed TMAO.  This is shown by an increase in the percentage of GFP-
positive cells in the sample over time (Figures 4.4 and 4.5).  However, after 60 min exposure 
to TMAO, it can be seen that only ~42% of the cells are expressing GFP, suggesting that 
approximately half of the population are not utilising TMAO.  This is despite the signal 
(TMAO) persisting, due to decreased reduction of TMAO by the strain.    
In order to further explore this, fluorescence microscopy was carried out on the same 
chemostat samples (Section 2.3.1).  Samples were washed and fixed with 1% (v/v) 
paraformaldehyde to poly-lysine coated glass slides as described (Sections 2.14.1, 2.14.2 and 
2.14.3).  Individual cells from continuous cultures were visualised using both differential 
interference contrast (DIC) and fluorescence microscopy using a FITC filter set, to visualise 
GFP expression (Section 2.14.4).  Samples withdrawn from the chemostat before the addition 
of TMAO did not have an observable GFP signal.  It was not until 60 min after TMAO addition 
to the chemostat that GFP expression was observed (Figure 4.6).  Expression of GFP appears 
to be uniform across the population, with every cell appearing to display similar intensities.  
However, expression of gfp appears to be is relatively low in these images, which leads to a 
“noisy” background, as there is little contrast between the GFP signal and the background 
fluorescence.  Around ~200,000 molecules of GFP per cell are considered high enough for 
conventional one-colour detection even in samples with high background autofluorescence 
(Wendland and Bumann, 2002).  The number of GFP molecules present in the samples 
studied here is likely to be low as a chromosomal fusion was used, leading to low contrast 
between background fluorescence and cellular expression of GFP.   
4.4. Analysis of torCAD transcription in response to different concentrations of TMAO 
Batch cultures of E. coli JRG6705 cells were grown in under anaerobic conditions in 
phosphate-buffered Evans medium at 37oC as previously described (Section 2.14.1).  Cells 
were exposed to different concentrations of TMAO for 1 h before being analysed by 
fluorescence microscopy and flow cytometry to observe the expression of torCAD in 
individual cells in response to different concentrations of TMAO.   
4.4.1. Expression of torCAD in response to low concentrations of TMAO is not uniform 
across the population  
In order to explore whether cell-to-cell variability in torCAD expression is dependent on 
concentration of TMAO, E.coli JRG6705 cells were grown for 1 h in the presence of different  
99 
 
 
Figure 4.4. The percentage of GFP-positive cells present in continuous cultures of E. coli 
JRG6705 in response to TMAO over time 
Using FlowJo analysis software, a GFP-negative sample (0 min) was used for gating, so that 
any cell detected by the BL1 filter as having a higher GFP signal than that of the GFP-negative 
sample was deemed to be expressing GFP (GFP-positive).  The graph shows the % of GFP-
positive cells present in each sample before (0 min) and after TMAO addition (2 – 1,440 min).  
The averages and standard deviations of three biological replicates are shown.   
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Figure 4.5. Gated GFP-positive and GFP-negative sub-populations are present in continuous E. coli JRG6705 cultures exposed to TMAO 
FlowJo analysis was carried out on fixed cell samples (over time) of continuous cultures exposed to TMAO.  A gate was placed on the 0 min sample (pre-
TMAO), so that any cell with a higher GFP emission was classified as GFP-positive.  Numbers shown are the percentage of cells that were deemed either GFP-
positive or GFP-negative in the 10,000 cells sampled.  Data shown are from one replicate that is representative of three biological repeats.  Flow cytometry 
files and analysis for all three replicates are given on the provided ‘Supplementary Data’ CD.  
0 mM 2 mM 5 mM 10 mM 
15 mM 20 mM 60 mM 1440 mM 
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 Figure 4.6. DIC and FITC images of samples from a continuous culture of E. coli JRG6705, 
showing expression of torCAD in response to TMAO over time 
Anaerobic continuous cultures of E. coli JRG6705 (Ptor-gfp) were exposed to the alternative 
electron acceptor TMAO (~40 mM) under anaerobic conditions.  Fixed cells from the culture 
were analysed using fluorescence microscopy to monitor expression of the torCAD operon 
in response to TMAO. DIC and FITC images are shown for one representative biological 
replicate.  Scale bars in all images represent 10 μm.  Image files for all three biological 
replicates are given on the provided ‘Supplementary Data’ CD. 
0 min 
60 min 
1,440 min 
Merged DIC and FITC images 
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concentrations of TMAO (0-40 mM) under anaerobic conditions before the levels of GFP 
expression in cultures were analysed by flow cytometry and fluorescence microscopy. 
Flow cytometry experiments showed that when the GFP-positive gate was placed using the 
0 mM TMAO (GFP-negative) sample, there was an increase in the number of GFP-positive 
cells present in cultures exposed to increasing concentrations of TMAO (Figure 4.7).  When 
cultures were exposed to a lower concentrations of TMAO, i.e. 10 mM, only 7.7% of cells 
were deemed to be GFP-positive (92.3% being GFP-negative). Even after exposure to the 
highest concentration of TMAO (40 mM) for 1 h, two distinct sub-populations were present 
(GFP-positive and GFP-negative) in the sample.  Only ~45% of E. coli JRG6705 cells were in 
the GFP-positive gate, thus less than half of the total population were expressing torCAD in 
response to a persistent concentration of TMAO (Figure 4.8).   
When DIC and FITC microscopy was carried out on the same cultures, a number of individual 
cells were seen to not be expressing torCAD in response to the presence of 10 mM TMAO 
(Figure 4.9).  This further confirms the presence of two sub-populations as shown by flow 
cytometry measurements.  These subpopulations were also present when cells were grown 
in concentrations of TMAO lower than 40 mM (20-30 mM)(Figure 4.10).  This is in contrast 
to cells grown in 40 mM TMAO for ~1 h, where the whole population appear to have a more 
uniform expression of torCAD (all cells are expressing GFP)(Figure 4.6).   
4.5. Deletion of the E. coli K-12 dam gene results in an increase in the number of individual 
cells expressing torCAD expression in response to low concentrations of TMAO  
As variation between the expression of torCAD in individual cells of a population exposed to 
lower concentrations of TMAO (2-10 mM) was observed by both flow cytometry and 
fluorescence microscopy, the mechanism responsible for this cell-to-cell variation was 
sought.  Analysis of the intergenic region between torC and torR genes (divergent promoter 
region) revealed the presence of an E. coli DNA adenine methyltransferase (Dam) recognition 
site (Figure 4.11) overlapping the -10 element of PtorC.   
In order to investigate the effect of methylation of the GATC site present in Ptor region of the 
E. coli MG1655 genome on the expression of torCAD operon, a commercially available dam 
mutant strain (E. coli ER2925, Table 2.1) was transduced with the Ptor-gfp construct (from E. 
coli JRG6705) (Figure 4.12a and b) to create strain E. coli JRG6842 (Table 2.1).  A dam mutant 
is unable to methylate DNA at GATC sites and thus, could promote transcription activation.  
If so, cultures of E. coli JRG6842 grown in the presence of TMAO under anaerobic conditions 
should uniformly express GFP (all cells green) even when low concentrations of TMAO are  
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Figure 4.7. The percentage of GFP-positive cells present in batch cultures of E. coli JRG6705 exposed to different concentrations of TMAO  
FlowJo analysis was carried out on fixed cells from cultures of E. coli JRG6705 exposed to different concentrations of TMAO (0-40 mM).  A GFP-negative gate 
was placed using the 0 mM TMAO sample.  Numbers shown are the percentage of cells that we deemed either GFP-positive or GFP-negative in 10,000 cells 
sampled.  Data shown are from one replicate that is representative of 3 biological repeats.  Flow cytometry files and analysis for all three replicates are given 
on the provided ‘Supplementary Data’ CD. 
0 mM 2 mM 5 mM 10 mM 
20 mM 30 mM 40 mM 
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Figure 4.8. Gated GFP-positive and GFP-negative sub-populations present in batch cultures 
of E. coli JRG6705 exposed to different concentrations of TMAO 
Using FlowJo software, a GFP-negative sample (0 mM TMAO) was used for gating so that any 
cell detected by the BL1 filter as having a higher GFP signal than that of the GFP-negative 
sample was deemed to be GFP-positive.  The graph shows the percentage of GFP-positive 
cells present in each fixed sample of culture exposed to different concentrations of TMAO 
(0-40 mM) for 1 h.  The average and standard deviation of three biological replicates are 
shown.   
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Figure 4.9. Expression of torCAD by individual cells in response to TMAO (10 mM) is not 
uniform  
The DIC and corresponding FITC images of E. coli JRG6705 batch cultures grown in the 
presence of 10 mM TMAO under anaerobic conditions were merged.  The black squares 
highlight the heterogeneous expression of gfp in individual cells in 3 fields of view.  Scale bars 
are shown for each field of view.   
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Figure 4.10. DIC and FITC images of batch cultures of E. coli JRG6705, showing the 
expression of torCAD (Ptor-gfp) in response to different concentrations of TMAO  
Anaerobic batch cultures of E. coli JRG6705 were exposed to different concentrations (0-30 
mM) of the electron acceptor TMAO for 1 h before being fixed and analysed using 
fluorescence microscopy. DIC and FITC images are shown for one representative biological 
replicate.  Scale bars in all images represent 10 μm.  Image files for all three biological 
replicates are given on the provided ‘Supplementary Data’ CD. 
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TCAGAGGGTTTTACTCATTCTGTTCATATCTGTTCATATTCTGCCGTAAGCCGTTCATCCTGACCAGT 
GCCGCTGTTCATATTTGCTCATTAAGATCGCTTCACTAAACCATAATTCTACAGGGGTTATTatg 
4.11. Transcriptional features of the intergenic region between torR and torC on the E. 
coli MG1655 chromosome 
The intergenic region between the divergent torR and torC genes on the E. coli MG1655 
chromosome is shown with the transcriptional features highlighted.  This region contains 
four direct repeats of a decametric consensus motif.  These motifs are called Tor boxes 
(shown in red and underlined) and boxes 1, 2 and 4 have exactly the same decameric 
sequence (CTGTTCATAT).  However, box 3 only matches 7 of the 10 bases of the motif 
(CCGTTCATCC; bold bases represent mismatched bases of the motif) (Simon et al., 1995).  
The transcriptional start site is shown (yellow).  The -10 and -35 regions are underlined and 
the Dam recognition site is highlighted in green. The start codon of the torC gene is shown in 
green.   
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4.12a and b. Confirmation of that the wild type dam gene is not present in the chromosome 
of E. coli JRG6843  
a. The position and size of the E. coli MG1655 wild type dam gene on the chromosome 
is shown, along with checking primers and where they anneal relative to the dam 
gene.  
b. An agarose (1%) gel showing PCR reactions amplification using TorC-fusion seq F and 
R or dam check F and R primer pairs (Appendix 1) with either E. coli JRG6842 or E. 
coli MG1655 genomic DNA as the template.  Lane 1, Hyperladder I (Bio Line); Lane 2, 
E. coli MG1655 genomic DNA as template and tor primer pair; Lane 3, E. coli MG1655 
genomic DNA and dam primer pair; Lane 4, E. coli JRG6842 genomic DNA and tor 
primer pairs; Lane 5, E. coli JRG6842 genomic DNA and dam primer pair.  Sizes of PCR 
products and fragments they represent are indicated by the arrows and sizes of DNA 
markers are indicated. 
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present, where expression of the reporter by wild type cultures is not uniform across the 
population.  
Flow cytometry was carried out on E. coli JRG6842 cultures exposed to either no TMAO or 
different concentrations of TMAO (10 or 40 mM) for 1 h.  When compared to previous wild 
type cultures grown under the same conditions (Section 4.4.1), dam mutant cultures have a 
higher percentage of individual cells expressing torC in response to lower concentrations of 
TMAO (10 mM) (Figure 4.13).  The difference in the percentage of cells is highly significant 
(p <0.01).  However, the number of individual cells expressing torC in response to a higher 
concentration of TMAO (40 mM) is comparable in wild type and E. coli JRG6842 cultures.   
4.6. Discussion 
The work reported in this chapter was carried out in order to determine whether the mixed 
metabolism observed in continuous cultures of wild type E. coli in the presence of sub-
optimal concentrations of TMAO, are a result of the whole population of cells carrying out 
fermentation and TMAO respiration simultaneously or whether two distinct sub-populations 
carrying out only one of these modes of metabolism are present (Figure 4.1).  
Here, work suggests that there are distinct two sub-populations of cells that either do or do 
not initiate the transcription of the torCAD operon in response to the presence of TMAO 
under anaerobic conditions.  Expression of torCAD in response to persistent excess 
concentrations of TMAO (40 mM) is not uniform.  Thus, the single-cell distributions of torCAD 
transcription in response to TMAO under anaerobic conditions are not uniform, particularly 
when cultures are exposed to low concentrations of TMAO.  This is similar to previous reports 
for cultures of E. coli grown in the presence of TMAO under aerobic conditions (Roggiani and 
Goulian, 2015).   
Initially, continuous cultures of E. coli JRG6705 were grown and maintained as previously 
described for the wild type strain.  Fluorescence microscopy suggested that the expression 
of GFP occurred ~15 min and onwards after the addition of TMAO and was uniform (all cells 
expressing GFP) across the culture.  However, when GFP expression was analysed using flow 
cytometry, only ~40% of cells were GFP-positive 60 min after the addition of TMAO.  This 
suggests that only a proportion of the cells in the cultures from the original experiments 
(Section 3.2) were initiating torCAD transcription, even when excess TMAO was present in 
the environment (Table 3.1).  Previously, it was shown that E. coli K-12 respires TMAO in both 
the presence and absence of oxygen (Ansaldi et al., 2007).    
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Figure 4.13.  The percentage of GFP-positive cells with a dam mutation is increased when 
exposed to lower concentrations of TMAO 
The percentage of GFP-positive cells is shown for both dam mutant (light grey) and wild type 
(dark grey) cultures when exposed to different concentrations of TMAO for 1 h is shown.  The 
graph is the average of three biological replicates and their standard deviations.  The p values 
are shown between wild type and dam mutants exposed to the same concentration of 
TMAO.  The wild type bars are the same as those shown in Figure 4.8.  Flow cytometry files 
and analysis for all three replicates are given on the provided ‘Supplementary Data’ CD.   
  
p < 0.01 
p > 0.60 
p > 0.70 
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In more recent work, it was shown that the average level of torCAD transcription in cultures 
containing TMAO grown in both anaerobic and aerobic conditions was similar (Roggiani and 
Goulian, 2015).  However, torCAD transcription in aerobic cultures was found to be highly 
heterogeneous between individual cells, compared to a relatively homogeneous increase in 
fitness that could be due to the production of alkaline TMA by TMAO reduction counteracting 
acidification of the environment (Ansaldi et al., 2007).  Even if only a subset of cells in a 
population is performing the TMAO reduction, this mechanism could be effective (Roggiani 
and Goulian, 2015).  Another hypothesis reflects a “bet-hedging strategy” whereby the cost 
of expressing the TMAO respiratory chain under aerobic conditions is balanced against the 
benefit of pre-expressed TorCAD should the environment rapidly become anaerobic.  
However, both these hypotheses apply to variability under aerobic conditions and here 
variability is seen under anaerobic conditions.   
The Dam enzyme encoded by the dam gene is responsible for the methylation of nearly all 
GATC sites in the E. coli genome (Geier and Modrich, 1979; Ringquist and Smith, 1992; Wang 
and Church, 1992).  The methylation state of bacterial promoter region can affect whether 
transcription of the corresponding gene occurs.  This plays a role in the regulation of a 
number of genes in E. coli (Løbner-Olesen et al., 2003; Oshima et al., 2002; Riva et al., 2004), 
including dnaA (Campbell and Kleckner, 1990).  Expression of various genes in other bacterial 
species have been found to be reliant on DNA methylation by Dam, for example, a Salmonella 
typhimurium dam mutant was found to be totally avirulent (Heithoff et al., 1999).  The 
presence of a GATC sequence in a promoter could affect expression of the gene through 
inhibition or promotion of repressor or activator binding (Marinus and Løbner-Olesen, 2014).  
DNA methylation can also influence chromosome replication by regulating the recruitment 
of the initiator of replication to the origin of replication (Boye and Løbner-Olesen, 1990).  
Also, DNA methylation is a post-replicative process, which means that newly synthesised 
strands of DNA are undermethylated and older strands are fully methylated (Marinus, 1976).  
Thus, DNA methylation can act as a regulator of DNA repair by informing the methyl-directed 
mismatch repair system about the age of the DNA (Glickman and Radman, 1980).   
The Dam methylase transfers a methyl group from S-adenosylmethionine to the N6 position 
of the adenine nucleotide in the sequence GATC (Geier and Modrich, 1979; Marinus and 
Morris, 1973). As E. coli dam mutants are viable this suggests that no essential genes are 
solely dependent on Dam methylation (Marinus and Løbner-Olesen, 2014).  Rather, Dam 
methylation can be considered to play a role in the fine tuning of basal levels of gene 
expression either by acting directly at GATCs in regulatory sequences or acting as a timing 
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switch or in an epigenetic fashion (Marinus and Løbner-Olesen, 2014).  A small fraction of 
the approximately 20,000 GATC sites in the E. coli chromosome are totally or partially non-
methylated in any given growth state and environmental condition (Casadesús and Low, 
2006).  The ability of Dam to methylate GATC sites is dependent upon competition between 
both Dam and specific DNA binding proteins.  The binding of proteins primarily at gene 
regulatory regions result in DNA methylation patterns, which are altered by growth 
conditions that affect regulatory protein level(s) and/or DNA binding properties (Casadesús 
and Low, 2006).  The E. coli ER2925 strain (Table 2.1) has several chromosomal mutations, 
including mutations in the two main DNA methylase enzymes (Dam and Dcm methylases).  
These mutations render the strain unable to methylate DNA.  The Ptor-gfp reporter construct 
was transduced into the chromosome of E. coli ER2925 and variability in individual cells’ 
expression of torCAD in response to TMAO was analysed.  Here, it was seen that the number 
of individual cells expressing torCAD in response to lower concentrations of TMAO (10 mM) 
was increased in a dam mutant cultures compared to wild type cultures (Figure 4.13).  
However, this increase compared to wild type was not observed when cultures were exposed 
to 40 mM TMAO.  This suggests that methylation of the torCAD promoter may be involved 
in the regulation of the operon.  It may be involved in the fine tuning of torCAD expression, 
which is more pronounced in cultures exposed to lower concentrations of TMAO.  An 
increase in percentage is not seen in cultures grown in higher TMAO concentrations, which 
could mean that the maximum expression of torCAD is occurring in the wild type and thus 
an increase in expression in a dam mutant is not observable.   
It is possible that a number of mechanisms, as well as DNA methylation are responsible for 
the cell-to-cell variation in torCAD expression described here.  Variability in torCAD 
expression could result from changes in numbers of TorS and TorT molecules present in 
individual cells (Roggiani and Goulian, 2015).  Ribosome profiling data were used to infer 
protein abundance and indicates that both TorT and TorS are expressed at low levels (~4 
molecules/cell for both) (Li et al., 2014).  It is feasible that stochastic effects may arise from 
different cellular abundances of TorS and TorT across the population, produced by random 
partitioning during cell division and gene expression (Elowitz et al., 2002; Huh and Paulsson, 
2011; Ozbudak et al., 2002).   For example, if the number of TorS molecules happens to 
exceed the number of TorT molecules in an individual cell, then excess TorS that is not bound 
to TorT will be insensitive to TMAO (Roggiani and Goulian, 2015).  This would lead to the 
dephosphorylation of TorR~P via reverse phosphotransfer (Ansaldi et al., 2001), thus 
producing lower levels of TorR~P.  It has previously been observed that overexpression of 
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torS represses the transcription of the torCAD operon (Ansaldi et al., 2001).  Cells that lack 
TorS molecules will also have low levels of TorR~P because of both spontaneous hydrolysis 
and dilution of pre-exsisting TorR~P from cell growth (Roggiani and Goulian, 2015).  Thus, it 
can be expected that cells with no TorS (or a TorS/TorT ratio too low) or when TorS numbers 
exceed TorT (a TorS/TorT ratio too high) should have lower than average TorR~P and thus 
the system is sensitive to changes in the numbers of both proteins (Roggiani and Goulian, 
2015).  These stochastic changes could also mean that there is a maximum number of cells 
in a population that can carry out TMAO reduction.  This could explain why an increase in the 
percentage of cells expressing torCAD in response to a high concentration of TMAO (40 mM) 
is not seen in a dam mutant, when it is in cultures exposed to lower concentrations of TMAO 
(10 mM).  However, whilst both the stochastic changes and the role of dam in torCAD 
regulation described here are likely to contribute to the variability in torCAD expression, at 
present, other mechanisms that might produce cell-to-cell variability cannot be ruled out.   
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5. The mechanism of formaldehyde sensing by the E. coli transcriptional regulator FrmR 
5.1. Introduction 
The detrimental effects of toxic chemicals must be withstood by all organisms.  Many 
organisms generate the toxic chemical formaldehyde endogenously (Chen et al., 2016; Yu et 
al., 2015).  Formaldehyde is generated: (i) as an intermediate of methylotrophic metabolism; 
(ii) in the degradation of glycine, either by the glycolytic byproduct methylglyoxal or by 
Fenton chemistry; (iii) in the degradation of haem, during iron acquisition by some Gram-
positive bacteria; (iv) by lipid peroxidation of sugars; (v) by the demethylation of histones; 
(vi) as a product of methylated DNA repair by AlkB; and (vii) by the action of N-
methyltryptophan oxidase (SolA)(Chen et al., 2016; Koyama and Ohmori, 1996; Trewick et 
al., 2002).  As a consequence, biological systems are often exposed to both endogenous and 
exogenous sources of formaldehyde.   
The toxic effects of formaldehyde are mediated via the modification of essential cell 
components, including proteins and DNA, thus leading to cellular dysfunction.  The formation 
of DNA-DNA and DNA-protein cross-links, as well as covalent DNA monoadducts are 
genotoxic effects mediated by formaldehyde (Chen et al., 2016; Lai et al., 2016; Yu et al., 
2015).  Formaldehyde is also able to covalently modify proteins, inhibiting their functions 
(Metz et al., 2004; Xie et al., 2016).  The broad chemical reactivity of formaldehyde, which 
leads to life-threatening damage, has driven the evolution of mechanisms to detoxify 
formaldehyde, in order to counteract its detrimental effects (Chen et al., 2016).   It is 
important to maintain specific response regulators in the cell that can sense the presence of 
formaldehyde, in order to regulate expression of these detoxification systems, to induce 
protection before significant damage occurs.    
When E. coli K-12 adapts to the presence of the alternative electron acceptor TMAO, 
formaldehyde is produced, which results in the induction of the frmRAB operon, as shown 
by work previously described here (Chapter 3).  An inability to respond (by induction of the 
frmRAB operon) to this endogenously produced formaldehyde resulted in growth inhibition, 
rather than growth promotion, when anaerobic cultures of E. coli were exposed to TMAO 
(Section 3.6).  The frmRAB operon encodes a regulator protein, FrmR; a formaldehyde 
dehydrogenase, FrmA; and an S-formylglutathione hydrolase, FrmB (Herring and Blattner, 
2004).  In E. coli and many other organisms, fomaldehyde present in the cytosol reacts with 
the major reductant glutathione, yielding S-hydroxymethylglutathione, which is then 
oxidised by FrmA to S-formylglutathione, before being hydrolysed to non-toxic formate and 
glutathione by FrmB (Gonzalez et al., 2006; Harms et al., 1996).  S-Nitrosoglutathione, a 
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product of nitrosative stress, is also a substrate for FrmA (Liu et al., 2001).  Therefore, the 
proteins coded by the frmRAB operon permit the bacterium to sense and detoxify 
formaldehyde. 
As previously stated, the first gene of the E. coli frmRAB operon codes for a regulatory 
protein, FrmR.  Escherichia coli FrmR is a member of the RcnR/CsoR family of transcriptional 
repressors (Giedroc and Arunkumar, 2007; Higgins and Giedroc, 2014).  Many characterised 
members of this family are metal-ion sensors; the properties of Cu(I) (CsoR, RicR), Ni(II) (InrS) 
and Ni(II)/Co(II) (RcnR, DmeR) sensors in diverse bacterial species have been reported, 
including  those of the sulfite/sulfide sensor CstR (Foster et al., 2014; Grossoehme et al., 
2011; Iwig et al., 2008; Iwig et al., 2006; Liu et al., 2007).  Members of the family whose role 
is metal-sensing possess characteristic amino acid signatures (W-X-Y-Z fingerprint), which is 
associated with metal binding.  CsoR binds Cu(I) via the X-Y-Z residues, whilst RcnR and InrS 
use all four positions to coordinate their cognate metal (Figure 5.1a).  Whilst the Ni(II)/Co(II)-
responsive and Cu(I)-responsive family members are relatively well-characterised, little is 
known about signal perception and DNA-binding mechanisms of the remaining proteins 
(FrmR and CstR), although they retain at least two residues of the W-X-Y-Z fingerprint.  All 
family members share one absolutely conserved residue (Cys35) and one highly conserved 
residue (His60) within the W-X-Y-Z fingerprint (Iwig et al., 2008; Ma et al., 2009).  Although 
amino acid residue variation within the fingerprint is implicated in signal specificity by 
coupling the metal-coordination preferences to the network connecting the metal- and DNA- 
binding residues of the protein (Higgins et al., 2012); the roles of specific residues in 
formaldehyde sensing are unclear.    
Salmonella enterica serovar Typhimurium FrmR (SeFrmR) retains two of the metal-binding 
ligands (Cys35 and His60, with Glu instead of His64 and Pro instead of His2) that are present 
in the S. enterica Ni(II)-binding regulator RcnR (Osman et al., 2015).  Recently, in vitro studies 
showed that SeFrmR binds Co(II), Cu(I) and Zn(II), but the binding affinities were weaker than 
those of the biological sensors of these metal ions in Salmonella (Osman et al., 2015).  Thus, 
SeFrmR was outcompeted by CueR, RcnR, ZntR and ZurR for their cognate metals.  
Furthermore, in vivo SeFrmR was able to act as a formaldehyde-responsive transcription 
regulator, but was unable to act as a metal ion sensor.  Even more recent work has shown 
that formaldehyde-sensing by SeFrmR is direct, specific and requires two residues of the W-
X-Y-Z fingerprint (Pro2 and Cys35A; Figure 5.1b) (Osman et al., 2016).  The crystal structure 
of an E64H mutant was solved and revealed that the protein consists of a homotetrameric  
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Figure 5.1a and b. The ‘metal-binding’ fingerprints of members of the CsoR/RcnR family 
and amino acid sequences of E. coli FrmR and S. enterica FrmR  
a. Amino acid residues in the W-X-Y-Z fingerprint of CsoR/RcnR family proteins and the 
signals perceived by the indicated proteins.  
b. Alignment of the E. coli (Ec) and S. enterica FrmR proteins (Se).  Identical (single letter 
code) and similar (+) residues, Pro2 (red font), Cys35 and Cys70 (yellow font) are 
indicated. Residues of the W-X-Y-Z fingerprint (blue font) are indicated. Residues in 
purple font and underlined have been implicated in DNA-binding in other CsoR/RcnR 
family members. 
  
Group Signature  Ligand/Signal 
 W X Y Z  
RcnR His Cys His His Ni(II)/Co(II) 
InrS His Cys His Cys Ni(II) 
CsoR X Cys His Cys Cu(I) 
FrmR Pro Cys His Thr/Glu formaldehyde  
CstR X Cys X Cys sulfide 
a 
b 
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disc with a positively-charged surface region, which is predicted to participate in DNA binding 
(Osman et al., 2016).  Amino acid sequence alignment of the E. coli K-12 and SeFrmR proteins 
reveals strong conservation in the first 63 amino acids (67% identical, 89% similar) but 
weaker conservation thereafter (21% identical; 39% similar; Figure 5.1b).  Escherichia coli 
FrmR retains Cys35 and His60 residues, but has a Thr residue at position 64, as well as an 
additional Cys residue (Cys70) that is absent from SeFrmR (Figure 5.1b).  The biological 
imperative to mount an effective response to both exogenous and endogenous sources of 
formaldehyde, as evidenced by the observation that the frmRAB operon was essential for 
adaptation of E. coli to growth on TMAO and the differences between the E. coli and SeFrmR 
proteins, prompted an investigation of E. coli FrmR.    
This is worthy of investigation because the mechanism(s) used by regulatory proteins to 
perceive and respond to formaldehyde are very poorly understood.  Importantly, FrmA acts 
upon the GSH-formaldehyde adduct, raising the question of the identity of the molecular 
signal to which EcFrmR responds and the mechanism of signal perception.  Hence, the aim 
of the work reported here was to provide new insight into the mechanism used by biological 
systems to sense the presence of the highly reactive and toxic chemical, formaldehyde.  In 
vivo and in vitro data show that FrmR senses formaldehyde directly with no metal-
dependence via the formation of methylene bridges between Pro2 and Cys35 residues of 
adjacent FrmR subunits.   
5.2. Properties of the isolated E. coli FrmR 
The transcriptional regulator, FrmR and its mutants were purified from the overexpression 
strains E. coli JRG6782 (wild type), JRG6783 (C35A) and JRG6784 (P2A) by Dr Svetlana E. 
Sedelnikova (Department of Molecular Biology and Biotechnology, University of Sheffield, 
UK) (Figure 5.2a) (Section 2.10.3.1).  The volume at which FrmR and its mutants were eluted 
from a calibrated size exclusion chromatography column was ~76 ml, which was indicative 
of a homotetramer (with a molecular weight of ~40 kDa) (Figure 5.2b), which is typical of 
other members of the CsoR/RcnR family (Iwig et al., 2008).  The concentration and 
authenticity of purified FrmR was then verified by total amino acid analysis (Section 2.10.9).  
Determining the concentration of purified FrmR using the A280/A320 (Section 2.10.4.2) was 
found to underestimate the actual concentration of FrmR, as measured by total amino acid 
analysis, by 7.6%.  Therefore, the concentration of FrmR was determined using A280/A320 
multiplied with a correction factor of 1.08.  Liquid chromatography-mass spectrometry (LC-  
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Figure 5.2a and b. Purification of FrmR protein 
a. A representative analysis by SDS-PAGE of the purification of wild-type FrmR protein.  
Lane 1, Mark12TM unstained standards (Thermo Scientific), sizes are shown; Lane 2, 
cell-free extract of induced culture; Lane 3, after HiTrap Heparin HP purification; 
Lane 4, after HiLoad Superdex 200 gel fitration (final purified FrmR preparation).     
b. Absorbance was monitored at 280 nm for all fractions eluted from the gel filtration 
column (fractions are shown by the red dashed lines).  An increase in absorbance (at 
280 nm) occurred at a volume of 76.1 ml, which was indicative of a homotetramer 
of ~40 kDa.  
Lane:          1       2        3      4     
200 kDa 
116.3 kDa 
97.4 kDa 
66.3 kDa 
55.4 kDa 
36.5 kDa 
31 kDa 
21.5 kDa 
14.4 kDa 
6 kDa 
a 
b 
Wild-type FrmR monomer  
~10 kDa 
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MS) (Section 2.10.10) showed that the isolated protein lacked an N-terminal methionine 
(which was also confirmed by N-terminal amino acid sequencing carried out by Dr Jeff Iwig 
(Department of Biochemistry and Molecular Biophysics, Washington University School of 
Medicine, USA)) and had the expected monomeric molecular mass of 10186.5 Da.  The 
isolated wild type FrmR protein was found to be metal-free as judged by ICP-MS analysis 
(Section 2.10.11).   
In order to determine the number of free sulfhydryl groups in the purified protein, reaction 
with DTNB (Section 2.10.8) was carried. The number of reactive thiols per monomer of wild 
type FrmR was found to be 1.86 ± 0.21 (expected number of reactive thiols was 2.00 as two 
cysteine residues are present in the monomer).  However, the number of reactive thiols per 
monomer decreased to 1.02 ± 0.08 upon aerobic storage of FrmR (>48 h).  Therefore, this 
suggests that the protein can adopt an oxidized form with two intermolecular disulfide bonds 
per tetramer. 
Recent research has shown that the SeFrmR protein is able to bind Zn(II) (Osman et al., 2015).  
Intrinsic fluorescence experiments were carried out in order to investigate the potential 
Zn(II)-binding properties of E. coli FrmR, (Section 2.10.9).  Titration of FrmR with Zn(II) 
resulted in changes in intrinsic fluorescence at 304 nm (Figure 5.3).  The specific binding 
isotherm obtained after subtraction of the linear non-specific binding phase, indicated that 
the reduced FrmR tetramer was able to bind ~4 atoms of Zn(II) (Figure 5.3), reaching 
saturation after the [Zn(II)]:[tetrameric FrmR] ratio exceeded four.  This response is indicative 
of high affinity Zn(II) binding, due to its non-hyperbolic nature.  Equivalent titrations with 
Mn(II) were carried out.  In contrast to Zn(II) binding, titrations with Mn(II) resulted in non-
specific binding response,  which did not reach saturation even at a [Mn(II):[tetrameric FrmR] 
ratio of 19 (data not shown).   
5.3. FrmR binds directly to the frmRAB promoter to repress transcription 
Electrophoretic mobility shift assays (EMSAs) were attempted with purified FrmR protein 
and frmRAB promoter DNA.  However, the procedure could not be optimised and never led 
to any reliable results, which was similar to what collaborators had experienced at Durham 
University.  Thus, Bio-Layer Interferometry (BLItz) measurements were used to investigate 
the interactions between the FrmR protein and frmRAB promoter DNA (Pfrm).  The Kd for FrmR 
binding to immobilised Pfrm DNA was ~220 nM, arising from an overall on-rate constant (kf) 
of ~13000 M-1 s-1 and an overall off-rate constant (kr) of 0.003 s-1 at 20oC (Figure 5.4a, Table 
5.1).  This interaction was specific because the Kd for FrmR binding to an immobilised  
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Figure 5.3. The E. coli FrmR tetramer binds Zn(II) 
Changes in intrinsic fluorescence for three titrations (indicated by different symbols) were 
normalised and plotted against the Zn(II):FrmR tetramer ratio. The solid lines show linear 
regression fits for the data points during the phase when fluorescence was changing and for 
the titration end points.  
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Figure 5.4a, b and c.  Formaldehyde enhances dissociation of the Pfrm-FrmR complex 
a. Bio-Layer Interferometry (BLItz) assays. Traces for the interaction between biotin-
labeled Pfrm DNA immobilised on a streptavidin probe with FrmR (6.16 M 
tetramer, black line, 0.88 M tetramer; red line), FrmR (0.88 M tetramer) pre-
treated with 200-fold molar excess of formaldehyde (blue line), and FrmR binding 
at a non-target DNA (PydhY, 0.88 M FrmR tetramer; green line) are shown. Analysis 
of the data was carried out using the BLItz Pro 1.1.0.31 software using global fitting 
and correcting both association and dissociation curves. 
b. Pre-formed Pfrm-FrmR complexes were exposed to different concentrations (0, black; 
0.05 mM, orange; 0.25 mM, grey; 0.62 mM, yellow; 1.25 mM, blue; 3.69 mM, green; 
4.92 mM, dark blue; 7.38 mM, brown) of formaldehyde and dissociation curves were 
recorded. 
c. Single exponential fits to formaldehyde dissociation curves were used to obtain the 
observed rate constants (kobs) which were plotted against formaldehyde 
concentration to obtain the apparent second order rate constant (kapp). 
a b 
c 
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Table 5.1. Rate constants for FrmR and DNA interactions 
 
Reaction kf (M-1 s-1)a kr (s-1)a Kd (nM) kapp (M-1 s-1) 
Pfrm-FrmR + HCHO  FrmR-HCHO + Pfrm - - - 4.2 
Pfrm-FrmR-(Zn)4 + HCHO  FrmR-(Zn)4-HCHO + Pfrm - - - 0.7 
a Value and standard error. 
 
Using the BLItz Pro software, rate constants obtained for the reactions shown.  In order to find the apparent second order rate constant (kapp), the BLItz 
data from dissociation curves were fitted to a single exponential function to obtain the observed first order rate constants (kobs), which were then plotted 
against formaldehyde concentration. 
 
 
  
Reaction kf (M-1 s-1)a kr (s-1)a Kd (nM) kapp (M-1 s-1) 
FrmR + Pfrm  Pfrm-FrmR 13000  390 0.0028  0.000086 220 - 
FrmR-(Zn)4 + Pfrm  Pfrm-FrmR-(Zn)4 5660  165 0.003  0.000078  520 - 
FrmR + PydhY  PydhY-FrmR 1950  1000 0.007  0.00017  3600 - 
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unrelated E. coli promoter (ydhY) fragment was ~3600 nM (Table 5.1).  Pre-treatment of 
FrmR with formaldehyde for 3 min abolished binding to Pfrm (Table 5.1).  Exposure of the pre-
formed Pfrm-FrmR complex to increasing concentrations of formaldehyde resulted in the 
dissociation of the complex (Figure 5.4b).  The speed of the dissociation of the complex 
increased with the presence of increasing concentrations of formaldehyde.  The dissociation 
curves were fitted to a single exponential function and dissociation of the Pfrm-FrmR complex 
exhibited a linear dependence on formaldehyde concentration, with a rate constant of ~4 M-
1 s-1 at 20°C (Figure 5.4c, Table 5.1).  Furthermore, in vitro transcription reactions showed 
that the synthesis of the frmRAB transcript was inhibited in the presence of FrmR and that 
this inhibition was relieved when FrmR was treated with formaldehyde (Figure 5.5).  In vitro 
transcription reactions with the E. coli ndh gene showed that transcription of this gene was 
not affected by the presence of either FrmR or formaldehyde.  Therefore, the in vivo and in 
vitro data show that FrmR is a repressor of frmRAB expression, which specifically responds 
to formaldehyde leading to the dissociation of the FrmR-Pfrm complex, allowing the 
expression of the formaldehyde detoxification system. 
5.3.1. The role of Zn(II) in FrmR binding to Pfrm DNA 
The ability of the E. coli FrmR and SeFrmR to bind Zn(II) (Section 5.2 and (Osman et al., 2015)) 
raises the possibility that formaldehyde sensing is metal-dependent.  Therefore, the effect 
of Zn(II) on the ability of EcFrmR to bind to DNA (Pfrm) was assessed by BLItz (Table 5.1).  Pre-
treatment of the EcFrmR tetramer with four molar equivalents of Zn(II) increased the Kd for 
binding at Pfrm ~2-fold due to a decrease in the rate of DNA-binding (Table 5.1).  However, in 
response to formaldehyde exposure the dissociation of the pre-formed Zn(II)-loaded Pfrm–
FrmR complex was ~7-fold lower than that observed in the absence of Zn(II), suggesting that 
Zn(II) blocks amino acid residues required for formaldehyde sensing.  Thus, the presence of 
Zn(II) would be antagonistic to the expression of the detoxification machinery.  Therefore, 
formaldehyde-sensing is not metal- (Zn(II)-) dependent and, it is likely that Zn(II) could only 
inhibit in vivo E. coli FrmR activity under conditions when Zn(II) homeostasis is severely 
perturbed (Figure 5.6; Table 5.1)(Osman et al., 2015). 
5.4. Identification of E. coli FrmR residues necessary for formaldehyde sensing 
Site-directed mutagenesis of the amino acids of the W-X-Y-Z fingerprint has revealed the 
importance of these residues for the function of CsoR/RcnR family proteins (Figure 5.1a).  
Previous β-galactosidase activity measurements carried out by Dr Jeff Iwig (Department of 
Biochemistry and Molecular Biophysics, Washington University School of Medicine, USA)) 
showed that two mutants were unable to respond to formaldehyde, FrmR(P2A) and  
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Figure 5.5. Inhibition of frmRAB transcription by FrmR in vitro is relieved by formaldehyde 
In vitro transcription reactions for FrmR with Pfrm and Pndh DNA.   Left panel, Pfrm; right panel, 
Pndh.  Lane 1, RNA size markers, sizes are shown; Lane 2, no FrmR; Lane 3, 1 nM FrmR 
tetramer; Lane 4, 1 nM FrmR tetramer pre-treated with 200-molar excess formaldehyde. The 
locations of the frmR and ndh are indicated.  The contents of the lanes are the same for frmR 
and ndh gels.  FrmR was reduced with 10 mM dithiothreitol and when required treated with 
200-fold molar excess of formaldehyde for 5 min at room temperature, before quenching 
with 10 mM glycine.  After this incubation, transcription was initiated by the addition of 2 µl 
solution containing UTP at 50 µM; ATP, CTP and GTP at 1 mM; and 2.5 µCi of [α-32P]UTP (800 
Ci mmol-1, PerkinElmer Life Sciences), followed by incubation for 15 min at 37oC in the 
presence of the formaldehyde-treated or untreated FrmR protein.   
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Figure 5.6a, b and c. Zn(II)-loaded FrmR exhibits an impaired response to formaldehyde 
a. Bio-Layer Interferometry (BLItz) assays. Traces for interaction of biotin-labelled Pfrm 
DNA immobilized on a streptavidin probe with FrmR (2.5 μM tetramer, black line) or 
FrmR(Zn(II))4 (2.5 μM tetramer; dark blue line) are shown. Analysis of the data was 
carried out using the BLItz Pro 1.1.0.31 software using global fitting and correcting 
both association and dissociation curves. 
b. Pre-formed Pfrm-FrmR(Zn(II))4 complexes were exposed to different concentrations 
(0, black; 0.05 mM, orange; 0.25 mM, grey; 1.23 mM, yellow; 2.46 mM, blue; 4.92 
mM, green) of formaldehyde and dissociation curves were recorded.  
c. Single exponential fits to the data shown in (b) were used to obtain the observed 
rate constants which were plotted against the concentration of formaldehyde to 
obtain the apparent second order rate constant.  
a b 
c 
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FrmR(C35A), suggesting that Pro2 and Cys35 (W and X positions in the CsoR/RcnR family 
fingerprint; Figure 5.1a) are essential for FrmR to perceive formaldehyde.  Additionally, 
replacement of the only other cysteine residue (Cys70) in FrmR did not impair the response 
to formaldehyde.  Based on this work, which suggested that Pro2 and Cys35 are required for 
FrmR to respond to formaldehyde, growth experiments were carried out with E. coli strains 
expressing FrmR(P2A) (JRG6825) and FrmR(C35A) (JRG6826) in place of wild type FrmR 
(Section 2.5).  Cultures expressing these variants exhibited enhanced sensitivity to 
formaldehyde when compared to cultures expressing wild type FrmR (JRG6726) (Figure 5.7).  
This in vivo data is consistent with the low frmRAB expression observed in the reporter fusion 
experiments described above, which presumably arises from permanent repression frmRAB 
expression (Figure 5.7).    
5.5. Reaction of the E. coli FrmR with formaldehyde  
Liquid chromatography-mass spectrometry (LC-MS) was used to analyse the modification of 
FrmR by formaldehyde.  In the absence of any formaldehyde, the major species 
corresponded to the FrmR monomer lacking the N-terminal methionine (10,186.60 Da; 
predicted mass 10,186.5 Da), with a disulfide-linked dimer (20,371.02 Da; predicted mass 
20,373.2 Da) present in lower amounts (Table 5.2).  FrmR was exposed to formaldehyde (8-
fold molar excess) for 3 min and LC-MS carried out.  This revealed a new species of molecular 
mass 20,396.87 Da, corresponding to an FrmR dimer plus an additional mass of 23.67 Da, 
along with a species corresponding to a tetramer with an additional mass of 22.30 Da 
(40768.73 Da) and the FrmR momomer (10,187.02 Da) (Table 5.2).  When FrmR was 
incubated with Zn(II) (4 Zn(II) per FrmR tetramer), before or after formaldehyde treatment, 
dimeric species of molecular masses 20,396.99 Da and 20,396.95 Da were detected, 
respectively.  The changes in mass described here are consistent with the formation of 
formaldehyde-mediated FrmR dimers linked by intermolecular methylene bridges (-CH2-) 
(net mass gain of 2 x 12 Da per FrmR dimer).   The formation of a modified tetramer 
(40,768.73 Da) upon exposure to fomaldehyde suggests that each subunit of the FrmR 
tetramer participates in only one methylene bridge (total of two in the tetramer) and that 
these cross-linked dimers are held together by one disulfide bond (Table 5.2).   
As FrmR(P2A) and FrmR(C35A) mutants were unable to respond to formaldehyde in vivo 
(Figure 5.7), formaldehyde modification of the purified mutant proteins was examined.  Both 
variants of the protein eluted in a volume indicative of a tetramer upon size exclusion 
chromatography, suggesting that the oligomeric state of the protein was not affected by 
either mutation.  In either the absence or presence of formaldehyde, LC-MS showed that the  
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Figure 5.7. Identification of formaldehyde-insensitive FrmR protein variants in vivo.  
Maximum growth rates (max) of E. coli MG1655 frmRAB transformed with plasmids 
expressing the frmRAB operon from Pfrm under the control of wild type FrmR (closed bars), 
FrmR(P2A) (grey bars) or FrmR(C35A) (open bars) cultured in the presence of the indicated 
initial concentrations of formaldehyde.  The mean and standard deviations (n=3) and the p 
values for one-tailed t-tests are shown.   
  
128 
 
Table 5.2. Liquid chromatography mass spectrometry analyses of FrmR proteins treated 
with formaldehyde 
Protein sample Measured 
mass (Da) 
Relative 
abundance (a. u.) 
Mass 
difference 
(Da)a 
Commentb 
FrmR wild type 
FrmR 10,186.60 
20,371.02 
2.0 x 107 
4.4 x 106 
0.1 
-2.18 
FrmR monomer 
FrmR disulfide-linked 
dimer 
HCHO-treated FrmR  10,187.02 
20,396.87 
 
1.8 x 106 
0.2 x 106 
0.52 
23.67 
FrmR monomer 
FrmR dimer with 2 
methylene bridges  
 40,768.76 2.0 x 105 22.30 Two FrmR dimers, each 
with 1 methylene bridge, 
forming a tetramer by 1 
disulfide bond 
HCHO-treated FrmR 
plus Zn(II)  
10,187.01 
20,396.95 
 
1.8 x 106 
0.3 x 106 
0.51 
23.75 
FrmR monomer 
FrmR dimer with 2 
methylene bridges  
Zn(II)-treated FrmR 
plus HCHO 
10,187.04 
20,396.99 
 
1.8 x 106 
0.4 x 106 
0.54 
23.79 
FrmR monomer 
FrmR dimer with 2 
methylene bridges  
FrmR P2A 
HCHO-treated 
FrmR(P2A) 
20,319.69 4.0 x 105 -1.11 FrmR(P2A) disulfide-
linked dimer 
HCHO-treated 
FrmR(P2A)c 
10,190.71 6.75 x 105 29.91 Hydroxymethylated 
FrmR(P2A) monomer 
FrmR C35A 
HCHO-treated 
FrmR(C35A) 
20,307.40 2.8 x 106 -1.40 FrmR(C35A) disulfide-
linked dimer 
HCHO-treated 
FrmR(C35A)c 
20,307.21 1.7 x 105 -1.59 FrmR(C35A) disulfide-
linked dimer 
aDifference between predicted mass and measured mass 
bInterpretation of mass difference; disulfide bond, -2.2 Da; methylene bridge, net mass gain 12 Da; 
hydroxymethylation, net mass gain 30 Da 
cExposure to formaldehyde without quenching 
 
FrmR and its variants were analysed by liquid chromatography-mass spectrometry before 
and after treatment with formaldehyde. 
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disulfide-linked FrmR(P2A) dimers (20,319.69 Da; predicted mass 20,320.8 Da) was present 
(Table 5.2).  When FrmR P2A was exposed to formaldehyde without quenching, a 
momomeric FrmR(P2A) species (10,190.17 Da) with an additional 29.91 Da, equivalent to an 
hydroxymethyl adduct was detected.  However, for FrmR(C35A) a disulfide-linked dimer 
(20,307.4 Da; predicted mass 20,308.8 Da) was detected, suggesting this mutant protein was 
not modified in the presence of formaldehyde with or without quenching (Table 5.2).   The 
LC-MS data suggests that the first step in formaldehyde perception by E. coli FrmR is reaction 
with Cys35 (Table 5.2) and is  consistent with a mechanism in which FrmR senses 
formaldehyde by the formation of two methylene bridges between Pro2 and Cys35 residues 
of adjacent subunits, which is supported by in vivo data (Section 5.4).   Also, FrmR is oxidized 
in air, forming dimers linked by intermolecular disulfide bonds.    
5.6. Discussion 
In vivo and in vitro experimental data presented here show that the E. coli FrmR 
transcriptional repressor specifically reacts with the toxic chemical formaldehyde, resulting 
in the formation of two inter-subunit methylene bridges between the N-terminal Pro2 and 
Cys35 residues of tetrameric FrmR and dissociation of the Pfrm-FrmR complex.   
The ability of the E. coli FrmR to bind Zn(II) was also investigated.  Here, it is shown that four 
atoms of Zn(II) can bind to a FrmR tetramer (Section 5.2), which is consistent with other 
members of the CsoR/RcnR family members (Foster et al., 2012; Iwig et al., 2008; Ma et al., 
2009).  Recently, SeFrmR was shown to bind 4 atoms of Zn(II) (Osman et al., 2015).  A KZn(II) 
of the Zn(II) binding sites in SeFrmR was estimated to be ~1.7 x 10-10 M, which suggests that 
Zn(II) affinity of FrmR is much weaker than the cognate Zn(II) sensors in S. enterica (ZntR and 
Zur) (Osman et al., 2015).  The presence of Zn(II) was shown to impair DNA-binding by FrmR 
and also slow down dissociation of the Pfrm-FrmR complex in response to formaldehyde 
(Section 5.3.1).  Metal sensors of the CsoR/RcnR family only bind DNA in the absence of their 
cognate metal(s), thus, these results contrast those (Foster et al., 2012; Iwig et al., 2006; Liu 
et al., 2007).  Recently, it was revealed that the binding of Cu(I) to its cognate sensor CsoR 
from Streptomyces lividans results in the constriction of the tetramer, via a bulge in the α2 
helices (Porto et al., 2015).  Dissociation of the CsoR-DNA complex occurs in response to this 
reduced flexibility of the protein (Porto et al., 2015).  Thus, it could be hypothesised that E. 
coli FrmR become more rigid when Zn(II) is bound, leading to impaired DNA binding.  The 
conserved Cys35 and His60 residues (Figure 5.1b) are the metal-binding ligands in many 
members of the CsoR/RcnR family and thus, are likely to be involved in Zn(II) binding (Iwig et 
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al., 2008; Liu et al., 2007).  As the Cys35 has been implicated in formaldehyde sensing here, 
the involvement of the Cys35 residue in Zn(II) binding could explain the reduced response to 
formaldehyde by Zn(II)-bound FrmR.   
Alongside the experiments described here, the crystal structure of formaldehyde-exposed 
FrmR was solved to a resolution of 2.7 Å (PDB: 5LBM) by Dr Claudine Bisson (Department of 
Molecular Biology and Biotechnology, University of Sheffield, UK).  FrmR oligomerises to 
form a disc-like tetramer, like other members of the CsoR/RcnR family of metal-sensors, 
which is constructed from two homodimers, each of which forms one face of the disc.  Each 
of the subunits was found to consist of three helices (α1, residues 2-30; α2, residues 35-68; 
and α3, residues 73-91), which were linked by two short loops (L1, residues 31-34; and L2, 
residues 69-72) that are arranged as a flattened S-shape (Figure 5.8).  The α3 helices slot 
together at the homodimer interface, such that each face of the tetramer is formed from a 
platform of five parallel helices with a hole at the centre (Figure 5.9a).  This arrangement 
differs from that seen in CsoR and SeFrmR(E64H), where the equivalent α3 helix is domain 
swapped onto the opposite face of the tetramer (Chang et al., 2014; Osman et al., 2016).  
This difference between E. coli FrmR and SeFrmR(E64H) could be a consequence of the 
differences in amino acid sequence in the region spanning the terminus of 2, loop 2 and 
the beginning of 3 (Figure 1b).    
Two different dimers were observed in the formaldehyde-treated FrmR tetramer.  An 
unmodified homodimer with a disordered N-terminal region (residues Pro2-Lys8) comprised 
one face of the tetramer (A/B face).  There was no electron density corresponding to Zn(II) 
or other metal ions.  However, located in similar positions in 3D space to those of the CsoR 
proteins from Geobacillus thermodenitrificans and Thermus thermophilus the W-X-Y-Z 
fingerprint residues in the unmodified homodimer are likely to constitute the FrmR Zn(II) 
binding site (Chang et al., 2014; Sakamoto et al., 2010).  The other face of the tetramer (A´/B´ 
face) is sandwiched against the A/B face.  In this face, electron density is present for residues 
Pro2-Lys8 in each of the subunits, which forms an extension to the N-terminal end of α1.  
The Pro2´-N atom is located within ~2.5 Å of the Cys35 atom of the corresponding subunit 
on the opposite face of the tetramer (Figure 5.9a), which supports the hypothesis that these 
residues are the site of crosslinking for the reaction with formaldehyde.  In further support 
of this, extra electron density between these two atomic positions was observed, indicating 
the presence of the formaldehyde cross-link and a methylene bridge (-CH2-) (Figure 5.9b).  
Thus, the structure of the crosslinked FrmR agrees with LC-MS data, which shows the 
formation of formaldehyde-mediated FrmR dimers linked by intermolecular methylene  
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Figure 5.8. Structure of E. coli FrmR 
Cartoon representations of uncross-linked (left) and cross-linked (right) FrmR monomers 
coloured blue (N-terminal) to red (C-terminal). Secondary structure elements (-helices, 1 
to 3; loops, L1 and L2) are labelled and the amino acid residues (single letter code, P2, C35 
and C70) that are involved in cross-linking and disulfide bond formation are shown as sticks. 
The disordered N-terminal region in the uncross-linked subunit is represented by the blue 
dashed line. 
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Figure 5.9a, b and c. Comparison between the uncross-linked and cross-linked faces of 
the E. coli FrmR tetramer 
a. The arrangement of the helices on each face of the tetramer, position of the 
methylene bridge and the disulfide bond are shown. The homodimer (A/B) on the 
uncross-linked face is drawn in shades of green and on the cross-linked face (A’/B’) 
in shades of orange.   
b. A section of the 2Fo-Fc map between chains A and A´ obtained when the coordinates 
for Pro2 and the methylene bridge were omitted from the refinement (black mesh, 
contoured at 1).  Residues are indicated by their single letter codes. 
c. Expansion of the surface upon cross-linking (black double headed arrow drawn 
between Arg14, highlighted in pink).  The homodimer (A/B) on the uncross-linked 
face is drawn in shades of green and on the cross-linked face (A’/B’) in shades of 
orange.   
a 
b 
c 
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bridges (-CH2-) (Table 5.2).  Unlike the E. coli FrmR, the N-terminal region of SeFrmR(E64H) is 
visible in the absence of the methylene bridge (Osman et al., 2016).  With the exception of 
the domain swapped 3, the structures of the uncross-linked (A/B) face of E. coli FrmR 
superposes well on the SeFrmR structure.   
DNA-binding data from BLItz shows that in vitro FrmR binds to Pfrm creating a Pfrm-FrmR 
complex (Section 5.3).  Dissociation of the Pfrm-FrmR complex was seen in the presence of 
formaldehyde.  The speed of this dissociation increased with increasing formaldehyde 
concentration.  The dissociation of the Pfrm-FrmR complex in the presence of formaldehyde 
enables the expression of the FrmAB enzymes to detoxify the toxic formaldehyde.   It has 
previously been suggested that CsoR/RcnR family members recognise their target DNA via a 
combination of: (i) specific interactions with the flanking inverted repeats; (ii) shape 
selectivity, resulting from the central GC tract’s propensity to adopt the A-DNA form; (iii) 
non-specific binding to distant DNA that might result in DNA-wrapping (Iwig and Chivers, 
2009; Tan et al., 2014).  The Pfrm region contains a large inverted repeat centered at -29 
relative to the predicted transcriptional start site.  Tandem FrmR-binding sites consisting of 
9 bp GC-rich tracts flanked by ATAC/GTAT inverted repeats are contained in this region 
(Figure 5.10a).  The DNA-binding site of E. coli RcnR also contains a G-tract, which is flanked 
by AT-rich regions.  It was previously shown that an RcnR binds to this region of the promoter 
sequence, using footprinting and isothermal titration calorimetry (Iwig and Chivers, 2009).  
It is highly likely that FrmR binds to the C- or G-tract within its promoter region, as other 
members of the CsoR/RcnR family also contain similar regions within their promoters (Foster 
et al., 2012; Rubio-Sanz et al., 2013).     
Modeling of the Pfrm-FrmR complexes with A- and B-form DNA (Figure 5.10b) was carried out 
(by Dr Claudine Bisson), as RcnR-binding sites in the E. coli rcnR-A impart some A-form DNA 
character on this region (Tan et al., 2014).  Models with both A- and B-form DNA suggested 
that residues (Lys10, Arg14, Arg16 and Arg17) form two positively-charged protrusions (~35 
Å apart) on the A/B face can pack into the major grooves of the DNA.  The SeFrmR(E64H) 
positively-charged patches were also separated by ~35 Å.  The ~45 Å that separates these 
two patches on the E. coli FrmR A´/B´ face precludes convincing interactions with either A- 
or B-form DNA (Figure 5.9c).  In addition, the crosslink also increases the distance between 
the cluster of residues within the positively-charged protrusions by ~10 Å, thus interacting 
with the major groove is no longer possible, breaking the FrmR-Pfrm complex (Figure 5.9c).  
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Figure 5.10a and b. The FrmR binding sites in E. coli Pfrm and modeling the Pfrm–FrmR 
complex 
a. The DNA sequence of the Pfrm contains tandem FrmR binding sites consisting of 
ATAC/GTAT inverted repeats (bold) separated by G/C-rich tracts (italic) that form a 
larger inverted repeat (convergent red arrows).  The -10 and -35 sites of Pfrm are also 
show in red boxes. 
b. One of the FrmR binding sites of Pfrm (dark grey) was modelled as A-form (left) and 
B-form (right) DNA as shown in the lower image.  FrmR is shown as surface 
representation with subunits colored in shades of green (uncross-linked A/B face) 
and orange (cross-linked A´/B´ face), with the amino acid side-chains on the A/B face 
that are implicated in DNA-binding highlighted in blue.  The major (M) and minor (m) 
grooves are indicated. 
 
 
-35 -10 
a 
b 
135 
 
These differences suggest a mechanism for dissociation of the FrmR-Pfrm in response to 
formaldehyde, as shown by BLItz data, and thus the de-repression of the frmRAB promoter.   
Therefore, In vivo and in vitro experimental evidence show that the FrmR specifically reacts 
with the toxic chemical formaldehyde, resulting in the formation of inter-molecular 
methylene bridges between adjacent N-terminal Pro2 and Cys35 residues.  The conservation 
of His60 and its proximity to Cys35´ in the adjacent subunit suggests that it could act to 
abstract a proton from the thiol group to facilitate reaction with formaldehyde forming an S-
hydroxymethyl adduct, which is then subject to nucleophilic attack by Pro2 (secondary 
amine) to produce the methylene bridge (Table 5.2, Figure 5.11).  FrmR is the first example 
of a CsoR/RcnR family protein where the asymmetry of the tetramer in the crystal structure 
reveals the conformational changes induced by signal perception that lead to de-repression 
of target promoters.  As formaldehyde-induced methylene bridge formation expands the 
A´/B´ surface of FrmR resulting in a similar change in size to that observed for G. 
thermodenitrificans CsoR upon Cu(I) binding (Chang et al., 2014), suggesting that the signal 
transduction mechanism that controls binding to and release from DNA may be conserved 
throughout the CsoR/RcnR family.  
Future work could focus on the role of the second Cys residue (Cys70), which is not conserved 
in SeFrmR.  The Cys70 forms a disulfide bond linking loops 2 of the A/B´ and the B/A´ chains.  
The effect of the disulfide bond on sensing formaldehyde has not be assessed here.  
However, there is potential for FrmR to act as a redox sensor, through the formation of a 
disulfide bond, which is of interest because glutathione-depletion and oxidative stress is 
associated with exposure to formaldehyde in higher organisms (Levovich et al., 2008; Yano 
et al., 2009; Zhang et al., 2013).  Further work to determine the possible role of glutathione 
(S-hydroxymethylglutathione is formed in E. coli exposed to formaldehyde) to better 
understand the role of oxidative stress in regulating FrmR activity in vivo could be 
undertaken, as well as determining the structure of the Pfrm-FrmR complex.  
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Figure 5.11. Schematic of the species of E. coli FrmR formed by oxidation and reaction with 
formaldehyde detected by LC-MS  
Subunits of the FrmR tetramers are represented by upper case letters (A and B on one 
surface and A’ and B’ on the other).  Disulfide bonds (red lines) and methylene bridges (grey 
lines) are shown linking FrmR subunits.  The associated mass changes are shown in bold font 
and are those detected by LC-MS.   
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6. Regulation of TMAO respiration in Escherichia coli MG1655 in the presence of electron 
acceptors with higher redox potentials 
6.1. Introduction  
Escherichia coli can use several compounds as exogenous electron acceptors, including 
oxygen, nitrate, nitrite, DMSO, TMAO and fumarate (Gennis and Stewart, 1996; Unden and 
Bongaerts, 1997).  Respiration in E. coli is a complex process, thus, to allow biosynthesis of 
the appropriate respiratory system, expression of the corresponding operons is controlled 
according to presence of environmental electron acceptors (Unden et al., 1994).  The 
prevailing regulatory rule, whereby pathways with high ATP or growth yields are favoured, 
leads to the induction of the most energy-efficient respiratory system.  Oxygen is the 
preferred electron acceptor and represses the terminal reductases of anaerobic respiration 
(Gennis and Stewart, 1996; Unden and Bongaerts, 1997).  In anaerobic respiration, nitrate 
represses other terminal reductases, such as DMSO-, TMAO- and fumarate reductases 
(Unden and Bongaerts, 1997).  Energy conservation is maximal with oxygen and lowest with 
fumarate.  The main regulators involved in the anaerobic response are the two-component 
regulatory system ArcBA and the transcription factor FNR (Lin and Iuchi, 1991; Unden et al., 
1994).  FNR directly senses the absence of oxygen (Khoroshilova et al., 1997) and is the 
master activator of the nitrate-, nitrite-, DMSO- and fumarate reductases (Constantinidou et 
al., 2006).  Whereas, ArcB monitors the redox state of the quinone pool (Georgellis et al., 
2001).  The TorCA respiratory system permits the reduction of TMAO, but neither regulated 
by FNR nor by ArcBA as the other anaerobic respiratory systems are (Pascal et al., 1984; 
Simon et al., 1994). 
Unlike other alternative electron acceptors that are reduced by E. coli, previous work has 
demonstrated that both the expression of torCAD and TMAO respiration occurred in the 
presence of the preferred electron acceptor, oxygen (Ansaldi et al., 2007).  Cells grown 
aerobically on rich medium (LB broth) in the presence of glycerol and TMAO had a higher 
growth yield than cells grown in glycerol without TMAO (Ansaldi et al., 2007). It was 
proposed that an advantage of TMAO reduction during aerobiosis is the production of 
alkaline TMA, which could enhance growth by increasing the pH of the culture.  This is 
important in E. coli, as acetate is synthesised as a by-product of metabolism.  
However, TMAO respiration has been shown to be repressed ~two-fold in the presence of 
nitrate, the preferred anaerobic electron acceptor (Takagi et al., 1981), with this repression 
not occurring in a narL mutant (Iuchi and Lin, 1987).  A more recent microarray analysis 
suggested that torCAD transcript levels are decreased in the presence of nitrate 
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(Constantinidou et al., 2006).  Nitrate-repression of torCAD would be consistent with the 
current dogma that the most energetically efficient mode is adopted because the redox 
potential of the NO3-/NO2- pair is +420 mV compared to +130 mV for the TMAO/TMA pair 
(Simon et al., 1994).  However, the mechanism of nitrate-mediated regulation of torCAD is 
unknown.  The E. coli two-component system NarXL is the key regulatory system involved in 
nitrate-sensing.  NarX acts as a sensory kinase whilst NarL, a 23.9 kDa protein, is a response 
regulator capable of transcriptional repression or activation of target genes (Williams and 
Stewart, 1997).  
In this chapter, TMAO respiration by E. coli K-12 in the presence of the preferred electron 
acceptor (oxygen) is investigated.  The mechanism of nitrate-mediated regulation of torCAD 
and whether this regulation is direct, are also explored in relation to the prevailing regulatory 
rule.   
6.2. TMAO is not reduced to TMA by aerobic batch cultures of E. coli MG1655 grown in 
defined minimal medium with glucose or glycerol as the sole carbon source  
The energy yield of aerobic respiration is far greater than that of anaerobic respiration using 
any of the alternative electron acceptors (Section 6.1).  The advantage for the cell to reduce 
TMAO in the presence of oxygen is not clear, even though TMAO reduction by wild type E. 
coli K-12 in aerobic conditions has previously been reported (Ansaldi et al., 2007).  Similar 
growth experiments to those reported by Ansaldi et al. (2007) were carried out, but using 
glucose and glycerol as carbon sources in minimal medium (Section 2.3.2).  Glucose can be 
respired aerobically and is fermentable in the absence of an electron acceptor (Unden and 
Bongaerts, 1997).  Even under fully aerobic conditions E. coli excretes acetate when glucose 
is provided in excess, probably due to an imbalance in glucose uptake and the capacity of the 
Krebs cycle to futher metabolize acetylCoA (Farmer and Liao, 1997).  However, metabolism 
of glycerol by E. coli requires the presence of external electron acceptors and thus is a non-
fermentable carbon source (Lin, 1976; Quastel and Stephenson, 1925; Quastel et al., 1925).  
Escherichia coli MG1655 cultures were grown aerobically in buffered Evans minimal medium 
with either glucose (10 mM) or glycerol (20 mM) as the carbon source.  The electron acceptor 
TMAO (40 mM) was added to cultures where indicated.  Growth on both carbon sources was 
followed over 8 h and the pH of the medium was measured (Figure 6.1).   
For glucose-grown cultures, the final cell density was slightly lower (~two-fold) in the 
absence of TMAO.  In contrast, the presence of TMAO did not increase the growth yield when  
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Figure 6.1. Growth curves of E. coli MG1655 cultures and their pH under aerobic conditions 
in the presence of the alternative electron acceptor TMAO, with either glucose or glycerol 
as the electron donor  
Aerobic growth curves of E. coli MG1655 cultures in Evans minimal medium, with either 10 
mM glucose (a and b) or 20 mM glycerol (c and d) as the electron donor, thus providing the 
cells with equivalent amounts of carbon.  The cells were grown either with (closed symbols) 
or without 40 mM TMAO (open symbols), as indicated.  Samples were removed every hour 
for 8 hours, with OD600 (squares (a and c)) and pH readings (triangles (b and d)) being 
recorded.  Average values are shown for 3 biological replicates and errors are standard 
deviations from the mean.   
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glycerol was supplied as the carbon source.  However, pH of the cultures was maintained 
closer to neutrality for 8 h when TMAO was present in both glucose and glycerol cultures, 
when compared to aerobic growth on both carbon sources in the absence of TMAO (Figure 
6.1).  In contast to the observations of Ansaldi et al. (2007) with aerobic cultures grown in 
glycerol (67 mM) and TMAO (10 mM) supplemented LB broth, NMR measurements for both 
the glucose (10 mM) and glycerol (20 mM) cultures analysed here revealed that very little 
TMAO (40 mM) reduction occurred (Figure 6.2a).  Peak-integration indicated that only 0.21 
and 0.23 mM TMA was produced from TMAO after 8 h growth of aerobic growth on glucose 
and glycerol, respectively.  The quantity of TMA produced in oxygenated cultures under 
these experimental conditions was far lower than had previously reported (3.6 mM over 6 
h) (Ansaldi, et al. 2007) (Figure 6.2b).  Thus, under these conditions, the maintenance of the 
pH of cultures grown in the presence of TMAO is not due to the production of alkaline TMA.   
At time zero both glucose and glycerol cultures contained ~0.37 mM acetate, presumably 
originating from the inocula (1 % (v/v) of an overnight aerobic culture grown in buffered 
Evans media).  In the absence of TMAO after 8 hours, the glucose-grown cultures contained 
~3.5 ± 0.39 mM acetate, whereas the glycerol cultures produced less acetate ~0.75 ± 0.57 
mM (for one of the replicate cultures acetate was estimated to be ~0.1 mM, whereas the 
other two cultures contained ~1.1 mM).   This showed that some of the carbon source was 
incompletely oxidized and acetate could contribute to lowering the pH of the cultures (Figure 
6.1).  In the presence of TMAO, rather than producing acetate the glucose grown cultures 
essentially maintained the original concentrations (0.28 ± 0.18 mM), whereas the glycerol-
grown cultures utilised acetate (~0.1 ± 0.12 mM).  Although preliminary, this data suggests 
that under aerobic conditions in a defined minimal medium, the presence of TMAO promotes 
the utilisation of acetate in cultures containing glucose or glycerol.  Nevertheless, it is clear 
that regulation of TMAO respiration by E. coli under aerobic conditions is likely to be more 
complex than previously thought and the growth promoting effects of aerobic TMAO 
reduction observed for the glucose-grown cultures reported here (Figure 6.1) are likely to be 
a result of maintaining the culture pH closer to neutral (in part by TMA) and by promoting 
the utilisation of acetate and/or the inhibition of acetate production.        
6.3. Regulation of the TMAO reductase-encoding torCAD operon by the nitrate response 
regulator NarL 
In order to investigate the mechanism of nitrate-mediated regulation of tor, the nitrate 
response regulator protein NarL was overproduced, purified and used in combination with 
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Figure 6.2.  Reduction of TMAO under aerobic conditions by E. coli MG1655 is lower than 
previously reported 
a. Comparison of spectra of cultures grown on glycerol (20 mM) or glucose (10 mM) 
and TMAO (40 mM) at 0 hours (black) and 8 hours (red). Peak identities are are 
shown where known. Chemical shift is given in ppm, whilst the y-axes are identically 
scaled but show percentage peak positions relative to the 0 hour TMAO peak. Due 
to peaks shifting caused by pH changes during culture the 8 hour curve has been 
shifted to allow overlay. No carbon 13 decoupling was used therefore 13C satellites 
are visible. Insets show scaled up versions of the glycerol and TMA/DMA regions of 
the spectra. 
b. Previously published NMR spectra showing TMAO reduction over 6 h under aerobic 
conditions with glycerol as the carbon source (Ansaldi et al., 2007; Figure 5).   
6 h 0 h 
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torCAD promoter DNA (Ptor) in EMSA reactions, to look for an interaction between purified 
NarL protein and Ptor DNA.   
6.3.1. Overproduction, purification and phosphorylation of E. coli NarL  
NarL was overexpressed and purified using a MBP-NarL fusion protein construct.  Once 
overproduced (Section 2.10.1.2), the protein was purified using affinity chromatography with 
a prepacked and equilibrated amylose resin column.  Cell-free extracts of cultures expressing 
the protein fusion were added to the column and eluted, after a series of wash steps (Figure 
6.3a), with 10 mM maltose (Figure 6.3b) (Sections 2.10.2.2 and 2.10.3.2).  MBP-NarL protein 
was purified and exhibited the expected molecular weight of ~67 kDa (Figure 6.3b).  Analysis 
of the final eluent using SDS-PAGE (Section 2.10.6), suggested that purified MBP-NarL was 
the most abundant species (~80% purity).  The contaminating proteins may be proteolytically 
cleaved MBP-NarL or prematurely terminated MBP-NarL proteins.  Purified NarL was 
phosphorylated for use in EMSAs, as phosphorylation is required in order to expose the C-
terminal DNA-binding domain of the transcription factor, which is otherwise concealed by 
the N-terminal domain (Zhang et al., 2003).  When the N-terminal domain is phosphorylated, 
a conformational change occurs via a hinge-like mechanism, which enables the C-terminal 
domain to bind to DNA as a dimer and affect transcription of its target genes (Zhang et al., 
2003).  NarL was phosphorylated by incubation of the purified protein with carbamoyl 
phosphate (100 mM) (Section 2.10.5).   
6.3.2. Using EMSAs to study Ptor DNA and NarL interaction 
The Thermo Scientific LightShift Chemiluminescence EMSA kit was used for EMSA 
experiments, which uses a nonisotopic method to detect DNA-protein interactions (Section 
2.11.3).  Biotin end-labelled DNA containing the binding site of interest was incubated with 
purified protein.  This reaction was then subjected to gel electrophoresis on a native 
polyacrylamide gel and transferred to a nylon membrane.  The biotin end-labelled DNA was 
then detected using Streptavidin-Horseradish Peroxidase Conjugate and the 
chemiluminescent substrate.   
6.3.2.1. Nitrate-mediated regulation of torCAD does not directly involve NarL  
In the E. coli MG1655 genome, the divergent torC and torR promoter regions are both 
present in the 133 bp intergenic region.  Oligonucleotide primers were designed to amplify 
this region, with the forward primer annealing ~150 bp upstream of the ATG start site of the 
torC gene (Appendix 1). The reverse primer was biotin-labelled and designed to bind ~25 bp 
downstream of the torC start site (Figure 6.4) (Appendix 1).  Sequence analysis of the torCAD  
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Figure 6.3. SDS-Polyacrylamide gel electrophoresis analysis of MBP-NarL purification  
a. Polypeptide profiles of samples (10 µl): Lane 1, uninduced culture; Lane 2, induced 
culture; Lane 3, cell-free extract; Lane 4, pellet containing insoluble proteins; Lane 5, 
amylose resin loading flow through; Lane 6 – 7, column washing at start and end.   
b. Lanes 1- 4, aliquots (10 µl) of fractions of MBP-NarL eluted from the amylose resin 
with 10 mM maltose.  The positions of protein are indicated.  Markers used for both 
gels are Bio-Rad Precision Plus Protein All Blue Protein Standards. 
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CCCTCCTGAGTGAAGTAGGATTGTAATCGCGCCTGGGTAACCGGCTCATCTTCAA-199CAATAACAA 
TGTGATGTGGCATCAGAGG-178GTTTTACTCATTCTGTTCATATCTGTTCATATTCTGCCGTAAGCCG 
TTCATCCTGACCAGTGCCGCTGTTCATATTTGCTCATTAAGATCGCTTCACTAAACCATAATTCTACA
GGGGTTATTatgCGGAAA+7CTCTGGAACGCGCTACGCCG+25ACCCAGTGCTCGTTGGTCGGTACTG
GCGCTGGTCGCAATTG 
Figure 6.4. Sequence of the Ptor region in E. coli MG1655 with transcriptional features 
highlighted  
The DNA sequence of the intergenic region of torR and torC of E. coli MG1655, which contains 
the torC and torR promoter regions and where transcription of both genes occurs 
bidirectionally, is shown.  The TorR binding sites within the promoter are shown in bold text.  
The ATG start codon for torC is shown in green and the transcription start point is shown in 
red.  The -10 and -35 regions are underlined.   No definitive NarL consensus sequences were 
identified in the torCAD promoter region (consensus sequence: TACYYMT; Y, C or T residue; 
M, A or C residue (Darwin et al., 1996)).  Oligonucleotide primers (sequences shown in 
Appendix 1) were designed to bind to ~150 bp upstream of the ATG start site and ~25 bp 
downstream of the start site, the locations of primer binding are highlighted in yellow in the 
above sequence.  The downstream oligonucleotide was biotin-labelled for detection.   
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promoter region revealed that a NarL consensus binding site sequence was not present 
(Figure 6.4).  In order to determine whether NarL was able to directly regulate torCAD 
expression by binding to the intergenic region (Ptor) to prevent expression in the presence of 
nitrate/nitrite, EMSAs were carried out.   
Firstly, 20 fmol Ptor DNA was incubated with increasing concentrations (0-20,000 nM) of MBP-
NarL protein.  When incubated with poly-deoxy-inosinic-deoxy-cytidylic acid (poly [d(I-dC)]) 
(1 μg), non-specific competitor DNA to mop up non-specific interactions, ‘smearing’ was 
observed in reactions containing higher concentrations of MBP-NarL (5,000 – 20,000 nM) 
(Figure 6.5).  It was possible that the smear resulted from an increased probability of non-
specific interactions occurring, due to the presence of excess protein in the assay.  To act as 
a comparator, unphosphorylated MBP-NarL was then used in EMSA reactions.  As the DNA-
binding domain of the NarL transcription factor is not accessible when it is 
unphosphorylated, there should be no shift (Zhang et al., 2003).  The EMSA reactions 
containing unphosphorylated MBP-NarL also resulted in ‘smearing’ at high concentrations of 
MBP-NarL (5,000 – 20,000 nM) (Figure 6.6).  The lack of any clear shift in Ptor mobility with 
phosphorylated MBP-NarL compared to the unphosphorylated protein samples, suggested 
that any binding was due to non-specific interactions at high protein concentrations.  
To ensure that NarL was being fully phosphorylated, EMSAs were repeated with reactions 
containing phosphorylated MBP-NarL protein (as before) and an excess of carbamoyl 
phosphate (1 M). This did not improve binding of MBP-NarL to Ptor (Figure 6.7).   
The presence of the maltose binding protein (MBP) (43.4 kDa), which is fused to NarL for 
protein purification could prevent NarL binding to Ptor DNA by steric hindrance.  In order to 
release NarL from the MBP-NarL, the protein was incubated with 0.2 ng enterokinase 
overnight at room temperature (Section 2.10.3.2).  MBP-NarL treated with enterokinase was 
then phosphorylated for use in EMSA reactions.  Once again, a mobility shift was only 
observed at the higher concentrations of protein (5,000 – 20,000 nM) (Figure 6.8).   
Verification of the ability of the EMSA method to detect a positive shift with NarL was sought 
using ydhY promoter DNA (PydhY).  The ydhY gene is part of an operon, which is known to be 
regulated by the NarXL system and encodes an oxidoreductase. NarL binds to the ydhY 
promoter and represses transcription of the gene, when nitrate is present in the 
environment (Partridge et al., 2008).  The binding site for NarL in the ydhY promoter is 
composed of two heptamers, separated by two base-pairs (Darwin, et al., 1997). 
Oligonucleotide primers were designed to anneal ~200 bp upstream of the ATG start codon   
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Figure 6.5. Phosphorylated NarL does not bind Ptor DNA 
Biotin-labelled promoter fragment of torCAD (20 fmol) was incubated for 20 min with poly 
[d(I-dC)] (1 µg) different concentrations of phosphorylated purified NarL protein (0 – 20,000 
nM) as follows: Lane 1, no NarL; Lane 2, 10 nM NarL; Lane 3, 50 nM NarL; Lane 4, 100 nM 
NarL; Lane 5, 200 nM NarL; Lane 6, 500 nM NarL; Lane 7, 1,000 nM NarL; Lane 8, 2,000 nM 
NarL; Lane 9, 5,000 nM NarL; Lane 10, 10,000 nM NarL; Lane 11, 15,000 nM NarL; Lane 12, 
20,000 nM NarL.  The position of free biotin-labelled Ptor DNA is indicated.  In the lanes (9 - 
12) with reactions containing a high concentration of NarL (5,000 – 20,000 nM), ‘smearing’ 
was observed. 
  
[NarL ~P]    -
     - 
Free 
Ptor 
DNA 
 
1           2         3          4           5           6           7           8           9         10        11       12 
147 
 
 
 
Figure 6.6. Phosphorylation of NarL does not affect the ability of the protein to bind Ptor  
a. Biotin-labelled promoter fragment of torCAD (20 fmol) was incubated for 20 min 
with poly [d(I-dC)] (0.5 µg) different concentrations of carbamoyl phosphate-
phosphorylated purified NarL protein (0 – 20,000 nM). 
b. Biotin-labelled promoter fragment of torCAD (20 fmol) was incubated for 20 min 
with poly [d(I-dC)] (0.5 µg) different concentrations of unphosphorylated purified 
NarL protein (0 – 20,000 nM) as follows: Lane 1, no NarL; Lane 2, 10 nM NarL; Lane 
3, 50 nM NarL; Lane 4, 100 nM NarL; Lane 5, 200 nM NarL; Lane 6, 500 nM NarL; 
Lane 7, 1,000 nM NarL; Lane 8, 2,000 nM NarL; Lane 9, 5,000 nM NarL; Lane 10, 
10,000 nM NarL; Lane 11, 15,000 nM NarL; Lane 12, 20,000 nM NarL. The 
concentration of NarL in each lane is the same for both gels.  The position of free 
biotin-labelled Ptor DNA is indicated.   
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Figure 6.7. The lack of NarL phosphorylation is not a factor preventing DNA binding 
Biotin-labelled promoter fragment of torCAD (20 fmol) was incubated for 20 min with poly 
[d(I-dC)] (0.5 µg) different concentrations of carbamoyl phosphate-phosphorylated purified 
NarL protein (0 – 20,000 nM).  The reactions were also incubated with excess carbamoyl 
phosphate (1 M) to ensure NarL was fully phosphorylated before complexes were separated 
on an acrylamide (6%) gel.  Lane 1, no NarL; Lane 2, 10 nM NarL; Lane 3, 50 nM NarL; Lane 4, 
100 nM NarL; Lane 5, 200 nM NarL; Lane 6, 500 nM NarL; Lane 7, 1,000 nM NarL; Lane 8, 
2,000 nM NarL; Lane 9, 5,000 nM NarL; Lane 10, 10,000 nM NarL; Lane 11, 15,000 nM NarL; 
Lane 12, 20,000 nM NarL.  The position of free biotin-labelled Ptor DNA is indicated.   
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Figure 6.8. Removing the MBP tag from purified NarL does not permit binding at Ptor at 
physiological NarL concentrations 
a. Prior to preparing EMSA reactions, purified MBP-NarL was treated with enterokinase 
to remove the MBP tag.  Biotin-labelled promoter fragment of torCAD (20 fmol) was 
incubated for 20 min with poly [d(I-dC)] (0.5 µg) different concentrations of 
unphosphorylated purified enterokinase-treated NarL protein (0 – 20,000 nM). 
b. Prior to preparing EMSA reactions, purified MBP-NarL was treated with enterokinase 
to remove the MBP tag.  Biotin-labelled promoter fragment of torCAD (20 fmol) was 
incubated for 20 min with poly [d(I-dC)] (0.5 µg) different concentrations of 
phosphorylated purified enterokinase-treated NarL protein (0 – 20,000 nM) as 
follows: Lane 1, no NarL; Lane 2, 10 nM NarL; Lane 3, 50 nM NarL; Lane 4, 100 nM 
NarL; Lane 5, 200 nM NarL; Lane 6, 500 nM NarL; Lane 7, 1,000 nM NarL; Lane 8, 
2,000 nM NarL; Lane 9, 5,000 nM NarL; Lane 10, 10,000 nM NarL; Lane 11, 15,000 
nM NarL; Lane 12, 20,000 nM NarL. The concentration of NarL in each lane is the 
same for both gels.  The position of free biotin-labelled Ptor DNA is indicated.   
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of the E. coli MG1655 ydhY gene and the biotin-labelled reverse primer ~25 bp downstream 
of the start codon (Figure 6.9) (Appendix 1).   An EMSA, with phosphorylated MBP-NarL, Ptor 
DNA and poly [d(I-dC)] (0.5 μg) were compared to a reaction containing PydhY DNA and MBP-
NarL (200 nM) (Figure 6.10).  An interaction between PydhY DNA (200 nM) and NarL was 
observed, demonstrating that DNA binding can be successfully detected using this method.  
The reaction containing PydhY DNA produced an obvious shift compared to reactions 
containing Ptor DNA.  MBP-NarL is capable of binding ydhY DNA with ~100X greater affinity 
than to the Ptor.  Therefore, it is likely that NarL is not directly involved in repressing the 
expression of the torCAD TMAO reductase system in the presence of nitrate, as it does not 
bind to Ptor DNA with high affinity. 
6.4. Discussion  
Escherichia coli, like other is a facultative anaerobes, is able to respire using several 
alternative electron acceptors, thus, regulation of the respiratory network is highly complex.  
The prevailing regulatory rule leads to the induction of the most energetically-efficient 
respiratory system, whereby pathways with high ATP or growth yields are favoured.  Thus, 
the presence of oxygen prevents the induction of anaerobic respiratory systems.  However, 
it was previously reported that TMAO reduction is carried out in the presence of the 
preferred electron acceptor, oxygen (Ansaldi et al., 2007).   
It was shown here using growth studies that although aerobic cultures reached a higher cell 
density in the presence of TMAO,  very little reduction of TMAO to TMA was detected in the 
cultures (Figures 6.1 and 6.2).  It was previously suggested that the production of alkaline 
TMA can help mitigate some of the acidification from the production of acetate that occurs 
in aerobic conditions (Ansaldi et al., 2007).  Oxygen limitation could account for the 
differences in TMAO reduction reported here, compared to previously published work, 
where aerobic cultures reached an OD600 ~7 (Ansaldi et al., 2007).   Whereas, in the 
experiments described here, cultures reached a maximum OD600 ~2.  This difference in OD 
and thus oxygen availibity, could have resulted in the increased TMAO reduction reported 
by Ansaldi et al. (2007).   
If the expression of an anaerobic respiratory system during aerobiosis does not offer any 
further respiratory capacity, then it should provide the cell with some other form of selective 
advantage (Ansaldi et al., 2007).  The only known anaerobic respiratory system of E. coli to 
be expressed during aerobiosis is the nitrate reductase NRZ.  The narUZYWV operon is 
weakly expressed during the exponential phase as it is under the control of the alternative  
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-199GTTAAGGGCTCAGAATAATCAC-178ATTATTTTTTCTCCTAACCATAAAGGATTAGTTTATCGGCG 
TTAATCTTTTCTCATACACTATCGGGTTAGGGAAAATATCTGGTGTTGGGGACAGAGTCAGCAGCG
TATTAGTTGAATGCTTAATATCAGGCTGCTGAATTGTCAGCACTGTGTTTGCGAAGAGGATGCGAA
ATAAatgAA+3CCCGGTTGATCGTCCACTATTAG+25 
 
Figure 6.9. Sequence of the ydhY promoter region in E. coli MG1655 with transcriptional 
features highlighted  
The DNA sequence of the yhdY promoter region of E. coli MG1655 is shown.  NarL binding to 
this gene has previously been shown (Partridge et al., 2008) and thus will act as a positive 
control in the EMSA experiments.  The ATG start codon of ydhY is shown in green and the 
transcription start point is shown in red.  The -10 and -35 regions are underlined.   The NarL 
consensus binding sequence is shown in red  and underlined where base pairs match exactly 
(consensus sequence: TACYYMT; Y, C or T residue; M, A or C residue (Darwin et al., 1996)).  
Oligonucleotide primers (sequences shown in Appendix 1) were the same as those used 
previously (Partridge et al., 2008) and the locations of primer binding are highlighted in 
yellow in the above sequence.  The downstream oligonucleotide was biotin-labelled for 
detection.   
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Figure 6.10. NarL binds PydhY DNA at a physiologically relevant concentration, but does not 
bind to Ptor DNA  
Biotin-labelled promoter fragment of Ptor (20 fmol) was incubated for 20 min with poly [d(I-
dC)] (0.5 µg) different concentrations of phosphorylated purified NarL protein (0 – 20,000 
nM) as follows: Lane 1, no NarL; Lane 2, 10 nM NarL; Lane 3, 50 nM NarL; Lane 4, 100 nM 
NarL; Lane 5, 200 nM NarL; Lane 6, 500 nM NarL; Lane 7, 1,000 nM NarL; Lane 8, 2,000 nM 
NarL; Lane 9, 5,000 nM NarL; Lane 10, 10,000 nM NarL; Lane 11, 15,000 nM NarL; Lane 12, 
20,000 nM NarL. The position of free biotin-labelled DNA is indicated.  Lane 13 contains 
Biotin-labelled promoter fragment of ydhY (20 fmol), incubated for 20 min with poly [d(I-dC)] 
(0.5 µg) and phosphorylated purified NarL protein (200 nM).  The position of bound ydhY-
NarL on the membrane is indicated. 
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sigma factor RpoS (Chang et al., 1999; Clegg et al., 2006).  It has been suggested that the E. 
coli NRZ could play an advantageous role during nutrient starvation (Clegg et al., 2006).  
Although reduction of TMAO was not observed in the experiments reported here, the pH of 
the cultures grown in the presence of TMAO under aerobic conditions was maintained closer 
to neutrality for longer, conferring a fitness advantage on cultures growing in the presence 
of both TMAO and the preferred electron acceptor, oxygen.  The maintenance of culture pH 
could be due to the production of a small amount of alkaline TMA (in part) and also the 
utilisation of acetate and/or the inhibition of acetate production.  However, how TMAO 
lowers acetate levels is still unclear.   
TMAO reduction is apparently repressed in the presence of nitrate (the preferred anaerobic 
electron acceptor), with repression of torCAD not occurring in a narL mutant (Iuchi and Lin, 
1987). Another study also showed that TMAO respiration was repressed in the presence of 
nitrate (Takagi et al., 1981).  A more recent analysis of gene expression showed that torCAD 
transcript levels were decreased in the presence of nitrate (Constantinidou et al., 2006).  
However, earlier studies suggested that contradictory to prevailing rule, in which respiration 
in bacteria is hierarchically regulated by the most energy efficient electron acceptor, the 
presence of nitrate did not inhibit TMAO respiration (Pascal et al., 1984).  As the torCAD 
promoter appears to lack putative NarL binding sites, there is much uncertainty surrounding 
the subject of NarL repression of the TorCA system (Simon et al., 1994) (Figure 6.4).   
NarL is unlikely to directly regulate TMAO reductase expression, as suggested by the 
experiments detailed here.  However, it may involved in the indirect regulation of TMAO 
reduction.  One hypothesis could be that nitrate is detected by the NarXL two-component 
system, with activated NarL then inducing the expression of an transcription factor (unknown 
thus far), which plays a role in the expression of the TorCA system.  Thus, by activating 
expression of a regulator protein an essential cofactor required for activity of the regulator, 
NarL may act as an indirect regulator of TMAO reduction by E. coli (Figure 6.11). 
Another route of indirect regulation may be that when nitrate is present, NarL requires the 
presence of TorR in order to regulate transcription.  TorR activates the expression of torCAD 
when TMAO is present.  In the presence of TMAO, TorR binds to the torCAD promoter and 
triggers TorCA synthesis.  If nitrate is available in the environment, NarL may bind to TorR, 
leading to a conformational change in TorR, which could then result in the repression of 
TMAO reduction by the TorCA system (Figure 6.12).TorR protein was not present in the  
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Figure 6.11. A model showing the indirect NarL-mediated regulation of torCAD by an 
unknown transcription factor  
This shows a potential model of indirect NarL-mediated regulation of the torCAD operon.  
NarX detects nitrate in the environment and activates NarL.  NarL is then either able to 
activate expression of a transcription factor of uknown identity (“?TF”), which can repress 
torCAD gene expression.  Alternatively, NarL activates the expression of a cofactor which is 
required by the unknown transcription factor, which can then go on to repress the expression 
of the torCAD operon.  Gene colour indicates operon membership.  
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Figure 6.12. A model showing the indirect NarL-mediated regulation of torCAD which 
requires the presence of TorR for repression in the presence of nitrate 
A summary of hypothesis that indirect regulation of the torCAD operon occurs, whereby TorR 
is required for NarL binding.  
a. When TMAO is present and nitrate is absent, TorR binds to the torCAD promoter and 
activates the expression of the torCAD operon, resulting in TMAO reduction.   
b. When both TMAO and nitrate are present in the environment, nitrate is detected in 
the environment by NarX, this eventually results in the phosphorylation of NarL.  
Phosphorylated NarL may be able to bind to TorR, whether bound to Ptor or not, 
causing a conformational change in TorR which may prevent TorR-mediated 
activation of the torCAD operon, meaning TMAO respiration is repressed.  Gene 
colour indicates operon membership.  
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binding reactions described here, so binding through this mechanism would not have been 
detected.  Identification of any unknown protein involved in the theoretical NarL-mediated 
indirect regulatory system could be the basis of further research.  It is important to 
determine whether NarL is capable of interacting with TorR and if this process alters the 
conformation of TorR, which could indirectly affect torCAD expression.  The role of the NarP 
protein on torCAD expression also needs to be studied.  NarQ is a sensory kinase which 
detects nitrate in the environment and phosphorylates NarP to regulate NarP-regulated 
operons (Stewart, 1994; Wang et al., 1999).  NarP is homologous to NarL in respect to its role 
as a nitrate-responsive transcriptional regulator.  The NarP regulon overlaps the NarL regulon 
because both NarL and NarP can bind to a NarP site, which is a 7-2-7 inverted repeat 
sequence where the seven conserved bases form the NarL heptamers (Darwin et al., 1997).  
It is possible that NarP may form part of a regulatory system by binding to the torCAD 
promoter and repressing its transcription, therefore EMSAs with the protein should be 
carried out.  However, there are no candidate NarP sites in the torR-torCAD intergenic region.  
This work shows that the simple hierarchical control based on substrate redox potential does 
not always apply.  
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7. Summary of findings and future directions 
7.1. Summary of key findings 
 New insights into the adaptive processes that occur when E. coli K-12 switches 
metabolic mode from fermentative growth to anaerobic growth with TMAO were 
gained. 
 A key unexpected event was the detection of DMA in continuous culture 
supernatants and formaldehyde production by cell-free extracts in response to 
TMAO, which suggests that E. coli K-12 possesses TMAO demethylase activity 
(EC4.1.2.32).   
 The concentration of formaldehyde produced by E. coli led to induction of the 
formaldehyde detoxification enzymes (FrmAB) and inhibited the growth of an 
isogenic frmRAB mutant when grown in the presence of excess TMAO.  
 Genes involved in copper Cu(I) resistance  were downregulated in response to 
TMAO, which could be accounted for by inhibition of Cu(II) reduction by TMAO 
reduction. 
 The expression of the torCAD in response to the presence of TMAO under anaerobic 
conditions is not uniformly distributed across the population of cells.  
 When an E. coli K-12 dam mutant was exposed to 10 mM TMAO, expression of 
torCAD expression across the population was more uniform, suggesting that 
methylation is involved in regulation of torCAD transcription.   
 The E. coli FrmR protein acts as a repressor by specifically binding to the Pfrm region, 
with the presence of formaldehyde causing dissociation of the Pfrm-FrmR complex 
and relieving repression. 
 FrmR specifically reacts with the formaldehyde via formation of two inter-molecular 
methylene bridges between Pro2 and Cys35 residues of adjacent subunits. 
 Cultures expressing FrmR P2A and C35A mutations exhibited enhanced sensitivity to 
formaldehyde when compared to wild type FrmR. 
 The presence of TMAO increases growth yield under aerobic conditions, as the pH of 
the culture is maintained closer to neutrality.  However, production of alkaline TMA 
is not solely responsible for this pH balancing.   
 NarL does not directly bind the Ptor region of E. coli K-12 and any nitrate-mediated 
regulation of TMAO reduction possibly occurs via an indirect route.   
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7.2. Future directions 
In the future, a number of directions could be taken to build upon the insights of the work 
described here.  It would be interesting to use other alternative electron acceptors (e.g. 
nitrate, nitrite, DMSO) in the experiments described here to characterise the different 
dynamic adaptive processes that E. coli K-12 utilises in order to respond to other electron 
acceptors.   
Work could be carried out to identify the source of the TMAO demethylase activity in E. coli 
K-12.  It would be interesting to see if there is a dedicated TMAO demethylase enzyme 
present in E. coli or whether another demethylase enzyme present in E. coli is able recognise 
and demethylate TMAO, in the presence of excess TMAO.  If there is a dedicated enzyme and 
this was isolated, characterisation of the protein could be carried out.  
Further investigation into the cell-to-cell variability of torCAD expression in response to the 
presence of TMAO could be carried out.  It would be interesting to carry out time-lapse 
microscopy with live cells, to see the initiation of torCAD expression in individual cells upon 
the addition of TMAO.  Fluorescence-activated cell sorting (FACS) could also be carried out 
to separate ‘responders to TMAO’ from ‘non-responders’ and see if non-responsders can 
eventually become responsive to TMAO over time.   
Another route would involve further characterisation of the E. coli FrmR protein.  Future 
work could focus on the role of the second Cys residue (Cys70), which is not conserved in 
SeFrmR.  Solving the structure of FrmR revealed that Cys70 forms a disulfide bond linking 
loops 2 of the A/B´ and the B/A´ chains.  The effect of this disulfide on the ability of all four 
subunits of the FrmR tetramer to undergo formaldehyde modification has not be assessed.  
Further work to determine the possible role of glutathione (S-hydroxymethylglutathione is 
formed in E. coli exposed to formaldehyde) to better understand the role of oxidative stress 
in regulating FrmR activity in vivo could be undertaken.  Solving the structure of the Pfrm-
FrmR DNA-bound complex could also reveal insights into the DNA-binding mechanism of 
FrmR.    
Future work could also look into the reasons why TMAO appears to sit outside of the 
hierarchical control of respiration in E. coli.  It would be intesting to use a transcriptional 
reporter strain for torC to see when TorCA is expressed under aerobic conditions and rule 
out whether a lack of oxygen availability could have produced the TMAO reduction results 
previously published (Ansaldi et al., 2007).  Attempting to identify the means by which NarL 
indirectly regulates TMAO reduction could also be carried out.  The role of the NarP protein 
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on torCAD expression also needs to be studied.  NarQ is a sensory kinase which detects 
nitrate in the environment and phosphorylates NarP to regulate NarP-regulated operons 
(Stewart, 1994; Wang et al., 1999).  NarP is homologous to NarL in respect to its role as a 
nitrate-responsive transcriptional regulator.  It is possible that NarP may form part of a 
regulatory system by binding to the torCAD promoter and repressing its transcription, 
therefore EMSAs with the protein should be carried out.  However, there are no candidate 
NarP sites in the torR-torCAD intergenic region.  
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9. Appendix  
Appendix 1. Oligonucleotide primers used in this study  
Primer   Sequence (5’  3’) Tm (oC) Function 
Frm knockout F CCC CCT ATA GTA TAT 
TGC ATG CAG ATG ATG 
AGG TGC GAA GTG TAG 
GCT GGA GCT GCT TC 
79.1 Forward primer for knockout of 
frmRAB operon in E. coli MG1655.  
Region in black has homology to 
the sequence immediately 
upstream of the start of the frmR 
protein coding region, red region 
is homologous to Kn-resistance 
cassette start (pKD4). 
Frm knockout R TAG GCC GGA TAA GGC 
GTT CAC GCC GCA TCC 
GGC AGT CGT GCT ATT 
ACA TAT GAA TAT CCT    
CCT TAG 
80.6 Reverse primer for knockout of 
frmRAB operon in E. coli MG1655.  
Region in black has homology to 
the sequence immediately 
downstream of the end of the 
frmB protein coding region, red 
region is homologous to Kn-
resistance cassette start (pKD4). 
Frm knockout seq 
F 
GAT TCC TTC TGC CGC 
CCG CTA TC 
60.6 Forward primer that is 
homologous to the MG1655 
chromosomal region upstream of 
frmR, to check, by sequencing, 
that the operon had been 
replaced with a Kn-resistance 
cassette from pKD4. 
Frm knockout seq 
R 
GTT TAT GGG CGA AGT 
GTA GAC CGG 
59.1 Reverse primer that is 
homologous to the MG1655 
chromosomal region downstream 
of frmB, to check, by sequencing, 
that the operon had been 
replaced with a Kn-resistance 
cassette from pKD4. 
Frm In-Fusion F TCG TCT TCA AGA ATT 
CGT ATT CAA CCG CTG 
ACT G 
66.3 Forward primer for use with the 
In-Fusion Cloning Kit (Clontech) to 
clone the frmRAB operon with its 
native promoter into the EcoR1 
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restriction site of the vector 
pBR322.  The primers were 
designed to be homologous to the 
insert (black) and the overhangs of 
the cut vector (pBR322).   
Frm In-Fusion R TCA AAC ATG AGA ATT 
TTA TCA ACG CAT ATT 
CAG TTA 
62.8 Reverse primer for use with the In-
Fusion Cloning Kit (Clontech) to 
clone the frmRAB operon with its 
native promoter into the EcoR1 
restriction site of the vector 
pBR322.  The primers were 
designed to be homologous to the 
insert (black) and the overhangs of 
the cut vector (pBR322).   
Frm In-Fusion seq 
F 
CTA AGA AAC CAT TAT 
TAT CAT  
 Forward sequencing primer, which 
is homologous to a region of 
pBR322 upstream of the frmRAB 
insert. 
Frm In-Fusion seq 
R 
TGA GCG CAT TGT TAG 
ATT TC 
 Reverse sequencing primer, which 
is homologous to a region of 
pBR322 downstream of the 
frmRAB insert. 
TorC-fusion F  GAT CGC TTC ACT AAA 
CCA TAA TTC TAC AGG 
GTT ATT ATG AAG GGC 
GAG GAG CTG TTC AC 
 
84.4 Forward primer for replacing torC 
gene in MG1655 chromosomal 
DNA with gfp and Kn-resistance 
cassette from p-DOC-G, using λred 
recombineering.  Region in black 
has homology to the sequence 
immediately upstream and 
including the start of the torC 
protein coding region, red region 
is homologous to the start of the 
gfp gene on p-DOC-G. 
TorC-fusion R TGC CAG AAA ACG CCG 
ACG TGA TGC CTG AAA 
GAG ATC GTT AAA TAT 
CCT CCT TAG TTC C 
87.1 Reverse primer for replacing torC 
gene in MG1655 chromosomal 
DNA with gfp and Kn-resistance 
cassette from p-DOC-G, using λred 
recombineering.  Region in black 
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 has homology to the sequence at 
the end of the torC protein coding 
region, red region is homologous 
to the P-REV sequence p-DOC-G, 
after the Kn-resistance cassette. 
TorC-fusion seq F GTA ATC GCG CCT GGG 
TAA 
 
63.6 Forward sequencing primer, which 
is homologous to a region of 
MG1655 chromosome upstream 
of the torC gene. 
TorC-fusion seq R CCG GCA ATC ATT TTC 
GAC 
64.1 Reverse sequencing primer, which 
is homologous to a region of 
MG1655 chromosome 
downstream of the torC gene. 
Tor biotin R EMSA BIO-CGG CGT AGC GCG 
TTC CAG AG 
60.0 Biotin labelled (at 5’ end) reverse 
primer for amplifying tor 
promoter region of MG1655 
chromosome for EMSAs.  The 
primer is homologous to the 
region between 7 – 26 bp after the 
start codon of torC.   
Tor F 150bp EMSA CAA TAA CAA TGT GAT 
GTG GCA TCA GAG G 
58.5 Forward primer for amplifying tor 
promoter region of MG1655 
chromosome for EMSAs.  The 
primer is homologous to the 
region 150 bp upstream of the 
torC start codon. 
YdhY biotin R 
EMSA 
BIO-CTA ATA GTG GAC 
GAT CAA CCG GG 
57.1 Biotin labelled (at 5’ end) reverse 
primer for amplifying ydhY 
promoter region of MG1655 
chromosome for EMSAs.  The 
primer is homologous to the 
region between 3 - 25 bp after the 
start codon of ydhY.   
YdhY F 200bp  
EMSA 
GTT AAG GGC TCA GAA 
TAA TCA C 
51.1 Forward primer for amplifying 
ydhY promoter region of MG1655 
chromosome for EMSAs.  The 
primer is homologous to the 
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region 200 bp upstream of the 
ydhY start codon. 
FrmR biotin R 
BLItz 
Bio-TTT CTT CTC TTC CGG 
AGT ACT G 
58.0 Biotin labelled (at 5’ end) reverse 
primer for amplifying frmR 
promoter region of MG1655 
chromosome for BLItz 
experiments.  The primer is 
homologous to the region 
between 3 - 24 bp after the start 
codon of frmR gene.   
FrmR F BLItz GGC CTT CCC TGC CGA 
TTA G 
61.0 Forward primer for amplifying 
frmR promoter region of MG1655 
chromosome for BLItz 
experiments.  The primer is 
homologous to the region 169 bp 
upstream of the frmR gene start 
codon. 
pGS2516 P2A 
SDM F 
ATG ATG AGG TGC GAA 
ATG GCC AGT ACT CCG 
GAA GAG AAG 
73.7 Forward primer used for SDM to 
create P2A mutant of frmR on 
pGS2516.  Sequence of codon 
change is shown in red. 
pGS2516 P2A 
SDM R 
CTT CTC TTC CGG AGT ACT 
GGC CAT TTC GCA CCT 
CAT CAT 
 
73.7 Reverse primer used for SDM to 
create P2A mutant of frmR on 
pGS2516. Sequence of codon 
change is shown in red. 
pGS2516 C35A 
SDM F 
CTG TTG GAG TAT GGC 
ACG GGC TTC GGC ATC 
ACC CTC CAG 
75.0 Forward primer used for SDM to 
create C35A mutant of frmR on 
pGS2516.  Sequence of codon 
change is shown in red. 
pGS2516 C35A 
SDM R 
CTG GAG GGT GAT GCC 
GAA GCC CGT GCC ATA 
CTC CAA CAG 
75.0 Forward primer used for SDM to 
create C35A mutant of frmR on 
pGS2516.  Sequence of codon 
change is shown in red. 
pGS2516 SDM seq 
F 
CTA AGA AAC CAT TAT 
TAT CAT 
48.1 Forward primer used to sequence 
pGS2516 to check mutations were 
created in the expected codon.  
This primer sits upstream of frmR 
on the plasmid.  
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pGS2516 SDM seq 
R 
TGA GCG CAT TGT TAG 
ATT TC 
53.2 Reverse primer used to sequence 
pGS2516 to check mutations were 
created in the expected codon.  
This primer sits downstream of 
frmR on the plasmid. 
PfrmR IVT F GAA ATT CTG ATT CCT TCT 
GCC GC 
60.6 Forward primer for PCR to amplify 
PfrmR region of MG1655.  Primer is 
homologous to region 197 bp 
upstream of frmR start codon.   
PfrmR IVT R CGT TTC CCG GAT ATG 
GCT TTC AAG 
62.7 Reverse primer for PCR to amplify 
PfrmR region of MG1655.  Primer is 
homologous to region 192 bp 
downstream of frmR start codon.  
Transcription of this PCR product 
would result in a product of ~200 
bp.  
Pndh IVT F ATG CCT GAT GCG CTT 
CTT ATC A 
58.4 Forward primer for PCR to amplify 
Pndh region of MG1655.  Primer is 
homologous to region 300 bp 
upstream of ndh start codon.   
Pndh IVT R CGT AGT CAA CGT GAC 
CCC C 
61.0 Reverse primer for PCR to amplify 
Pndh region of MG1655.  Primer is 
homologous to region 7 bp 
downstream of ndh start codon.  
Transcription of this PCR product 
would result in a product of ~100 
bp.  
dam check F CAG ATG TCC AGG CCA 
AAA AC 
57.3 Forward primer used in PCR to 
verify that the wild type dam gene 
is no longer present in the 
JRG6842 strain. 
dam check R GCA AGG ATT TCA GCA 
CCA TT 
55.3 Reverse primer used in PCR to 
verify that the wild type dam gene 
is no longer present in the 
JRG6842 strain. 
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Oligonucleotide primers used in this study for RT-PCR  
Primer   Sequence (5’  3’) Tm (oC) Function 
Frm RT-PCR F CTG GAA CGG TCG CTG 
GAG 
60.5 RT-PCR; forward primer to analyse 
the expression of frm mRNA in 
response to the presence of 
environmental TMAO.  
Frm RT-PCR R ATC AGC CCA TTA GCC 
GCG 
58.2 RT-PCR; reverse primer to analyse 
the expression of frm mRNA in 
response to the presence of 
environmental TMAO 
gyrA RT-PCR F ACC TTG CGA GAG AAA 
TTA CAC 
63.1 RT-PCR; forward primer analyse 
the expression of the 
housekeeping gyrA mRNA in 
response to the presence of 
environmental TMAO  
gyrA RT-PCR F AAT GAC CGA CAT CGC 
ATA ATC 
63.5 RT-PCR; reverse primer analyse 
the expression of the 
housekeeping gyrA mRNA in 
response to the presence of 
environmental TMAO 
Tm = melting temperature  
 
